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ABSTRACT 
Cytochrome c oxidases (CcO) are terminal oxidases in the respiratory chain and contribute to a 
large fraction in the heme-copper oxidase superfamily. They are transmembrane protein complexes 
catalyzing the reduction of dioxygen to water with a variety range of electron donors. During the 
process, electrons are transferred into the enzyme while protons are up taken at the same time. Some 
of the protons participate in the transformation of dioxygen into water as substrate. The rest of the 
protons are translocated across the plasma membrane, conserving energy in the form of 
electrochemical potential.  
Different subfamilies of CcO are identified mainly based on the sequence homology. They vary 
in a wide range of aspects but also share certain conserved features:  a) A binuclear center consisted of 
CuB and a high spin heme for catalysis; b) a low spin heme and six histidines as metal ligand; c) at least 
one proton uptake pathway and d) catalytic cycle for dioxygen reduction. In this study, cbb3 type 
cytochrome c oxidase from V. cholerae and bo3 type ubiquinol oxidase from E. coli were investigated 
separately. 
Site directed mutagenesis were carried out in the case of cbb3 protein based on crystal structure 
and sequence alignment. Activity data suggested that the D pathway analogue is blocked with 
hydrophobic residues and no mutant altered enzymatic activity. Only one proton pathway exists which 
is analogous to K pathway in A type oxidases. Moreover, EIII49 from the third subunit were 
demonstrated to be most likely the entrance of K pathway. Two key residues E126 and E129 had been 
believed to be part of proton exit pathway. However, crystal structure, activity assay and metal analysis 
suggested the two residues are more than likely to be of structural importance rather than part of a 
proton pathway. A group of residues located in the proximity of heme b propionate groups were also 
studied and shown their correlation with subunits assembly and heme c incorporation.  
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Bo3 type ubiquinol oxidase enzyme activity can be inhibited by quinol analogues. To facilitate 
the study of quinone binding sites of bo3, a competitive inhibitor aurachin 1-10 was synthesized through 
a seven-step synthetic route as my preliminary work on bo3 project. 
When mixed-valence cytochrome c oxidase (R2) reacts with dioxygen, the first adduct 
intermediate (A) decays into a radical intermediate (PM). It’s a four electron reduction of O2 in which two 
electrons comes from Fe2+, another from Cu+ and the source of fourth electron is still under debate. 
Injection of the first electron from electron donor will transform this PM intermediate into another one 
called F. In this work we studied the PM of bo3 protein by a mimic reaction with hydrogen peroxide. The 
time scale for the mimic reaction is at least 1000 times slower than the O2 steady state turn over which 
allowed a successful capture in detail the formation of PM and F.  Mutant data suggested that Y288 is 
required for PM formation and Y173 is crucial for F formation. CW-EPR experiments demonstrated WT 
and Y288H generated a radical of the same origin while Y173 gave rise to a different radical species and 
Y288H+Y173F failed to generate radical of any kind.  Auxotrophic strains were made for every mutant. 
We found out that when ring deuterated tyrosine (d4-tyr) was incorporated in to bo3, all the above 
radical signal collapsed into a simpler splitting pattern, which demonstrated the radicals originates on 
tyrosines. Further analysis of the signal splitting pattern revealed that the radical is on Y173 in the case 
of WT and Y288H, while in the case of Y173F radical is likely on Y288. Together with stop flow data, we 
were able to conclude that for H2O2 reaction, radical is first produced on the cross-linked Y288 to form 
PM and then migrate to Y173, for the decay of PM into F.  
We also took advantage of the amber codon suppressor technique developed by Peter Schultz 
lab and genetically replaced Y288 and Y173 with 3-amino-tyrosine (YNH2). The midpoint potential of 
YNH2 is 90mV lower than tyrosine and thus could serve as a potential radical trap. Characterization of 
Y288YNH2 and Y173YNH2 mutants were carried out in this thesis.  
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Chapter 1 : INTRODUCTION 
1.1     Respiratory Chain in Bacteria 
Respiration is one of the most important metabolic pathways in living organisms. The 
overall process is redox chemistry between two redox couple with different electrochemical 
potentials under physiological condition. Take aerobic respiration of E. coli for example, one of 
the redox couple combinations is NAD+/NADH and O2/H2O. The reduction potential of 
NAD+/NADH couple is 1.1V lower than O2/H2O couple.  Instead of direct reaction between NADH 
and O2, the redox chemistry process is mediated by the respiratory chain in a stepwise way. 
Components of this chain include several integral proteins in the plasma membrane and a 
versatile collection of electron shuttles. Reductive substrate NADH reacts as electron donors 
with NADH dehydrogenases. Through the quinone pool inside the plasma membrane, the 
electrons are further transferred into terminal oxidases bd and bo3 where oxidative substrate O2 
gets reduced. As electrons are passed through the chain of respiration, the dehydrogenase and 
oxidases utilize the energy to translocate protons across the plasma membrane against proton 
electrochemical gradient. Eventually, energy released in the overall redox reaction between 
NADH and O2 is conserved in the form of electrochemical proton gradient across the membrane. 
This electrochemical proton gradient is used for ATP synthesis and further supports a wide 
range of biological activity including active solute transport and other energy requiring 
processes such as cell motility.  
Different organisms, especially bacteria, branch both at the dehydrogenase and 
oxidase/reductase sits and also at electron carriers, such as quinones, iron-sulfur clusters and 
cytochromes [1, 2].  This adaptation in respiratory systems allows the bacteria to meet different 
environmental conditions and physiological demands (Figure 1.1).  For instance, iron bacteria 
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take dissolved ferrous ion as electron source and obtain energy through respiration via O2. 
Sulfur-reducing bacteria take H2 as electron source to reduce SO4
2- as its respiration. 
 
Figure 1.1. The respiratory chain of bacteria is branched at both dehydrogenases and terminal 
oxidases/reductases. Electrons from various substrates are transferred from dehydrogenases to 
the quinone pool. Terminal oxidases and reductases transfer electrons from the quinone pool to 
different electron acceptors. 
E. coli has two terminal oxidases, namely cytochrome bo3 and cytochrome bd.  Bd has a higher 
affinity for oxygen and is predominant under microaerobic conditions when there is low oxygen 
tension while bo3 is utilized by the organism in aerobic conditions when oxygen availability is not 
a limit. Electrons from the quinone pool are directly transferred to either bo3 or bd. On the other 
hand, V. cholera, a similar bacterium belonging to the same γ proteobactria clade as E. coli, has 
four terminal oxidases, namely cytochrome cbb3 and three cytochrome bd oxidases. Bd could be 
utilized only under microaerobic conditions while cbb3 could be used from microaerobic to 
aerobic conditions. Electrons from the quinone pool are not directly transferred to cbb3 but 
another complex namely bc1 instead. Electron transfer between bc1 and cbb3 is achieved by a 
small soluble protein, namely cytochrome c4 [3] (Figure 1.2).  
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Figure 1.2. The respiratory chain of E. coli and V. cholerae is different regardless the two 
organisms are close with each other in natural habitat, structure and genome.   
         
1.2     Bioenergetics of Respiratory Chain 
As mentioned above, the function of any respiratory electron transport chain is to use 
the energy released from exergonic redox reactions to generate the electrochemical proton 
gradient across the membrane, providing energy for various biological activities. The Gibbs free 
energy change (  ) from any redox reaction depends on the redox potential difference (   ) 
between the electron donor and accepter redox couple involved and is given by 
              Eq.  1.1 
where   is the number of electrons transferred and   is the Faraday constant. The redox 
potential (    ) at pH 7 of each redox couple involved is related to its standard (midpoint) redox 
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potential (  
 ) as well as the ratio between substrate in its oxidized form and reduced form. 
Therefore, the redox potential can be determined from the following Nernst equation: 
                                                          
      
  
  
      (
[        ]
[       ]
)                                          Eq. 1.2 
Where   is the gas constant and   is the temperature in Kelvin. However, as for the actual 
electrochemical process in the cell, pH effect should also be taken into account. 
The free energy release in Eq 1.1 is then used to translocate protons across the 
membrane. In order to move proton across the membrane, work must done against both  the 
uphill proton gradient from cytoplasmic side to periplasmic side and the proton electrical 
potential difference between the aqueous phases separated by the membrane (the ‘membrane 
potential’ ΔΨ).  Therefore, the Gibbs energy needed for this work is a linear combination of the 
two aspects: 
                                                      (
[  ]            
[  ]           
)                            
Eq.1.3 
Normalized by morality, Eq 1.3 is presented as: 
           ̃                       Eq. 1.4 
Where    is the protonmotive force in millivolts and     is defined as the pH in the periplasmic 
phase minus that in the cytoplasmic phase. Using    and substituting values for R and T at room 
temperature,    can be represented as: 
                                                                 (  )                                                              Eq. 1.5 
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Protonmotive force is defined by Mitchell to facilitate comparison with redox potential 
difference in the respiratory chain complexes, emphasizing that we are dealing with a potential 
driving a proton circuit through the membrane. The circuit is generated by respiratory 
complexes and flow back via ATP synthesis or net leakage given rise by inherent proton 
permeability of plasma membranes.  Up to 80% of the free energy could be converted into 
protonmotive force. In the case of NAD+/NADH and O2/H2O combination,    is around 200mV 
or 19kjmol-1.  
Not all the respiratory enzymes participate in the generation of proton motive force. For 
example, the reactions catalyzed by NADH dehydrogenase II (NDH-II) and cytochrome bd-II 
oxidase do not result in the translocation of protons across the cytoplasmic membrane as shown 
in Figure 1.2. [4, 5]. It is also possible that enzymes have different efficiencies in their 
contribution to the proton motive force. For example, cytochrome bo3 moves two protons from 
the cytoplasm to the periplasm per electron transfer (2 H+/e–), while cytochrome cbb3 and bd 
carries out the same redox reaction with half the energetic efficiency of cytochrome bo3 [6, 7]. 
1.3     Heme-Copper Oxidase Superfamily 
The oxygen reductases we have mentioned so far differ from each other in many ways 
like use of substrates, oxygen affinity, prosthetic groups and metal composition. Despite all 
these differences, most of them are closely related members of a single superfamily namely 
heme-copper oxidase superfamily. ALL HCOs feature a binuclear center, high and low spin 
hemes, six conserved histidines as metal ligands in the catalytic subunit and they share high 
sequence similarity within the catalytic subunit I. HCOs can be generally classified into two large 
groups of enzymes: heme-copper oxygen reductases and heme-iron nitric oxide reductases 
(NOR) [8]. Oxygen reductases, which utilize O2 as oxidative substrate and reduce it to H2O, 
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mostly have one to two proton input pathways at one side of the membrane and translocate 
protons to the other side. By comparison, NORs, which utilize NO as oxidative substrate and 
reduce it to N2O, have one proton input pathway but are not able to translocate protons across 
the membrane. In addition, oxygen reductases has a copper in the binuclear center while NORs 
have an iron instead and they are usually found in nitrate and nitrite denitrification bacteria, 
archaea and in some bacteria for detoxification of NO[9].  Moreover, The NORs are also missing 
an important tyrosine residue that is post-translationally crosslinked to a histidine ligand to the 
binuclear center Cu ion in the O2 reductases [10]. 
Heme-copper nitric oxide reductases and oxygen reductases can be further classified 
into different subfamilies respectively. Based on sequence homology of subunit I, the latter falls 
into three major groups, namely A, B and C family (type). A type oxidases are present in all three 
domains of life and account for 72% of the HCO oxygen reductases. C type oxidases are present 
only in bacteria but comprise 24% of the total population, while B type oxidases, which are 
present in both bacteria and archaea only account for 3 % of the population.  So far, crystal 
structures are available for at least one representative from each subfamily to allow structural, 
functional and mechanistic studies. Among them, the A type oxidases are most well investigated 
and most of the theories involving structure-function correlation have been established from 
studies within this subfamily. aa3 type oxidases are typical representatives of this subfamily and 
have different subunit compositions from mitochondria to bacteria. aa3 oxidases from bacteria 
like P. denitrificans, R. sphaeroides have only four subunits instead of 13, like in mitochondria, 
making  it easier to express and study bacterial HCOs than HCOs from eukaryotes. 
The whole complex of aa3 from P. denitrificans or R. sphaeroides includes four subunits I, 
II, III and IV, with molecular masses 60kDa, 27kDa, 30kDa and 5kDa respectively.  All the four 
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subunits consist of transmembrane alpha helices with only subunit II having a C-terminal 
hydrophilic soluble globular domain at the periplasmic side of the membrane. Redox cofactors 
are found in subunit II and catalytic subunit I but not in the other subunits (Figure 1.3).
  
Figure 1.3. Left: Subunits composition and topology of aa3 from P. denitrificans and Right: redox 
cofactors of the whole enzyme are only found in the first two subunits. 
Most structural and functional studies so far have been intensively focused on subunit II 
and especially catalytic subunit I  since they are the sites of catalysis and substrate transport. 
Subunit II has only one redox active cofactor in its globular domain almost on the border with 
subunit I called CuA, which is a two copper atoms site. The two transmembrane helices are also 
interacting tightly with helix III IV V from subuint I. Subunit I has 12 transmembrane helices 
without any large extra membrane domain. They are arranged in a counterclockwise direction 
and form three semicircular arcs with a quasi-threefold axis of symmetry. Three pores A, B and C 
are formed in the center of the arcs. Pore B holds the binuclear center comprising a heme 
(heme a3) and one copper atom (CuB). Pore B is also home to the proton input pathway K, 
leading from the border of subunit I and II from the cytoplasmic side to the BNC. Pore C retains 
Periplasmic side
Cytoplasmic side
Sub I
Sub II
Sub III
Sub IV
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another heme (heme a) and pore A holds another proton input pathway D (Figure 1.4 ). The 
binuclear center high spin heme a3 and CuB are coordinated by one and three histidines 
respectively. The histidines are part of the six conserved histidines shared by all HCO members. 
The other two histidines coordinate heme a which is a low spin heme. 
            
Figure 1.4. Left: Topology of the 12 transmembrane helices of subunit I and relative orientation 
of redox cofactors. Right: Conserved 6 histidines in the heme-copper oxidase superfamily and 
their structural correlation with binuclear center and low spin heme in aa3.  
The heme groups present in the oxygen reductase subunit I are used to derive their 
names. For oxidase aa3, ‘a’ stands for the low spin heme a and ‘a3’ stands for the high spin heme 
a in the binuclear center where O2 binds. The two hemes found in each of these terminal 
oxidases can be of different types such as heme b, o and a. Presence of heme c and heme d are 
also possible in subunits other than the catalytic subunits like caa3 and cbb3, or oxidases not 
classified in heme-copper superfamily like bd from E. coli. Figure 1.5 describes the correlation of 
proto heme (b) and other hemes in biosynthesis. 
In addition to the three redox-active metal centers, a unique post-translationally 
generated crosslink between a conserved tyrosine residue and a histidine ligand to the CuB has 
been observed in all members of the heme-copper O2 reductases (Figure 1.6) [11-13]. 
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Different electron donors can act as substrates for different members of the heme-
copper oxygen reductases. For instance, aa3 from P. denitrificans and cbb3 from V. cholerae use 
water soluble c cytochromes as electron donor and are thus called cytochrome c oxidases while 
bo3 from E. coli uses ubiquinol Q-8 in the plasma membrane as electron donor and is thus called 
a quinol oxidase. 
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Figure 1.5. Biosynthetic pathway  from proto heme (heme b) to other type of hemes. 
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Figure 1.6. Binuclear center and the crosslink cofactor between tyrosine 280 and histidine 276 in 
P. denitrificans aa3 type cytochrome c oxidase.  
1.4     Conserved Mechanism of O2 Reduction by Heme-Copper Oxidases 
The heme-copper oxidases play important roles in bioenergetics, oxygen scavenging 
(detoxification) and signal transduction. Numerous works have shed light on the mechanism of 
cytochrome c oxidases, with aa3 cytochrome c oxidase being chosen as the preferred system.  
With the help of crystal structures of high resolution, fast kinetic studies and a variety of 
spectroscopic experiments were carried out to reveal the structure function correlation and to 
identify the intermediates of catalytic cycle and transitions between them. The following 
discussions are therefore all based on aa3 cytochrome c oxidase from R. sphaeroides.  
The reduction of oxygen into water takes place at the binuclear center and requires 
both delivery of substrates (electron, protons and oxygen) and release of product (water). All 
the substrates are transported within the protein through specific pathways. 
1.4.1     Substrates and Their Pathways 
A)         O2 
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O2 is the terminal substrate in the respiratory chain as a powerful oxidant to supply 
maximum energy through aerobic respiration. As a diatomic uncharged molecule, Dioxygen can 
freely permeate membranes and diffuse into the active site of cytochrome c oxidase. The rate of 
diffusion through the membrane and protein medium is slow and most likely not sufficient to 
maintain the normal catalytic activity of the oxidase. Therefore, the existence of certain 
structural features within the protein that can channel dioxygen rapidly into the binuclear 
center deserves a careful inspection. Analysis of X-ray structures with inert gas xenon co-
crystallized in cytochrome c oxidase corroborated this theory [14, 15]. Both experimental [16-18] 
and computational experiments [19] followed. Different numbers of hydrophobic passages, 
leading from surface of the protein in the middle of its membrane domain, were demonstrated 
for collection and maybe concentration of dioxygen towards the active site. Interestingly, even a 
single residue mutation can dramatically influence the binding of dioxygen and consequently, 
the catalytic chemistry [17, 18, 20]. 
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Figure 1.7. Pathways for the three substrate, proton, electron and O2. Numbering in the text 
refers to that in P. denitrificans.  
B)         Electrons 
Electron transfer is a complicated process modulated by a number of factors. In 
biological systems, electron transfer rate is defined by the distance between donor and acceptor 
and the specific pathway is determined by the protein medium. Two main theories are present 
to describe the pathway. One believes electron transfer must occur specifically through bonds 
and can be modulated by conformational changes herein [21] while the other one [22, 23] 
support that electron transfer is not limited to any specific designed pathway.                            
Electron transfer in the aa3 cytochrome c oxidases is believed to occur among the redox 
cofactors in a linear way (Figure 1.7)[24]. Electron is initially delivered from the periplasmic side 
into cytochrome c oxidase via reduced cytochrome c [25, 26]. Cytochrome c is a small mono 
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heme c containing soluble protein. In the respiratory chain of R. sphaeroides, it serves as an 
electron shuttle, taking electrons from complex III (bc1 complex) and donating electrons to 
complex IV (cytochrome c oxidase). Reduced cytochrome c binds to a cleft between subunit II 
and III on the periplasmic side where the surface negative charge interacts with the positive 
charge on the surface of cytochrome c.  
This electron is then transferred extremely fastto CuA [27, 28] through highly conserved 
TrpII121 [29, 30] followed by electron transfer to the low spin heme a across 19.5 Å of distance 
and finally to the binuclear center through a minimal distance between hemes of  4.7 Å (Figure 
1.7) [26, 31]. Electron transfer within the relatively less polar environment of membrane is 
facilitated by the redox active cofactors inside the protein and the unidirection of electron 
transfer is guaranteed by the transfer of electrons through a sequence of redox cofactors with 
increasing reduction potentials.                                      
C)         Protons 
For the reduction of one molecular O2 via aa3 cytochrome c oxidases, a total of 8 H
+ are 
taken from the cytoplasmic side in a single catalytic cycle.  These protons have two different 
fates. Four of them participate in the chemical reaction as real substrates to produce two H2O 
molecules with the O2. The other four are directly transferred from the cytoplasmic side to 
periplasmic side via the protein across the span of the phospholipid bilayer. This proton 
translocation results in both electrolyte (H+) and charge separation across the membrane, and 
generates proton motive force to drive a wide range of biological activities. 
As a charged species, proton transfer is more complicated and worse investigated than 
electron transfer. Unlike electron transfer, the protein medium itself cannot facilitate proton 
delivery and thus specially designed proton conductive structures or channels are adopted by 
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oxidases to fulfill the mission. It is proposed that these proton conductive structures function 
based on chains of hydrogen bonds between polar or protonable residue side chains and water 
molecules and proton transfer occurs through these structures via Grotthuss mechanism (Figure 
1.8) [32, 33].  
There are two channels for proton uptake called K and D pathways (or channels) 
identified by site-directed mutagenesis [34-37] and later confirmed by X-ray spectroscopy [14, 
15, 26, 38]. Both of them consist of water, polar/protonable residues leading from cytoplasmic 
side into the catalytic site. The nomenclature for K and D pathways is based on highly conserved 
Lys354 and Asp124 within each channel respectively.  
K pathway starts from Glu78 from subunit II [39-41] and continues through conserved 
residues Ser291, Lys354 and Thr351 towards hydroxyl group on the farnesyl side chain of heme 
a3 and ends at Tyr280 (Figure 1.7), which is cross-linked to one of the CuB ligands His276 [42-44]. 
Two to three tightly bonded water molecules can be found. One is situated between Thr351 and 
a hydroxyl group of heme a3, the other between Ser291 and Lys354. The amino acid residues 
and waters of the K pathway are connected by hydrogen bonds, with only one interruption at 
the gap between Lys354 and Thr351, where no water molecules have been found so far. It is 
proposed that this gap might be bridged by a movement of lysine residue [19]. 
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Figure 1.8. Grotthuss mechanism of proton transfer. Single proton transfers through hydrogen 
bond chains.  For a continuous, unidirection transfer of proton, donor and acceptor of protons 
must reorient in the way that donor always provides proton in every single hydrogen bond. 
D pathway starts from Asp124. Together with Thr203 and Asn199, Asp124 forms an 
opening [35, 37, 45] that leads via polar residues Asn113, Asn131, Tyr35, Ser134, Ser192 and 
Ser193 to Glu278 [23, 26, 36, 42, 46-48](Figure 1.7). Like K pathway, water molecules are also 
present along the above residue alignment and form a continuous hydrogen bond chain with 
the amino acid side chains from Asp124 to Glu278. Beyond Glu278, there is no polar/protonable 
residues or water molecules detected that could extend the hydrogen bond chain either to the 
binuclear center for water formation or to the periplasmic side for proton translocation. 
However, it is proposed that this ‘empty space’ could be occupied temporarily by three to four 
water molecules and to extend the hydrogen bond chain from Glu278 to continue proton 
delivery [49, 50].  
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For the reduction of a single O2 molecule, the four substrate protons are uptake by both 
D and K pathways with K pathway responsible for at least two out of four [51-55]. All four 
protons that are translocated through the oxidase are taken up only by D pathway [32, 52]. 
Beyond Glu278, the temporarily formed water hydrogen bond chain might conduct the ‘pumped’ 
protons to a highly hydrophilic domain above the hemes via the carboxylic group of D-
propionate of heme a3. This domain contains an extended hydrogen bond network of charged 
and polar residues and thus believed to be a good candidate for the exit pathway of ‘pumped’ 
protons [15, 26, 42].  
1.4.2     Catalytic Cycle 
Reduction of O2 into H2O via the catalysis of cytochrome c oxidase is a rapid and 
complicated procedure. Development of fast optical absorbance spectra enabled monitoring of 
the change in heme groups at single wavelength or even the whole spectral range and thus 
revealed step wised transitions between different intermediates. Resonance Raman spectra 
study were further carried out to track the transition of O2 substrate and nature of the bonding 
between oxygen and binuclear center [48, 56-58].  Detailed analysis of membrane potential 
generation combined with parallel kinetic optical measurements allowed the assignment of 
proton translocation stoichiometry between intermediates transition [59-62]. Electron transfer 
coupled with intermediate transitions was characterized by electron backflow reactions where 
equilibrations of electrons among redox cofactors could be studied [63]. The entire catalytic 
procedure in steady state turn over can be summarized as a cycle with 6 optically 
distinguishable intermediates as shown in Figure 1.9. The following intermediates are 
introduced in the clockwise way for a single round of steady state turnover starting off with the 
reduced state. 
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Figure 1.9. [64]Catalytic cycle of aa3 cytochrome c oxidase in steady state turn over. CuB, high 
spin heme a3 and cross-linked tyrosine 280 are shown for each intermediate. Every single 
translocated H+ is indicated in red arrow, substrate H+ and e- are shown in bold black letter. 
.
O-
tyr stands for neutral radical from of the cross-linked tyrosine 280 while -O-tyr stands for its 
anionic tyrosinate form. 
1).Reduced State - R2 
In the reduced state R, 2 to 4 electrons can be present on the four redox centers and R2 
specifically stands for the case where only CuB and heme a3 are reduced while both CuA and 
heme a stay oxidized.  R2 (mixed-valence) most likely represent the reduced state in the fast 
steady state turn over since it’s more realistic to have the redox center only partially reduced in 
a rapid turnover instead of having them all reduced. In this state, the reduced ferrous high spin 
heme a3 is ready to bind substrate O2. There are extra two electrons at the binuclear center(Fe
2+, 
Cu+) compared with the stable oxidized form of enzyme (Fe3+, Cu2+) and thus lower the midpoint 
2 
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redox potential. This energetically unfavorable state is in turn favorable for proton uptake 
driven by charge compensation [65-67].  
2). Adduct Intermediate – A 
Enzyme in the R2 state can rapidly react with O2, forming a spectroscopically detectable 
adduct, an intermediate called compound A. It features a peak at 591nm and a trough at 611 
nm compared with oxidized form. At room temperature, the time scale for the rapid formation 
of compound A is 8μs at 1mM oxygen concentration [68, 69]. As in oxyhemoglobin, triplet O2 in 
the axial coordination position induces a dipole on     
  . This ends up with     
   turning into low 
spin with     
   like feature and O2 with   
   (superoxide) like feature. The two unpaired 
electrons from     
   and   
  couple antiferromagnetically, giving rise to diamagnetic properties. 
The Raman spectrum of compound A has a characteristic stretching mode at 568 cm-1 which is 
assigned to     
  -O=O (heme a3 ferrous iron and O2 head on). Similar stretching mode is also 
seen in oxyhemoglobin and oxymyoglobin [56, 57]. 
3).Peroxy Intermediate, PM 
Compound A is unstable and decays with time constant ~ 150 μs into so-called peroxy 
(PM) intermediate with a characteristic peak at 570nM and 607nM compared with oxidized from 
[70-72]. Subscript M in P indicates that this intermediate is originated from mixed-valence 
reduced enzyme R2. This compound was named ‘peroxy’ since it was thought to have a     
  -O-
O bond. Later on kinetic resonance Raman [58] and isotope-ratio mass-spectrometry [73] clearly 
demonstrated that the O-O bond is broken and heme a3 forms an oxo-ferryl  bond with one of 
the O atoms as     
  =O with the other O bound to CuB as    
  -OH. Formation of PM is a fast 
electron rearrangement process where both of the oxygen atoms in the substrate O2 get fully 
reduced from valence of 0 to valence of -2 and results in O-O bond cleavage. In order to get O2 
20 
 
fully reduced, four electrons are drawn from the active site simultaneously.     
   undergoes two 
electron oxidation to form     
   and forms a double bond with one oxygen as     
  =O. 
   
 undergoes one electron oxidation to form a single bond with the other oxygen as    
  -OH. 
The fourth electron is so far believed to be contributed by the crosslinked Tyr280. In addition, 
   
  -OH formation requires one proton which is also believed to provided by Tyr280 since no 
external proton uptake is observed with transmembrane electrochemical potential 
measurement experiments [61, 74]. Therefore, the Tyr280 is transformed into a neutral radical 
theoretically to provide both the fourth electron and proton for O-O cleavage.   
It should be noted that there is another P intermediate called PR which is 
spectroscopically similar to PM in the way that heme a3 and CuB share the same chemical bond 
with oxygen. On the other hand, a significant fraction of low spin heme a also becomes oxidized 
while CuA stays reduced [75] and this give rise to a little difference in UV-Vis spectra. PR is 
generated when fully reduced oxidase relaxes from compound A with a time scale of around 30-
40 μs [68, 69]. Since heme a donates electron already in the formation of PR, Tyr280 only 
provides a proton and becomes a tyrosinate instead of a neutral radical. Like PM, no external 
proton uptake is observed in PR formation. 
4). Ferryl-oxo Intermediate F 
    
  =O in the PM significantly raises the midpoint potential for heme a3 and as a result, 
the active site initiates four single electron reduction steps through intermediates. F is the first 
one in the series which comes right after PM. Specifically, PM undergoes transition with τ~120 μs 
into F when one electron is drawn into the active site of PM [76] to reduce Tyr280 radical into 
tyrosinate, coupled with uptake of two external protons via D pathway. One of the protons is 
translocated across the membrane as indicated and interpreted by charge separation from 
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electrometric experiments [77, 78]. However, no proton release is observed and the other one is 
used as substrate proton. This substrate proton could be either used for protonation of Tyr280 
or hydroxyl group at CuB. Intermediate F can be easily distinguished from PM spectroscopically 
with the characteristic peak at 580nm compared with the oxidized form.  
The PR intermediate discussed above is also capable of transition into F with τ~60 μs. 
Instead of input of protons and electrons at the same time, only protons uptake is observed in 
this case. However, proton uptake is coupled with electron re-equilibration between CuA and 
heme a [68], where ~ 60% of CuA are oxidized [27]. Similarly, no proton release is detected and 
proton translocation is merely interpreted with the electrometric data.   
5). Oxidized State (high-energy), OH 
With one proton uptake in the F state, the redox potential of     
  drops , but still it is 
high enough to draw a second electron into the active site and reduce     
  =O into     
  -O- at a 
slower rate with τ~1.5 ms [27, 68, 79]. At the same time, two protons are uptake via D pathway 
like in the P  F transition [52].  One is the translocated proton and the other is more than likely 
to form a hydroxyl with O bound to heme a3 (    
  -OH). The subscript H indicates that the state 
is a ‘high-energy’ state implying that the energy conserved in this intermediate [77] will be used 
during further transitions of the cycle for proton pumping [54, 80]. OH is not stable and can relax 
into the low-energy O state (the state in which the enzyme is purified, the so-called resting 
enzyme, incapable of translocating protons upon reduction) possibly by a protonation of a 
hydroxyl to water, or tyrosinate to tyrosine. 
6). One-electron reduced intermediate, EH 
Laser activated single electron injection study indicates that the conserved energy 
stored in OH from redox chemistry is further used to reduce    
  to    
  on a time scale of ~1ms 
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with uptake of one chemical proton to the binuclear center [80]. Theoretically, the proton is 
used to neutralize the Tyr280 tyrosinate and the H2O ligand on    
  is released as product. 
Moreover, the last theoretical transition from EH to R2 would close the catalytic cycle and gets 
the oxidase ready for the next round of catalysis. The last transition should be responsible for 
uptake of the last electron and substrate/ ‘pumped’ proton as well while release the second H2O 
as substrate. 
Artificial single-electron-reduced state could also be obtained by reacting CO (2-electron 
reductant) with the peroxide-generated F state. Photoreduction of this E state results in a 
transmembrane charge separation similar to that in F to O transition. This discovery supports 
the theoretical proton pumping in EH to R2 and also leaves the stoichiometry of pumped proton 
in OH to EH highly likely to be 1. 
The catalytic cycle summarized above can be divided into two phases. The transition 
from R2 state to OH state is called oxidative phase while the transition from OH to R2 is called 
reductive phase.        
7). Summary 
The catalytic cycle summarized above can be divided into two phases. The transition 
from R2 state to OH state is called oxidative phase while the transition from OH to R2 is called 
reductive phase.        
1.4.3     Proton Translocation Mechanism 
In the catalytic cycle proton translocation (pumping) stoichiometry is discussed from PM 
to R2 while the detailed mechanism is left unresolved. The model of mechanism presented 
below (Figure 1.9) best describes what researchers know about this complicated bioenergetics 
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issue thus far. The model is mainly based on the experimental data available for the transition 
from OH to the artificial E state in laser activated single electron injection. The model is also 
highly likely applied to the other transitions where the proton pump is coupled. 
The mechanism model could be briefly summarized as follows. Upon injection from 
reduced cytochrome c to CuA, the electron rapidly travels into the low spin heme a across ~ 1/3 
of the membrane depth and reaches equilibrium (heme a / CuA = 7/3) with τ~10 μs. The energy 
level in electron transfer in cytochrome c  CuA  heme a is indeed raised by 0.6 kcal/mol even 
though the electron is delivered uphill the redox potential arrangement of the cofactors. 
However, these energy unfavored events are overcome by the following steps of transitions. At 
a slower time scale ( τ~120 μs ) the first proton is uptake into the active site to compensate the 
negative charged  that has been transferred  to heme a. This proton is not used as substrate for 
O2 reduction but instead, it’s stored presumably at a ‘pump site’ which has a variable pK
r 
sensitive to the location of injected electron. Electron movement from CuA to heme a results in 
the increment of pump site proton affinity or pKr from 5 (ground state) to 9 which allows a 
successful trapping of the first proton. The protonation of the pump site, in turn, raises the 
midpoint redox potential of heme a3 and further attracts the electron into the binuclear center 
within 1 ns. Again, the pKr of pump site increases to 11 upon movement of the electron from 
heme a to heme a3. The above tune up of pK
r from 9 to 11 leads to a further increment of 
proton affinity at the pump site. As a result, the second proton is taken up within 0.8 ms to the 
active site and serves as a substrate for O2 reduction. Uptake of this second proton compensates 
the negative charge of the electron at the binuclear center and thus dramatically decreases the 
proton affinity of pump site to its ground state pKr of 5 which releases the stored first proton as 
the pumped proton in 2.5 ms. 
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It’s entirely possible that the mechanism requires further gating that has not been 
identified so far. It is also clear that the described sequence of electron transfer need not be 
unique, but that both the sequence and the intrinsic rates may vary in the four proton pumping 
transitions of the catalytic cycle, even though the basic coupling principles prevail: 1) scalar 
electron movement is coupled with scalar proton uptake event. 2). Existence of pump site and 
its pKr is sensitive and tunable by electron movement. Moreover, based on calculation from the 
experimental data, this model suggests A-propionate group of heme a3 as the candidate for 
pump site while other models proposed a dissociated histidine ligand of CuB with different 
orders of electron and substrate/pumped protons uptake [81, 82].  
                         
Figure 1.10. Proton translocation mechanism model. Electrons are shown in red color fill, 
protonation is shown in grey fill and the pump site is shown in X with pK values noted.   
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Chapter 2 : ORGANIC SYNTHESIS OF CYTOCHROME BO3 and BD 
COMPETITIVE INHIBITOR – AURACHIN C 1-10 
2.1     Introduction 
2.1.1     Quinones and Respiratory Chain  
Quinones are small, freely diffusible, lipophilic, membrane-entrapped organic molecules 
in the plasma membrane that can carry two electrons and two protons when fully reduced into 
quinol. In many respiratory and also photosynthesis systems membrane quinones shuttle 
electrons between electron donating and accepting proteins through transient interaction. 
Different types of quinones exist all the domains of life except for certain archaea where 
quinones are replaced by phenazine-based compounds. Different quinones possess different 
electrochemical potentials and many bacteria can synthesize more than one type of quinone. 
Ubiquinone and menaquinone (Figure 2.1) are the most commonly produced quinones. 
Ubiquinone [  
 =+40 mV] prevails under aerobic condition in eukaryotes and bacteria while 
menaquinone [  
 =-80 mV] takes charge under anaerobic condition in bacteria when the 
cellular redox state is more reduced. 
           
                           
Figure 2.1. (To be continued on page 26) 
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Figure 2.1. Structures of menaquinone or MQ (upper left) and ubiquinone or UQ (middle left). 
Both of them can have various number of isoprenyl subunits in the longer alkyl side chain. Upon 
2-eletron reduction, they could pick up 2 protons and convert into their quinol equivalents 
respectively (upper and middle right). Plastoquinone or PQ and plastoquinol are shown in the 
lower left and right. 
 
The respiratory complexes that utilize quinones sometimes do not distinguish their 
quinone substrates based on their tail lengths, and it has been shown that E. coli can grow 
normally using quinones with different tail lengths [83]. The activity of cytochrome bo3 ubiquinol 
oxidase is also routinely measured with UQ-1 which has a much shorter tail than its physiological 
counterpart [38, 84]. Many dehydrogenases in E. coli such as NADH dehydrogenases I and II can 
reduce all three types of quinones, whereas some dehydrogenases such as succinate 
dehydrogenase and most terminal complexes are restricted to specific quinones [85]. In the 
respiratory chain of E. coli, ubiquinone is used as the electron shuttle between NADH 
dehydrogenase and bo3 type ubiquinol oxidase while both menaquione and ubiquinone can 
serve as electron shuttle between NADH dehydrogenase and bd I type quinol oxidases 
depending on the oxygen tension in the culture [85, 86]. Bd type oxidases from some other 
organisms like B. stearothermophilus can use only menaquinol as electron donor or another 
type of quinone called plastoquinol as substrate. 
2.1.2     Quinone Binding Site in E. coli bo3 and bd 
The interaction between Q/QH2 and respiratory complexes requires specific structures 
on or near the surface of these enzymes that could bind Q/QH2 at least temporarily to allow 
27 
 
electron transfer. Structures of proteins co-crystallized with Q/QH2 as substrate or cofactors are 
available for several respiratory complexes. Q/QH2 binding sites can be classified into two 
categories: reduction as in different dehydrogenases (Qi site in bc1 complex, QA and QB sites in 
reaction center, NADH dehydrogenase, succinate dehydrogenase) and oxidation as in many 
terminal oxidases (Qo site in bc1 complex, bo3 from E. coli and cytochrome aa3 from bacillus 
subtilus). Direct redox chemistry in quinone is a two electron process while many quinone 
binding sites such as Qi site from bc1 complex and QH site from cytochrome bo3 can convert the 
two electron redox chemistry into two tandem single electron redox chemistry reactions via a 
semiquinone stabilized by Q sites [87, 88]. 
A)         Quinone Binding Sites in E. coli bo3  
Evidence so far suggests that one quinone binds to cytochrome bo3 and does not 
exchange with the quinone pool, which lead to the proposal for two ubiquinone binding sites 
known as QH and QL with high and low affinities for ubiquinone respectively [84, 89]. The QL site 
is believed to be the real substrate binding site, where the ubiquinone is in dynamic equilibrium 
with the ubiquinone pool. On the other hand, the ubiquinone at QH site acts as a redox co-factor 
which mediates electron transfer between the ubiquinol at QL site and the low spin heme b. No 
crystal structure of cytochrome bo3 showed any bound ubiquinone. However, HPLC analysis 
demonstrated cytochrome bo3 co-purified with a tightly bound ubiquinone-8 with n-dodecyl β-
D-maltoside containing buffer. Assuming binding of this ubiquinone at QH site, a model has been 
constructed using the binding pocket of ubiquinone-2 in the photosynthetic reaction center as a 
reference. It suggested that QH involved R71, D75, H98 and Q101 [38] (Figure 2.2). Site-directed 
mutagenesis and EPR studies have confirmed that these residues are critical for the stabilization 
of semiquinone radical at QH site - especially the hydrogen bond between UQ-8 and Nε from R71 
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[38, 90]. The unpaired spin distribution among the nitrogen atoms in the binding pocket shed 
lights on the interaction between the semiquinone and the protein QH binding site. A collection 
of experimental data suggested that the QL site is located in the subunit II of cytochrome bo3 
comparable to the CuA site in cytochrome c oxidase [91-94]. However, the crystal structure and 
mutagenesis study were not able to confirm the location of QL site, which remains elusive [38, 
84]. 
 
Figure 2.2. The proposed model of the QH site from cytochrome bo3 based on the X-ray crystal 
structure [38]. 
 
B)         Quinone Binding Site in E. coli bd  
Cytochrome bd is the only well-studied member from the novel tri-heme family other 
than heme-copper superfamily. It’s widely spread among prokaryotes but has not yet been 
found in eukaryotes [95]. Cytochrome bd catalyzes the reduction of dioxygen by oxidation of 
ubiquinol or menaquinol from the membrane quinone pool. Studies have shown that the 
enzyme is a transmembrane protein with two subunits at 58 and 43 kDa of M.W. respectively 
 
H98 
Q101 
D75 
R71 
       1 
 2 
3 
 4 
5 
 6 
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[96]. Subunit I with M.W. at 58 kDa harbors a low spin heme b558 and a high spin heme b595 while 
subunit II with M.W. at 43 kDa helps to bind a high spin heme d. So far no crystal structure is 
available but two-dimensional membrane topology has been predicted using hydropathy 
analysis of the amino acid sequence [97, 98] combined with gene fusion methods [99, 100]. It 
has been proposed that heme b595 is in close proximity with heme d which forms a di-heme 
binuclear center for the reduction of dioxygen[101]. Moreover, the hydrophilic linkage between 
transmembrane helices VI and VII in subunit I at the periplasmic side has been indicated as part 
of the quinol binding site and is referred to as the “Q-loop” [102-106].  
                 
Figure 2.3. 2D model of cytochrome bd-I from E. coli showing the large hydrophilic “Q loop” 
indicated for quinol oxidation. Filled circles represent the highly conserved residues [101]. 
Site-directed mutagenesis in cytochrome bd-I from E. coli indicated that mutations at 
Gln 249, Glu 278, Glu 279 and Glu 280 perturbed the quinol oxidation site and that Lys 252 and 
Glu257 were involved in the quinol oxidation likely by direct interaction with C1-OH and/or C4-
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OH groups of ubiquinol [107]. Overall, the quinol binding site in cytochrome bd oxidase is less 
studied due to the lack of a crystal structure. 
2.1.3     Inhibition Study of Cytochrome bo3 and bd  
One way to study the property of quinone binding pocket is to probe the unidentified 
binding sites with potent inhibitors [108-111]. Combined with site-directed mutagenesis study, 
the pattern of substrate analogue binding affinity and catalysis kinetics will provide primitive 
information on which subunits and residues are associated with substrate binding. For example, 
radiolabeled and photoreactive azido-ubiquinone derivative [110] was used to investigate the Q 
binding site of cytochrome bd oxidase from E. coli. The observation of subunit I correlation with 
this radioactive labeled inhibitor photolysis other than subunit II successfully revealed the Q 
binding site is in subunit I. Another example was mentioned in 2.1.2 about the site directed 
mutagenesis study for the Q binding site in cytochrome bd from E. coli [107] in which a list of 
conserved residues were evaluated for their interaction with Q analogue inhibitor to discover 
their significance in substrate binding. A selection of different inhibitors was used to probe the Q 
binding pocket in both cytochrome bo3 and bd (Figure 2.4.). Most of them could suppress Q 
binding for only one of the two cytochromes with Ki in milli molar or micro molar range 
competitively or non-competitvely [109](Table 2.1). However, synthetic aurachin C and D 
quinone analogues stand out with Ki falling into nano molar scale. Aurachin C deriviatives were 
demonstrated to potently inhibit both cytochrome bo3 and bd while aurachin D analogues 
displayed only selective inhibition on cytochrome bd (Table 2.1.).  
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Figure 2.4. Part of the synthetic or natural inhibitors used in the study of Q sites in cytochrome 
bo3 and bd. Aurachin derivatives have different numbers of isoprenyl building blocks while the 
natural products have 3 of them. X stands for a variety of functional groups. 
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Table 2.1. Inhibition of compounds on the quinol oxidase activities of cytochromes bo3 and bd. 
 
2.1.4     Organic Synthetic Pathway for AC 1-10 
Aurachin C derivatives were selected in our study for their highly effective inhibition on 
both cytochrome E. coli bo3 and bd enzyems as previous studies [108, 109, 112] have shown. 
Aurachin C analogues with 3-(n-(CH2)nCH3)-2-CH3 alkyl chains where n=7,9,10 and 11 or 
analogues with 3-CH3-2-(n-(CH2)n-CH3) alkyl chains where n=7,9,10 and 11 (Figure 2.5) displayed 
most potent inhibition for the QL site of ubiquinone oxidases (Ki ~ 10
-8 M) [113]. AC 1-10 is 
eventually selected in our study as the synthetic inhibitor for investigation of QL sites in 
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cytochrome bo3 and bd. The total synthesis route generally followed the strategy in Miyoshi’s 
work [108]with substantial modification and corrections in the each step. 
 
Figure 2.5. Natural aurachin C and its analogues. R1 and R2 are both saturated alkyl chains with 
different number of methylene groups. 
 
Figure 2.6. Synthetic route of aurachin C 1-10. 
 
34 
 
2.2     Materials and Methods 
2.2.1     Materials 
Reagents: Ethyl acetoacetate, iodomethane, sodium hydride, aniline, acetic acid, 
Mg2SO4, diphenyl ether, n-butyl lithium, 1-bromononane, KI, ethyl chloroformate, 
hexamethylphosphoramide, m-chloroperoxybenzoic acid in CHCl4, NaOH and HCl were all 
obtained from Sigma Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). Other 
commercial reagents were purchased from Sigma-Aldrich, Fisher Scientific, Alfa Aesar, or 
WaterStone Technology, and were used without further purification unless otherwise noted. 
Solvents  were  purified  via  passage  through  packed  columns  (THF, Et2O, CH3CN, CH2Cl2: dry 
neutral alumina; hexane, benzene, and toluene, dry neutral 
alumina  and  Q5  reactant;  DMSO,  DMF:  activated  molecular  sieves). Water was double 
distilled. Diisopropylamine was freshly distilled under an atmosphere of nitrogen from CaH. 
Solvent: THF, toluene, hexane, diphenyl ether, chloroform and ethanol were all obtained from 
Sigma Aldrich (St. Louis, MO).  
Structural Analysis:  1H NMR spectra were recorded at 23 ˚C on one of the following 
instruments: Varian Unity 400, Varian Unity 500, and Varian Unity Inova 500NB. Chemical shifts 
(δ) were reported in parts per million (ppm) downfield from tetramethylsilane and referenced to 
residual proton in the NMR solvent (CHCl3, = 7.26; CD2HCN, = 1.93, center line) or to added 
tetramethylsilane (δ = 0.00). Data were reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, sept = septet, m = multiplet, b = broad, app = 
apparent), coupling constant (J) in Hertz (Hz), and integration. 13C NMR spectra were recorded at 
23 ˚C on one of the following instruments: Varian Unity 500 or Varian Unity Inova 500NB. 
Chemical shifts (δ) were reported in ppm downfield from tetramethylsilane and referenced to 
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carbon resonances in the NMR solvent (CDCl3, = 77.0, center line; CD3CN, = 1.30, center line) or 
to added tetramethylsilane (δ = 0.00).  
2.2.2     Synthetic Route 
1. Synthesis of ethyl 2-methylacetoacetate (Figure 2.7). 2.54 g (63.4 mmol, 1 equiv) 60% 
NaH dispersed in mineral oil was washed by 30mL dry hexane 3 times under dry N2. Supernatant 
was drained via siphon technique. To the washed 2.54 g NaH in 40 mL dry THF was added 7.3 mL 
(57.6 mmol, 1.1 equiv, diluted in 20 mL dry THF) slowly under N2 protection in ice bath. The 
reaction was stirred for 45 minutes.  3.9 mL (63.4 mmol, 1.1 equiv) iodomethane was then 
injected into the reaction by syringe. The reaction was stirred and refluxed at 46.6 ⁰C for 19 
hours. The system turned from clear to white cloudy and then yellow/yellow brownish. The salt 
was filtered with filter paper. 100mL H2O was added and the system was extracted with 50mL 
CH2Cl2 3 times. Organic solvent in the collected organic layer was removed under rotavap down 
to 150 mL, washed by saline and dried over MgSO4.  Silica gel purification was applied with 
100mL CH2Cl2 to wash/elute product. Ethyl 2-methylacetoacetate yield was 83% (6.74 g). 
Stoichiometry was under tight control to prevent double methylation.  
2. Synthesis of ethyl 3-anilino-2-methylcrotonate (Figure 2.8). To a mixture of 67.9 g 
(472 mmol, 1 equiv) ethyl 2-methylacetoacetate and 51.6 mL (566 mmol, 1.3 equiv) aniline in 
750 mL toluene, in the presence of 165.1 g (1413 mmol, 3 equiv) MgSO4, was added catalytic 
amount (24mL) of acetic acid (glacial) at room temperature. The reaction was stirred for 24 
hours. Filtered (use vacuum) the MgSO4 and concentrate the system. Most of the time, MgSO4 
was not powerful enough to absorb all the H2O generated during condensation. As a result, 
conversion was only 70%. To drive the reaction further down the condensation direction, 300 
mL methanol was added to make azeotrope which evaporated away under vacuum at 50 ⁰C (3 
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times). Overnight reaction stirred at 50 ⁰C under high vacuum improved the yield up to 94% 
(97.1 g).  
3. Synthesis of 2,3-dimethyl-4-quinolone (Figure 2.9).  To a mixture of 12.6 g (81.8 
mmol, 3 equiv) biphenyl and 6.0 g (27.3 mmol, 1 equiv) 3-anilino-2-methylcrotonate was added 
100 mL diphenyl ether. Reaction was refluxed at 200 ⁰C for 21 hours. The system was cooled 
down to room temperature to quench the reaction and 150 mL hexane was added and stirred 
for 1 hour. Recrystallization with 80 mL methanol yielded 0.93 g (19.6%) of 2,3-dimethyl-4-
quinolone. A lot of product was lost in the solvent (diphenyl ether). Given the high boiling point 
of solvent and high solubility of product in solvent, it’s hard to separate most of the quinolone 
product from reaction system. 
4. Synthesis of 2-n-decyl-3-methyl-4-quinolone (Figure 2.10). In situ generation of LDA 
was carried out first as follow: Flame dried reaction flask (250 mL) was chilled down in dry N2 
and followed by injection of 200 mL distilled dry THF via 10 mL gas-tight syringe. The system was 
then chilled down in isopropanol/dry ice bath. 1.69 mL (12 mmol, 2.4 equiv) newly distilled 
isopropylamine from Marti Burke’s Lab was injected into the system. 10 mL (15 mmol, 3.0 equiv) 
n-butyl lithium thaw in dry box was introduced into the system.  
0.90 g 2,3-dimethyl-4-quinolone  (5 mmol, 1.0 equiv) was introduced into the system via 
funnel and the residual quinolone was rinsed off by dry THF. The system was sealed again and 
kept stirring under dry N2 protection for a while till the color turned yellow. The reaction was 
warmed up to room temperature and stirred till quinolone completely dissolved. The color 
should turn orange or even darker. In case of in situ LDA generation failure, commercial LDA was 
introduced. Enoloate was then ready for the next step of alkylation.  
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Alkylation was initiated by introducing 0.95 mL (5 mmol, 1 equiv) n-bromononane slowly 
via syringe. After homogenization, 1g (5mmol, 1 equiv) KI was added. The reaction was then 
stirred under N2 protection for 15 hours. Stoichiometry was under tight control to prevent 
double nonylation. 
Salts were removed by regular vacuum filtration.  Silica gel filtration was then applied 
with 150 mL ether to separate salts. 500 mL 5% methanol was then used for product elution. 
Recrystallization with methanol yielded 0.55 g (36.5%) 2-n-decyl-3-methyl-4-quinolone. 
5. Hydroxyl (carbonyl) group protection by ethyl chloroformate (Figure 2.11). To a 
flame dried vessel was introduced 10 mL dry THF (Dr. Katzenellenbogen Lab) followed by 
injection of 0.38 mL LDA (Dr. Katzenellenbogen Lab) at 2.0M (0.75 mmol, 1.5 equiv) and chilled 
down in ice bath. 0.18 mL (0.75 mmol, 1.5 equiv) HMPA was then introduced and stirred to 
homogenization. Deprotonation was initiated upon loading of 0.15 g (0.5 mmol, 1 equiv) 2-n-
decyl-3-methyl-4-quinolone and the reaction was allowed to stir at room temperature for 1 
hour. Protection reaction started upon injection of 96.6 μL (1.0 mmol, 2.0 equiv) ethyl 
chloroformate and was left stirring for another 6 hours. The color of aqueous phase turned 
lighter and the system became cloudy within 15 minutes. Reaction was quenched by adding 10 
mL saturated Na2CO3 and was subjected to diethyl ether extraction (10 mL, 3 times). Organic 
phase was further washed with brine twice and distilled water once. It was further subjected to 
silica gel purification with hexane, diethyl ether wash and followed by 2% methanol/ether 
elution to yield 0.15 g product (80.5%). 
6. Oxidation of imine to N-oxide (Figure 2.12). 0.11 g (0.49 mmol, 1.2 equiv) m-
chloroperoxybenzoic acid dissolved in 0.68 mL chloroform was slowly added into 0.15 g (0.40 
mmol, 1.0 equiv) protected 2-n-decyl-3-methyl-4-quinolone diluted in 1.34 mL chloroform. 
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Reaction was stirred at room temperature for 1 hour and was subjected to silica gel (10mL) 
column chromatography (diethyl ether/chloroform = 1/10) to give N-oxide 0.14 g (89%). 
7. De-protection of Aurachin C 1-10 (Figure 2.13). To a solution of 1.32 g (3.4 mmol, 1 
equiv) N-oxide in 200 mL ethanol, 50 mL 1 M NaOH was slowly added. Reaction was stirred for 6 
hours at room temperature and then subjected to acidification by adding 3 M HCl to pH=5.0 
monitored by pH meter. Silica gel purification was applied for crude product with diethyl ether. 
Elution of product was carried out by hot methanol. Recrystallization generated 0.16 g (15%) 
aurachin C 1-10.  
2.3     Results and Discussion 
2.3.1     Monomethylation of Ethyl Acetoacetate 
 
Figure 2.7. Monomethylation of ethyl acetoacetate – the reaction 
Rf=0.44 (CH2Cl2), 
1H NMR (CDCl3, 500 MHz), δ 1.27 (t, J=7.2 Hz, 3H, ethyl CH3), 1.34 (d, 
J=7.2 Hz, 3H, Cß-CH3), 2.24 (s, 3H, Cγ-CH3), 3.49 (q, J=7.2 Hz, 1H, Cß-H), 4.19/4.18 (q, J=7.2 Hz, 2H, 
ethyl CH2, both ketone and enolate forms) as shown in Figure 2.14. Cß and Cγ methyl-H were 
also present as singlets at δ 2.16 and 2.04. 13C-NMR showed no evidence of double methylation 
product. 
2.3.2     Aldo Condensation of Aniline and Ethyl 3-Methyl-Acetoacetate 
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Figure 2.8 Aldo condensation of aniline and ethyl 3-methyl-acetoacetate 
Rf=0.54 (ethyl acetate/hexane = 1/4), 
1H NMR (CDCl3, 500 MHz), δ 1.3 (t, J=7.1 Hz, 3H, 
ethyl CH3), 1.86 (s, 3H, Cγ-CH3), 2.03 (s, 3H, Cß-CH3), 3.65 (broad s, 1H, N-H), 4.17 (q, J=7.1 Hz, 
2H, ethyl CH2), 7.02 (d, J=8.1 Hz, 2H, aromatic ring-o-H), 7.10 (t, J=8.1 Hz, 1H, aromatic ring-p-H), 
7.30 (t, J=8.1 Hz, 2H, aromatic ring-m-H) as shown in Figure 2.15. Unreacted aniline signals were 
present at δ 6.19 (d), 6.26 (t) and 7.15 (t). Unreacted ethyl 3-methyl-acetoacetate could be 
found with its characteristic Cß-H signal at δ 3.52 (q).  
2.3.3     Aromatic Nucleophilic Intramolecular Acetylation of 3-Anilinocrotonate 
 
Figure 2.9. Aromatic nucleophilic intramolecular acetylation of 3-anilinocrotonate 
Rf=0.60 (ethyl acetate/hexane = 1/4), 
1H NMR (CD3COD, 500 MHz), δ 2.15 (s, 3H, Cγ-CH3), 
2.52 (s, 3H, Cß-CH3), 7.35 (t, J=7.3 Hz, 1H, aromatic ring-H4), 7.52 (d, J=8.0 Hz, 1H, aromatic ring-
H6), 7.63 (t, J=8.0 Hz, 1H, aromatic ring-H5), 8.23 (d, J=8.0 Hz, 1H, aromatic ring-H3) as shown in 
Figure 2.16. Strong solvent signals were present at δ 3.41 and 4.91. 1H-NMR showed no 
evidence of intermolecular nucleophilic reaction product. 
2.3.4     Nonylation of 2, 3-Dimethyl-4-Quinolone 
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Figure 2.10. Nonylation of 2, 3-dimethyl-4-quinolone 
Rf=0.57(methanol/diethyl ether = 5/95), 
1H NMR (CD3COD, 500MHz), δ 0.89 (t, J=7.1 Hz, 
3H, alkyl chain terminal C10H3), 1.30 (broad m, 10H, alkyl chain C5H2-C9H2), 1.37 (m, J=7.1 Hz, 2H, 
alkyl chain C4H2), 1.46 (m, J=7.1 Hz, 2H, alkyl chain C3H2), 1.72 (m, J=7.1 Hz, 2H, alkyl chain C2H2), 
2.17 (s, 3H, quinolone ring CH3), 2.82 (t, J=7.1 Hz, 2H, alkyl chain C1H2), 7.37 (t, J=8.1 Hz, 1H, 
aromatic ring-H4), 7.54 (d, J=8.1 Hz, 1H, aromatic ring-H6), 7.64 (t, J=8.1 Hz, 1H, aromatic ring-H5), 
8.12 (d, J=8.1 Hz, 1H, aromatic ring-H3) as shown in Figure 2.17. 
13C-NMR showed no evidence of 
double nonylation product. 
2.3.5     Protection of Quinolone Hydroxyl Group by Ethyl Chloroformate 
 
Figure 2.11. Protection of quinolone carbonyl (hydroxyl) group by ethyl chloroformate 
Rf=0.80(methanol/diethyl ether = 2/98), 
1H NMR (CD3COD, 500MHz), δ 0.89 (t, J=6.9 Hz, 
3H, alkyl chain terminal CH3), 1.29 (broad m, 10H, alkyl chain C5H2-C9H2), 1.37 (m, J=6.9 Hz, 2H, 
alkyl chain C4H2), 1.40 (t, J=7.1 Hz, 3H, protection group CH3), 1.47 (m, J=7.1 Hz, 2H, alkyl chain 
C3H2), 1.76 (m, J=7.4 Hz, 2H, alkyl chain C2H2), 2.37 (s, 3H, quinolone ring CH3), 3.04 (t, J=8.3 Hz, 
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2H, alkyl chain C1H2), 4.37 (t, J=7.4 Hz, 2H, protection group CH2), 7.37 (t, J=8.2 Hz, 1H, aromatic 
ring-H4), 7.54 (d, J=8.2 Hz, 1H, aromatic ring-H6), 7.64 (t, J=8.7 Hz, 1H, aromatic ring-H5), 8.12 (d, 
J=8.7 Hz, 1H, aromatic ring-H3) as shown in Figure 2.18. HMPA was used to facilitate the 
salvation of Li cation and improve the performance of LDA base.  
2.3.6     Oxidation of Imine into N-oxide via m-Chloroperoxybenzoic Acid 
 
Figure 2.12. Oxidation of imine into N-oxide by m-chloroperoxybenzoic acid 
Rf=0.20(diethyl ether / chloroform = 1/10), 
1H NMR (CD3COD, 500MHz), δ 0.89 (t, J=6.6 
Hz, 3H, alkyl chain terminal C10H3), 1.29 (broad m, 10H, alkyl chain C5H2-C9H2), 1.40 (m, J=6.6 Hz, 
2H, alkyl chain C4H2), 1.40 (t, J=6.7 Hz, 3H, protection group CH3), 1.53 (m, J=6.8 Hz, 2H, alkyl 
chain C3H2), 1.74 (m, J=7.1 Hz, 2H, alkyl chain C2H2), 2.39 (s, 3H, quinolone ring CH3), 3.26 (t, 
J=7.6 Hz, 2H, alkyl chain C1H2), 4.41 (t, J=6.7 Hz, 2H, protection group CH2), 7.77 (t, J=8.6 Hz, 1H, 
aromatic ring-H4), 7.90 (d, J=8.6 Hz, 1H, aromatic ring-H6), 7.96 (t, J=9.0 Hz, 1H, aromatic ring-H5), 
8.64 (d, J=9.0 Hz, 1H, aromatic ring-H3) as shown in Figure 2.19. The signals were generally 
similar with un-oxidized precursor, except that aromatic H and two alkyl chain H were up-shifted 
in both J and δ values as a result of N oxidation.  
2.3.7     Deprotection via Hydrolysis in Alkaline Solution 
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Figure 2.13. Deprotection by hydrolysis in alkaline solution 
Rf=0.50 (methanol/diethyl ether = 5/95), 
1H NMR (CD3COD, 500MHz), δ 0.89 (t, J=6.6 Hz, 
3H, alkyl chain terminal C10H3), 1.31 (broad m, 10H, alkyl chain C5H2-C9H2), 1.41 (m, 2H, alkyl 
chain C4H2), 1.51 (m, J=7.1 Hz, 2H, alkyl chain C3H2), 1.72 (m, J=7.1 Hz, 2H, alkyl chain C2H2), 
2.22 (s, 3H, quinolone ring CH3), 3.04 (t, J=8.1 Hz, 2H, alkyl chain C1H2), 7.42 (t, J=6.7 Hz, 1H, 
aromatic ring-H4), 7.74 (d, J=8.1 Hz, 1H, aromatic ring-H6), 7.98 (t, J=8.4 Hz, 1H, aromatic ring-H5), 
8.28 (d, J=8.4 Hz, 1H, aromatic ring-H3) as shown in Figure 2.20. 
43 
 
 
Figure 2.14. 1H NMR of ethyl 2-methylacetoacetate 
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Figure 2.15.  1H NMR of 3-anilino-2-methylcrotonate 
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Figure 2.16. 1H NMR of 2,3-dimethyl-4-quinolone 
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Figure 2.17. 1H NMR of 2-n-decyl-3-methyl-4-quinolone 
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Figure 2.18. 1H NMR of 2-decyl-3-methylquinolin-4-yl ethyl carbonate 
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Figure 2.19. 1H NMR of 2-decyl-4-((ethoxycarbonyl)oxy)-3-methylquinoline 1-oxide 
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Figure 2.20. 1H NMR of Aurachin C 1-10 (2-decyl-1-hydroxy-3-methylquinolin-4(1H)-one) 
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Chapter 3 : SITE-DIRECTED MUTAGENESIS STUDY OF PROTON 
PATHWAYS OF CYTOCHROME CBB3 FROM VIBRIO CHOLEREA 
3.1     Introduction  
3.1.1     cbb3 Type Oxidase Composition and Physiological  Function  
The well-studied aa3 type cytochrome c oxidase discussed in chapter one belongs to the 
heme-copper oxidase (HCO) super family [8]. This superfamily diverges into two large groups of 
members that perform either oxygen or nitric oxide reductase functionality. All the members 
from this super family are transmembrane enzymes. The oxygen reductases couple the 
reduction of O2 reduction to an electrogenic proton translocation across the membrane from 
cytoplasmic to periplasmic side (e.q. 3.1), while the nitric oxide reductases (NORs) catalyze the 
reduction of NO to N2O which is not electrogenic (e.q. 3.2). NORs take substrate protons from 
periplasmic side and don’t translocate protons across the membrane. 
                                                O2 +      
  +n    
 + 4e-   2H2O + n    
                                  e.q. 3.1 
                                                       2NO + 2    
  + 2e-   N2O + H2O                                         e.q. 3.2 
Within oxygen reductase members, three major subfamilies namely A, B and C 
dominate, comprising 72%, 3% and 24% of the population respectively (Figure 3.1).  
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Figure 3.1. Heme-copper oxidase superfamily members clade view. C type O2 reductases are 
more related with NORs rather than A and B type O2 reductases which are more closely related 
with each other.  
A type oxidases occurs in all three domains of life while C type oxidases are only found in 
bacteria (mainly proteobacteria) [114] with cbb3 type oxidases as the only representative. Cbb3 
type cytochrome c oxidase from P. stutzeri is a typical C family enzyme. It is encoded by 
ccoNOQP gene cluster which is translated into CcoN, CcoO, CcoQ and CcoP subunits to 
constitute the complex of cbb3 [115]. A consensus sequence (TTGAT-N4-GTCAA) that recognizes 
members of oxygen dependent transcriptional regulators (FNR), is located -88 and -102 bp 
upstream of the ccoN start codon [116]. FNR type regulator gene can also be found for many 
other cbb3 from different organisms [117]. This is consistent with the observation that FnrA is 
required by P. stuzeri and many others for the expression of cytochrome cbb3 under 
microaerobic conditions [118]. Another gene cluster, known as ccoGHIS, is always found close to 
ccoNOQP and its expression is necessary for the assembly of a functional cbb3 oxidase [119-121].  
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Figure 3.2. Organization of the ccoNOQP operon in P. stuzeri [122]. The ccoNOQP operon of P. 
stuzeri encodes the four structural proteins that comprise the cytochrome cbb3 oxidase complex. 
Upstream is the FNR type regulator gene aer and downstream is the helper gene ccoGHIS for 
copper insertion and subunits recruiting. 
The most complex version of cbb3 oxidase is a complex consisting of four subunits: 
CcoN(50 kDa), CcoO(23 kDa), CcoP(35 KDa) and CcoQ(6.5 kDa). However, not all C family type 
oxidases share the same composition of subunits as shown by homology analysis of genomes 
from over 400 organisms. Substantial amount of members only have CcoN and CcoO encoded. 
It’s functional with the deletion of CcoQ in B. japonicum [123] and R. sphaeroides [124]. The 
mutation has no apparent effect upon activity of cbb3 oxidases in either case. It’s also 
compatible with studies on subunits assembly in vivo which demonstrated that the significance 
of CcoQ lies in stabilizing the interaction of CcoNO core complex and CcoP [125] and also in 
protecting the CcoNOQP complex from proteolytic degradation in the presence of O2 [126]. In 
other words, it’s plausible for CcoNO complex to survive certain conditions.  
The nomenclature of cbb3 follows the same rule as that in aa3. CcoN is the catalytic 
subunit consists of 12 transmembrane helices and harbors a low spin heme b and a high spin 
heme b3 in the binuclear center. CcoO and CcoP retain one and two c hemes in their periplasmic 
soluble domains respectively which are covalently linked to the backbone of protein via disulfur 
bond (Figure 1.5). CcoN is genetically more related to NorB from NOR than the catalytic subunit I 
from A and B type HCO. CcoO exhibits no similarity with subunit II from A or B type HCO and also 
minimal similarity to known c-type cytochromes with notable exception of NorC from NOR. CcoP 
and the single transmembrane helix CcoQ share no homology with subunits from A or B type 
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oxidase. However, the periplasmic heme c containing domain from CcoP belongs to the 
cytochrome c superfamily.  
Substrate binding studies on cbb3 from B. japonicum revealed almost 10 to 100 fold 
higher O2 binding affinity compared with the A type oxidases [127]. This high affinity for 
substrate O2 is coherent with the fact that proteobactria have learned to adapt to environments 
with low oxygen tension. In fact, genes encoding (ccoNOQP) cbb3 oxidase were initially identified 
in B. japonicum and designated fixNOQP. Their expression is required to scavenge O2 where the 
nitrogenase is protected against destructive O2 [128]. Genomic analysis have identified in some 
other proteobactria, for example, R. capsulatus [129], A. caulinodans [130], and three human 
pathogens C. jejuni [131], H. pylori [132] and N. meningitides, that cbb3 is the only HCO or even 
the only oxidase (N. meningitides and some H. pylori ) encoded by the genome. Presumably, 
cbb3 in this case is also responsible for electrochemical potential generation to maintain redox 
homeostasis and thus support ATP synthesis and other energy requiring activities. Besides the 
O2 reduction chemistry, cbb3 also retains substantial NO reduction activity compared with A type 
oxidases [133]. The NO reduction capability in cbb3 can be inferred from the higher degree of 
homology shared between NOR and cbb3 compared with other HCOs [134, 135]. In R. 
sphaeroides, cbb3 also displays a dominant role in regulation of photosynthesis genes indirectly 
as part of a signal transduction pathway [136].  
The preferred natural electron donor of cbb3 is still elusive. Early studies on the cbb3 
from R. capsulatus showed the ability of cbb3 to oxidize soluble cytochrome c2 both in vivo and 
in vitro and addition of quinone analogue in vitro did not elicit O2 uptake, verifying that the 
enzyme is not a quinol oxidase but more than likely a cytochrome c oxidase [137].   Unlike the 
high overall structural homology shared by the mitochondrial cytochrome c (electron donor for 
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aa3 in mitochondria) and soluble domain of membrane-anchored c552 (electron donor for aa3 in 
bacteria like P. denitrificans), examples from limited numbers of organisms revealed electron 
donors with distant relationship. In the case of cbb3 from H. pylori, soluble cytochrome c553 
displayed donor like activity which is sensitive to ion strength [138]. Another similar examples 
were seen in cbb3 from V. cholerae [3] and R. sphaeroides [139] where soluble cytochrome c4 
and c2 is most likely the preferred natural electron donor respectively. In the case of cbb3 from B. 
japonicum, horse heart cytochrome c could be oxidized by cbb3 [140]. However, greater O2 
uptake activity was observed with TMPD as electron donor than when horse heart cytochrome c 
is used [141].  
3.1.2     Structure Based Investigation of cbb3 Catalytic Mechanism 
In spite of nearly one quarter of the total population taken up by cbb3 type oxidases in 
HCO oxygen reductases, little beyond the substrate interaction or redox cofactor 
characterization is known so far because of the lack of an X-ray crystal structure. Recently, 
Bucshmann et. al. resolved the structure of cbb3 from P. stutzeri at 3.2 Å [135] which brought 
our understanding of this enzyme one great step forward.  
A)          Subunits and redox cofactors associated 
Crystal structure displays a complex of CcoNOP with a dimension of 45Å × 65Å × 100Å, 
with CcoN localized in the membrane and CcoO and CcoP predominately in the periplasm 
(Figure 3.3.).  CcoN has the expected architecture of the central subunit where 12 
transmembrane helices retain one low spin heme b with two His ligands in pore C and the 
binuclear center, consisting of a single His coordinated high spin heme b3 and CuB with 3 His 
ligands, in pore B. CcoO is composed of one N-terminal transmembrane helix and a soluble 
heme c carrying domain which is in close contact with the periplasmic side of CcoN. CcoP 
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consists of two N-terminal transmembrane helices, a long helical linker of ~ 40Å, and a soluble 
globular unit built up by two heme c carrying domains. All the three c hemes are coordinated 
with one His and one Met which is different from that in the low spin heme from the catalytic 
subunit of HCOs. It’s believed that the Met axial ligand for at least some of the c hemes undergo 
temporary dissociation in CO binding study [142]. These results are consistent with early studies 
via EPR and NIR-MCD spectroscopy on the stoichiometry of high and low spin hemes and nature 
of heme ligands. 
B)         Electron transfer between redox cofactors 
The electron supply apparatus in cbb3 completely differs from that of the well studied 
aa3 type oxidase. Equilibrium redox titration experiments carried out on cbb3 from R. capsulatus 
[137], B. japonicum [143], P. stutzeri [144] and R. sphaeroides [145] all demonstrated the same 
order of midpoint potential arrangement among hemes even though the absolute value differs 
in each case. Inevitably,   
  values start low for the two c hemes in CcoP, raised by ~100 mV to 
the single c heme in CcoO, and finally increased further by 20-70 mV in the low spin heme b. 
From the crystal structure, edge-to-edge distances between hemes are confidently traceable. 
Two c hemes in CcoP and two b hemes in CcoN are within van der Waals contact and the 
distance between heme b and heme c from CcoO is at least two times shorter than the distance 
between CuA and heme a in A type oxidases. Therefore, based on the ET theory [21-23], 
electrons are believed to shuttle from the outer c heme of CcoP to the binuclear center via inner 
c heme of CcoP, c heme of CcoO and heme b of CcoN. 
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Figure 3.3. Strucuture and redox cofactors arrangement of the cbb3 oxidase from Pseudomonas 
stutzeri. CcoN (green), CcoO (orange) and CcoP (cyan) interact to form the enzyme complex 
CcoNOP on the left half. Heme groups with edge-to-edge distances are also presented without 
the protein backbone on the right half. All the c hemes are coordinated with one His and one 
Met ligand.  
C)         Proton conductive pathways 
From the structure of cbb3 from P. stutzeri, an a line of hydrophilic residues are found in 
the pore B of CcoN which support the existence of a proton conductive pathway analogue 
positioned equivalently to the K channel in A type HCOs. Unlike the situation in A type oxidases, 
no such arrangement was found in the other two pores (Figure 3.4.). In addition, no water 
molecules are detectable under the available experimental conditions [135].  
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Figure 3.4. The arrangement of hydrophilic residues (V. cholerae numbering) that line up the K 
pathway analouge in cbb3 from P. stutzeri. The crosslinked Y255 is from helix VII instead of VIII .  
Bucshmann et. al proposed the K pathway analogue in cbb3 starts with E
III49-OH (V. cholerae 
numbering ) in CcoP and extends through S244-OH, Y227-OH, H247-Nε2, Y321-OH and T219-OH 
to the cross-linked Y255-OH that is ~4 Å away from the O2 binding site. Cross link of Y255 from 
helix VII with His203 is confirmed by comparative genomic study and Mass spectroscopic studies 
in the case of V. cholerae [13, 146] and R. sphaeroides [147]. Migration of this cross-linked 
tyrosine results in slightly enlarged K pathway below heme b3 [135]. Hydroxyl group from heme 
a farnesyl chain is missing. However, the hydroxyl group of T219, which is in the equivalent 
position, might replace the role as mutagenesis work has shown [146]. EIII49 is more than likely 
to be the entrance of cbb3 with CcoP subunit from R. sphaeroides based on the reduced turn 
over activity and proton uptake in its Aln and Gln mutants [148]. This entrance residue is 
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reminiscent of the Glu from subunit II as the entrance in the A type oxidase. Mutagenesis work 
carried out on cbb3 from V. cholerae and R. sphaeroides have also verified the significance of 
some of the residues lining the K pathway analogue [146]. However, detailed systematic 
investigation of the roles of these residues was required, and was done as explained in this 
chapter of the thesis. In addition, candidate residues from Pore A were also examined using 
mutagenesis to completely rule out the possibility of any other proton conducting pathway. 
Four conserved Arg groups above heme b and conserved His/Asn pair right over heme b3 are 
also investigated in this chapter (Figure 3.5.).  
D)          Proton exit pathway and proton pumping 
C type oxidases share close homology with NORs and two conserved Glu are found in 
both of them. Study has shown that NOR takes substrate proton from the periplasmic side and 
mutation of these two Glu significantly lowers the turn over activity [149]. The view that the two 
conserved Glu play a role in proton uptake pathway in NOR gave rise to the speculation that 
their counterparts in cbb3 might share a similar function, but as a part of the proton release 
pathway. Mutagenesis work displayed impaired activity in cbb3 from V. cholerae and R. 
sphaeroides [146]. However, crystal structures once they were available for both NOR [134, 150] 
and cbb3 oxidase diminished the possibility of this postulation (Figure 3.5). There is a redox 
inactive calcium ion clamped by one of the Glu and also carboxylic oxygen from D propionate 
groups of both b hemes. The presence of Ca2+ coordination makes it less likely that both the Glu 
are involved in proton transfer and studies on the real role of the Glutamates are presented in 
Chapter 4 of this thesis. 
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Figure 3.5. The two conserved Glu, the conserved His/Asn pair above heme b3 and conserved 
four Arg above heme b in cbb3 oxidase from V. cholerae. 
Cbb3 enzyme has displayed the ability to translocate protons across the plasma 
membrane in either whole cell [151, 152] or artificially reconstituted cbb3 containing lipid 
vesicles [140, 153]. However, there has never been a consistently observed number for proton 
translocation stoichiometry. Various numbers from 0.1 H+/e- to 1 H+/e- have been reported in 
the past. Recently, Han et al demonstrated with whole cell assays that cbb3 from different 
organism seem to share a universal pumping translocaiton stoichiometry of 0.5 H+/e-  [154].                     
3.2     Materials and Methods 
3.2.1     Materials 
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Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT, 
Coralville, IA). QuickChange Kits were from Stratagene (Agilent Technologies, Santa Clara, CA). 
The pBADVCB plasmid (Ampr) used as template for mutagenesis and 1kb DNA standard for DNA 
agarose gel were purchased from Invitrogen (Life Technologies, Grand Island, NY). Restriction 
enzyemes were purchased from New England BioLabs (Ipswich, MA). Miniprep Kit was 
purchased from Fermentas (Thermo Scientific, Glen Burnie, MD). N-dodecyl-ß-D-maltoside 
(DDM) was purchased from Anatrace (Maumee, OH). Arabinose, ampicillin, streptomycin and 
other chemicals used in LB/M9 medium and purification buffers were from Sigma-Aldrich (St. 
Louis, MO) or Fisher Scientific (Pittsburgh, PA). Filter paper/kits were purchased from Millipore 
(Billerica, MA). Ni-NTA resin for purification was purchased from Qiagen (Valencia, CA). Slide-A-
Lyzer dialysis cassettes were obtained from Pierce (Thermo Scientific, Glen Burnie, MD). 
GeneMate Express 6%-18% gradient SDS PAGE gels were purchased from ISC BioExpress 
(Kaysville, UT). E. coli X10 Gold used for cloning of sited-directed mutagenesis PCR products was 
purchased from Stratagene (Agilent Technologies, Santa Clara, CA). V. cholerae O395 strain 
(deletion of pathogen gene and ΔccoNOQP Smr) used for cbb3 expression was from Dr. Hemp. 
Microfluidizer for cell lysing was manufactured by Watts Fluidair, Inc. Beckman ultracentrifuge L-
8M was manufactured by Beckman Coulter, Inc (Indianapolis, IN) and Sorvall RC-5B+ centrifuge 
systems were manufactured by DuPont (Wilmington, DE). 
3.2.2     Site-directed Mutagenesis 
Site-directed mutagenesis was performed using QuickChange kits as previously reported 
[155]. The quick change PCR primers used for mutagenesis were synthesized by Integrated DNA 
Technologies (IDT). Sequence verification of the mutagenesis reactions was performed at the 
Biotechnology Center at the University of Illinois, Urbana-Champaign.  
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3.2.3     Expression and Purification of WT and Mutant cbb3 Protein 
The wild-type and mutant cbb3 proteins from V. cholerae with poly-histidine tags were 
overexpressed and purified as previously described in [156]. V. cholerae cells were grown 
aerobically at 37°C in LB media with 100 µg/mL ampicillin (Fisher Biotech) and 100 µg/mL 
streptomycin (Sigma). Cbb3 oxidase overexpression in V. cholerae was induced with 0.2% L-(+)- 
arabinose (Sigma). Both kinds of cells were collected by centrifugation at 7000 rpm for 15 min 
when their growth reached early stationary phase. V. cholerae cell paste was re-suspended in 10 
mM Tris buffer at pH 8.0 with 10mM MgCl2, 30mM KCl, DNaseI and protease-inhibitor cocktail. 
Then the cells were lysed by microfluidizer (Watts Fluidair, Inc.) and centrifuged at 40,000 rpm 
for 4 hours to collect the membranes. Afterwards the membranes were solubilized with 1% 
dodecyl-D-maltoside (Anatrace) for 2 hours. Membranes which were not solubilized were 
removed by centrifuging at 40000 rpm for 30 min. The solubilized protein was mixed with Ni2+-
NTA resin (Qiagen, CA) in the presence of 5 mM imidazole for 2 hours and then purified through 
gravity column (Bio-rad). The column with resin was washed with 5 column volumes of Tris 
buffer with 10mM imidazole and then another 5 column volumes of Tris buffer with 20 mM 
imidazole. Bound cbb3 protein in red color was eluted with 100-200mM imidazole containing 
buffer.  
3.2.4     UV-Vis Spectroscopy 
Shimadzu UV/Vis-2101PC spectrophotometer was used to obtain the spectra of wild-
type and mutant enzymes. The concentrated protein samples were diluted with 20 mM Tris 
buffer and 0.05% DDM at pH 8.0. The enzymes were oxidized by air and reduced with sodium 
dithionite (Sigma). Spectra were measured from 300 to 800 nm and analyzed using OriginPro 
software. 
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3.2.5     Pyridine Hemochrome Assay 
The concentrations of heme b and heme c were determined as previously described 
[157]. 0.5ml of a stock solution containing 200 mM NaOH, 40% (by volume) pyridine and 3 µL of 
0.1M K3Fe(CN)6 were placed in a 1mL cuvette. A 0.5ml aliquot of the protein sample (~5 mM) 
was added with thorough mixing and oxidized spectrum was recorded within 1 minute. Solid 
sodium dithionite (2-5 mg) was then added and several successive spectra of the reduced 
pyridine hemochromes were recorded. The absorbance differences at the selected wavelengths 
were multiplied as a vector by the inverse of the matrix of extinction coefficients at these 
wavelengths to obtain the concentration of heme b and heme c. In the case of baseline line 
drifting upon dithionite reduction, exponential decay fitting and sometimes 3rd order 
polynomial fitting was applied to cancel the baseline drifting effect by scattering from small 
population of non-homogenized protein.  
3.2.6     SDS-PAGE 
GeneMate Express 8%-16% gradient PAGE gels from ISC BioExpress with Tris/Hepes/SDS 
buffer system or the home made 15% SDS/2.5 M urea gel with Tris/Glycine/SDS buffer system 
were used to separate the purified protein complexes. Gel were subject to either Coomassie 
Brilliant Blue R-250 staining for all subunits or heme staining to identify just CcoO and CcoP as 
the heme c is covalently attached to these two subunits [158]. Gels were then incubated in a 
mixture of 15ml 6.3 mM 3,3’,5,5’-tetramethylbenzidine methanol solution and 35ml 0.25 M 
sodium acetate solution at pH 5.0 in dark for 1 h. The gels were then stained for heme c by 
adding 30 mM H2O2. After 30 minutes incubation the gels were washed by a mixture of 30% 
isopropanol and 70% 250 mM sodium acetate solution at pH 5.0.  
3.2.7     Steady State Enzymatic Activity 
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The steady state oxygen reduction activity of cytochrome cbb3 oxidase was measured at 
25 ⁰C with a YSI model 53 oxygen electrode which was assembled with a temperature-controlled 
1.8mL electrode chamber. The reaction buffer contained 50 mM NaCl, 50 mM NaPi and 0.05% 
DDM at pH 6.5. 10 mM ascorbic acid and 500 μM N,N,N′,N′-tetramethyl-p-phenylenediamine 
(TMPD) was added as mimic reductive substrate to shuttle electron from ascorbate, via TMPD, 
into cytochrome cbb3. In the presence of O2 (aerobic), the reaction was initiated by injection of a 
few micro liters of diluted enzyme. Inhibition of KCN at 100 μM in some cased was applied to 
rule out the possibility of oxygen consumption by artifact rather than oxidase turnover.  
3.3     Results 
The current work investigated a large scope of different residues which can be classified 
into four categories: residues in pore A, pore B, above heme b3 and above heme b.  Pore A and 
pore B are homes to the D pathway and the K pathway analogues respectively in cbb3 type 
oxidase. The data summarized in Table 3.1 are interpreted in details in the following sections.  
3.3.1     Conservation  
337 sequences were analyzed in total. In the D pathway analogue, only R156 is highly 
conserved (98%) while Y209 and Y145 are much less conserved at 86% and 69% coordinately. In 
the K pathway analogue, Y321, Y227 and the cross-linked Y255 are fully conserved (100%) while 
N293 and T219 are also highly conserved (99%). H247 and S287, however, possess lower degree 
of conservation at 75% and 54% respectively even if they were considered structurally 
important based on homology model analysis before the crystal structure is available. Down to 
the entrance part of the K pathway analogue, W166 is another fully conserved residue. S244, 
S240 and T297 are also highly conserved at a degree of 95%, 99% and 98% respectively. Above 
the high spin heme b3, H341 is 99% conserved while N337, in close proximity, displays 92% 
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degree of conservation. Above the low spin heme b, R59, R61 and R441 are all highly conserved 
with a degree of 98%, 99% and 97% respectively.  
3.3.2     SDS PAGE and Heme Ratios  
All mutants for D pathway analogue and K pathway analogue displayed correct assembly 
of subunits and normal range of heme c / heme b ratios like WT cbb3. Denatured subunit CcoN, 
CcoO and CcoP showed up on SDS gel at ~43kDa, 24kDa, 35kDa respectively. However, some 
mutants above the hemes demonstrated impaired heme ratios together with subunit loss. R59Q, 
Asp and Ile mutants of N337 and all H341 mutants lost CcoP subunit and at the meanwhile, 
heme c / heme b ratio dropped to 1:2. In addition, no CcoP band staining showed up for the 
above mutants in either Coomassie or heme staining. CcoP band in R61Q turned weaker on SDS 
gel. Nevertheless, a normal 3:2 ratio for heme b / heme c and regular heme staining of CcoP 
band exclude the possibility of CcoP loss in R61Q.  No recombinant protein could be obtained 
with R441Q mutant. Some of the mutants have their heme-staining gel and reduce-minus-
oxidized difference spectra displayed in Figure 3.6 and 3.7. 
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Figure 3.6. Example of UV-Vis difference spectrum (reduced minus oxidized) for H341 and N337 
mutants compared with WT cbb3. Soret band is shown on the left and alpha band is shown on 
the right. For the Soret band, WT has a peak at 422 nm, indicating more heme c feature while 
the mutants have a peak around 428 nm, indicating more heme b feature. In the alpha band, 
similar pattern is seen in WT where prominent heme c features are present at 520 nm and 550 
nm. The mutants have significantly less heme c features and leave heme b features at 532 nm 
and 560 nm more prominent.  
 
 
Figure 3.7. Heme stained SDS-PAGE gel of selected mutants of cbb3 oxidase from V. cholerae. 
Lane assignments: M, marker; 1, WT; 2, W166F; 3, S240A+S244A+T297V; 4, H341Y; 5, N337D. 
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3.3.3     Enzymatic Activity  
Using the artificial reductant combination of ascorbic acid and TMPD in the oxygen 
reduction assay, Y255F Y321F and T219G in the K pathway analogue were shown to fully 
inactivate the enzyme without perturbing CcoP subunit assembly, while H341 mutants and 
N337D above heme b3 fully inactivate the enzyme and impaired CcoP assembly at the same time. 
Low activity (<25%) was also displayed by Y227H/A, N293D/K/L, H247A/G, W166F/A and 
S240A+S244A+T297V triple mutant from K pathway analogue. N337I/L and R61Q above the 
hemes, at the same time, also lower the activity below 10%. Rest of mutants demonstrated 
various activity between 100% and ~ 40% except that Y145F+Y209F double mutant from D 
pathway analogue exhibited 203% of WT activity. Detailed correlation between structure, 
activity and functionality is discussed below.  
3.4     Discussion 
3.4.1     No D-pathway Observed 
In the aa3 protein, pore A, consisting of helix III VI V VI, harbor the well-studied proton 
uptake pathway (D pathway) leading from the conserved entrance residue Glu132. In contrast to 
the A type oxidase, cbb3 does not have a conserved pattern of polar or hydrophilic residues 
lining Pore A, according to phylogenetic analysis. Alignment of D pathway polar residues in aa3 
from R. sphaeroides starts from D132 through N121, N139, S201 and ends up at E286 near the 
active site, while in the cbb3 from V. cholerae these equivalent positions are L93, Y82, V99, V141, 
A213 instead (Fig 5). Therefore, the prediction was that the D pathway analogue doesn’t exist in 
cbb3. In this work, three hydrophilic residues inside pore A with the highest degree of 
conservation, R156 (98%), Y209 (86%) and Y145 (69%) were subjected to mutagenesis (Figure 
3.8). R156K and R156A retained 117% and 89% WT activity respectively, while 70% and 90% WT 
activity were observed in Y209F and Y145F respectively (Table 3.1). In addition, Y209F/Y145F 
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double mutation demonstrated 200% WT activity (Table 3.1). The fact that enzymatic activity 
wasn’t impaired upon mutagenesis clearly pointed the non-existence of D pathway even though 
Y209F has been suggested to retain only 15% WT activity in cbb3 from R. sphaeroides [159].  
Even though no conserved residue for proton translocation is found in pore A, a cluster of non-
polar residues at the top of pore A is always found in a vast majority of C type members. 
Evolutionarily, this cluster of non-polar residues might be adopted by C type oxidases as a 
strategy to block D pathway and allowed the development of a single proton uptake pathway 
mechanism as C type evolved from A type oxidases.  
                    
Figure 3.8. Residues chosen for mutagensis in the D pathway analogue (pore A) are labeled on 
the right side. The residues aligned on the left side belong to K pathway analogue. V. cholerae 
numbering is mapped onto P. stutzeri structure.  
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3.4.2     Identification of a K-pathway Analogue as the Only Proton Input Pathway 
The aa3 oxidase has two proton uptake pathways called D pathway and K pathway 
respectively. D pathway is responsible for all ‘pumped’ protons and part of the substrate protons 
while K pathway is only responsible for substrate proton translocation. In contrast, cbb3 oxidase 
has a single proton uptake pathway which is analogous to K pathway in the A type oxidase. 
Therefore, the K pathway analogue in cbb3 oxidase has to be responsible for both substrate and 
‘pumped’ protons theoretically given that studies have suggested cbb3 is capable of proton 
translocation across the membrane [151, 153, 154, 160]. The cbb3 K pathway analogue consists 
of 8 highly conserved residues (V. cholerae numbering): T297, S240, S244, N293, Y227, Y321, 
T219 and Y255 (cross-linked) as shown in Figure 3.7. We systematically mutated these residues 
to investigate their contribution to enzymatic activity, and the results are summarized in Table 
3.1.  
The first group of residues includes two fully conserved tyrosines at the BNC end of this 
pathway: Y321 and the cross-linked Y255 (Figure 3.4). Both Y255F and Y321F mutants has shown 
0% activity compared with WT [146]. Mutation Y255F blocks the uptake of proton into the active 
site as it does in A and B type oxidases while it’s not clear so far how Y321F mutation leads to 
the complete loss of activity. Nevertheless, both of Y255 and Y321 are thus suggested essential 
for substrate and chemical proton translocation. 
The second group of fully conserved residues Y227, N293 and T219 (Figure 3.4) 
displayed different range of activity upon mutation. 1). Y227 has a polar aromatic side chain and 
was mutated into phenylalanine, histidine and alanine. Phenylalanine has a similar side chain 
size but decreased side chain polarity. The Y227F mutant retained 57% WT activity. His has a 
side chain with a closer polarity but smaller aromatic ring size than tyrosine. Y227H 
demonstrated only 18% of WT activity. In addition, with a dramatic decrease in both side chain 
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size and polarity, Y227A demonstrated 12% activity. In conclusion, from the pattern of the 
above trend, Y227 spot is more sensitive to side chain size perturbation than to polarity change. 
2). N293 has a polar uncharged side chain and was mutated into aspartic acid, glutamine, 
leucine and lysine respectively. Compared with asparagine, aspartic acid side chain bares an 
extra negative charge (increased polarity) while the side chain size stays virtually the same. 
N293D mutant displayed 26% WT activity. Glutamine side chain retains the same polarity but is 
longer by one methylene group. N293Q displayed only 8% WT activity. Leucine has a side chain 
at a comparable size with decreased polarity. N293L mutant maintained 15% WT activity. Lysine 
side chain has increased polarity with a positive charge and is longer by two methylene groups. 
N293K mutant displayed 3% WT activity. Introduction of positive charge in N293K might greatly 
hinder the proton uptake. In conclusion, N293 spot is sensitive to both structural change and 
side chain polarity or charge change. However, structural change has a bigger impact than 
polarity change. 3). T219 side chain, similar to that of N293, has a polar uncharged side chain 
and was mutated into Serine, Valine, Alanine and Glycine. Serine has a side chain of the same 
polarity while T219S demonstrated 51% WT activity. Valine has a non-polar side chain at a 
comparable size and T219V mutant demonstrated 48% WT activity. Alanine has reduced side 
chain length as well as polarity, and yet displayed 53% WT activity. Glycine has minimum side 
chain size and polarity, and it killed the activity completely. So far, T219 residue displayed similar 
moderate sensitivity upon change in either side chain polarity or size. Glycine mutant might 
have disturbed the local conformation too much and thus lead to inactive enzyme. 
There are two other interesting residues in the K pathway, H247 and S287 (Figure 3.4). 
Neither of them is fully conserved in the C family (75% and 88% respectively) and yet their 
mutants demonstrated moderate to significant reduction of turnover rate. H247 was believed to 
be a key residue in K pathway based on its drop of turnover rate in glycine mutants of cbb3 from 
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R. sphaeroides [146]. Moreover, H247 locates in the equivalent position as the highly conserved 
K375 of K pathway in aa3 from P. denitrificans [135, 159]. However, H247 is not fully/highly 
conserved in C family and variations as Ser, Ala and Gly occur naturally. Ser variants are mostly 
found in organisms that encoding ccoNOQP while Ala and Gly variants are mostly associated with 
organisms encoding ccoNO only. Our data of cbb3 from V. cholerae showed that both Ala and Gly 
mutants reduced the enzymatic activity down to approximately 20%, instead of completely 
inactive the enzyme like those in A type oxidases [36]. In addition, cbb3 from H. pylori has Ser at 
this equivalent spot instead and is capable of proton translocation [153]. Clearly, H247 in C type 
oxidase is not a functional equivalent of K375 from A type oxidases even if their locations in the 
subunits share similarity. However, H247 is playing a role in maintaining the efficiency of proton 
uptake. S287 shows even smaller variation degree (28 cases of Val, and only one case of Phe and 
Ala each) via phylogenetic analysis and the conservation degree is 13% higher (88%) than H247. 
In addition, all these variants are found in organisms encoding only ccoNO. Despite the higher 
degree of conservation of S287 over H247, S287A mutant only lower the enzymatic activity 
moderately to 54%, suggesting even less contribution to proton translocation compared with 
H247.  
In the group of fully conserved residues, only Y255 and Y321 seem to be important 
residues given that only these two fully inactive the enzyme up on mutagenesis. All the others 
failed to fully inactivate the enzyme, which might indicate a delicate hydrogen bond network 
system: together with H2O molecules, all these residues contribute to an arrangement that 
allows most efficient proton translocation. Factors like charge/polarity or size of their side chain 
plays a role in maintaining the efficiency. Side chain mutations at different sites will introduce 
perturbation into this hydrogen bond network at various degrees. In most cases (away from the 
BNC end of the K pathway analogue), local perturbation won’t fully inactive the enzyme but 
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slowed down the enzyme instead, which demonstrates more flexibility of the K pathway 
analogue than its counterpart in A type oxidases. 
3.4.3     Investigation of K-pathway Entrance 
EII101 from subunit II of A type oxidases (R. sphaeroides) was identified as the pathway 
entrance [39] based on impaired enzymatic activity (8-29%) in mutants [161], reduced proton 
release rate in electron backflow reaction and partial protonation coupled with heme a3-CuB 
center oxidation. Moreover, the fact that PR intermediate formation was not affected in E
II101 
mutants further support the possibility of EII101 as the entrance of K pathway over S299 in A 
type oxidases. In the cbb3 oxidase, we also searched for conserved residues within the proximity 
of cytoplasmic domain’s access to the bulk solution. In V. cholerae, S240, S244 and T297 are 
good candidates as pathway entrance residue as shown in Figure 3.4. We directed studies to 
investigate the perturbations caused in the enzyme by mutation.  
Since single mutation of these completely conserved residues don’t affect activity at all 
[146], double and triple mutations (S240A+S244A, S240A+S244A+T297V respectively) were 
designed. The double mutant slowed the activity to 45% while the triple mutant further reduced 
the activity down to 5%. This indicated that S240, S244 and T297 play an important role in the 
pathway, but in a different way from that of EII101 in aa3.  E
III49 in R.s. cbb3 has been suggested 
to be the entry point of K pathway [148]. Based on the structure of P.s. cbb3, E
III49 is more open 
to the bulk solution while T297 is more berried into the protein backbone and the side chain is 
not accessible to the bulk solution. In addition, low activity in EIII49 single mutant in R.s. cbb3 
might exclude the possibility of T297 as an alternative entrance, or otherwise, single mutation 
shouldn’t display any activity impairment. So far it seems for V. cholerae, EIII49 is also likely the 
physical entrance for the pathway, and S240, S244, T279 together constructs a relative spacious 
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cavity which might harbor an alternative local hydrogen bond network rather than a single linear 
chain for proton translocation as proposed [146].  
 
Figure 3.9. Residues around the entrance of K pathway analogue (prore B) in cbb3. Hydrogen 
bond between W166 and I161 is presented in dashed line at 3.10 Å. V. cholerae numbering is 
mapped onto P. stutzeri structure. 
There is a conserved W166 on helix X with its side chain facing the cytoplasmic side and 
in contact with a conserved Arg from CcoO. At the same time the side chain of W166 is also 
facing the side chain of EIII49. The high conservation degree of W166 had been purely attributed 
to structural stability [146] till our work revealed that W166H could lower the activity to 34% 
and W166F/A further reduced the activity down to 10% while the assembly and cofactor 
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integrity were not perturbed. We propose that shrink in side chain size leads to a wider opening 
of the entrance and therefore leak of H2O from the pathway as a result. Moreover, the N atom 
on the side chain of W166 is suggested to form hydrogen bonded with I161 backbone oxygen 
(Fig 3.9) and loss of this hydrogen bond with the backbone further destabilizes the opening area 
of the entrance and deteriorates the leak of H2O from the pathway. This might be rationalized by 
the lower activity seen with W166F and W166A than that with W166H.  
3.4.4     Conserved Residues in the Proximity of b Heme Propionate Groups  
There are five highly conserved residues other than the ones lining the K pathway.  H341 
and N337 are located above the high spin heme b3 while R59, R61 and R441 are located above 
the low spin heme b (Figure 3.5).  Structure analysis revealed close proximity between these 
residues and the hemes, and therefore site-directed mutagenesis study has been carried out and 
the results are summarized in Table 3.1. 
H341A/Y/D and N337D completely inactivated the enzyme while N337I/L substantially 
impaired the activity down to 2%.  Pyridine hemochrome analysis displayed lower heme c/b 
ratio at less than or close to 1/2 for all mutants. No CcoP band can be visualized with either 
Coomassie or heme staining in SDS PAGE. The data lead to the conclusion that any mutation in 
either of these two residues results in CcoP assembly failure. There is a strong hydrogen bond 
interaction between His341 Nδ / Asn337 Nδ and heme b3 A propionate group oxygen atom 
(2.86/2.82 Å) as shown in Figure 3.10. Activity elimination upon mutation of these two residues 
might indicate that they are not only stabilizing heme b3 conformation and possibly midpoint 
potential, but may also be playing a role as ‘pumped H+’ loading site comparable to heme a3 A 
propionate group, which has been suggested as a good candidate for ‘pumped H+’ loading site 
[64]. It’s still elusive why these mutants also have long range effect on CcoP assembly.  
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One might argue that the inactive enzymes in H341 mutants were a direct result of CcoP 
subunit lost. Ongoing studies of turn over assay reconstituted with the soluble domain of CcoP, 
however, suggested ‘truncated cbb3’ (the rest part of cbb3 without CcoP soluble domain which 
was successfully over expressed and assembled) under the same assay condition still retain 
some low enzymatic activity (unpublished data). This indicates inactive enzyme in the mutants 
can’t simply be explained by the loss of CcoP.  
 
Figure 3.10. Locations of H341 and N337 above the high spin heme b3 in cbb3. Hydrogen bonds 
between His341 Nδ / Asn337 Nδ and heme b3 A propionate group oxygen atom (2.86/2.82 Å) are 
shown in dotted lines. V. cholerae numbering is mapped onto P. stutzeri structure. 
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Equivalent conserved His and Asp (instead of Asn) also occur in B type oxidase (but not A 
type) where Ala mutant of His eliminates the activity while Tyr and Phe act like WT [162]. The 
difference of His mutant activity pattern diminishes the possibility that His341 is a control 
element share by both C and B type oxidases since they both use single proton pathway for both 
substrate and ‘pumped’ proton translocation.  
      
Figure 3.11. Location of R59 above the low spin heme b in cbb3. Distance between important 
atoms for hydrogen bond or charge interaction are shown in dotted lines for R441, D344, KII108 
and heme b propionate A oxygen. V. cholerae numbering is mapped onto P. stutzeri structure. 
 
R59, R61, R441 retained around 70% activity in their Lys mutants while Gln mutants only 
had 3% and 11% activity (no recombinant protein obtained for R441Q). Hemochrome assay and 
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SDS PAGE demonstrated normal heme ratios and staining pattern except for R59Q (Figure 3.11) 
which displayed a lowered heme c/b ratio at less than 1/2 and a failure of CcoP band staining at 
the same time. Obviously, the positive charge on Arg and maybe, the HB network is playing an 
important role. In the case of R61 and R441, they are forming hydrogen bond with heme b 
propionate oxygen atoms as shown in Figure 3.10. In addition, there is a hydrogen bond/charge 
network among propionate A oxygen, D344, KII108 and R441 (Figure 3.11). Gln mutants relax the 
locked conformation of heme b, which is also probably how the Lys mutants lower the activity. 
However, Gln mutants might further perturb heme b midpoint potential which ends up with 
significant slowing-down of electron transfer from heme c (CcoO) to heme b. This perturbation 
becomes even more devastating in R441Q where no recombinant protein could be obtained at 
all. R59Q mutant was greatly slowed down to 3% of WT activity. It was found in close contact 
with a highly conserved (84%) residue EII68 from CcoO. Charge interaction between EII68 and 
R59 might be essential to keep close contact at the CcoN and CcoO interface, and therefore 
guarantee efficient electron transfer from heme c to heme b. Gln mutation on R59 destabilized 
subunits’ interface interaction and thus dramatically slowed down electron transfer. Similar to 
H341 mutants, there is no rationale, so far, for the long range effect of R59Q on CcoP assembly.  
 
 
 
 
 
 
 
 
77 
 
Table 3.1. Summary of Vibrio cholerae cbb3 mutant protein phenotype and performance. 
Mutants Conservati
on 
Activity 
% 
Heme c:b CcoP band in 
gel 
D pathway 
analogue 
R156K 98% 117 3.3 : 2 + 
R156A 89 3.7 : 2 + 
Y209F 86% 70 3.9 : 2 + 
Y145F 69% 90 2.8 : 2 + 
Y145F+Y209F N/A 203 3.6 : 2 + 
K pathway 
analogue 
upper part 
Y255F 100% 0 3.5 : 2 + 
Y321F 99% 0 3.1 : 2 + 
T219V 99% 48 2.9 : 2 + 
T219A 53 2.8 : 2 + 
T219S 51 2.8 : 2 + 
T219G 0 2.7 : 2 + 
Y227F 100% 57 3 : 2 + 
Y227H 18 3.7 :2 + 
Y227A 12 4 : 2 + 
N293D 99% 26 3.8 : 2 + 
N293Q 8 3.5 : 2 + 
N293L 15 4 : 2 + 
N293K 3 3.8 : 2 + 
H247A 75% 15 3.8 : 2 + 
H247G 20 3.6 : 2 + 
S287A 54% 54 3.1 : 2 + 
K pathway 
analogue 
lower part 
(entrance) 
S244A 95% 100 3.8 : 2 + 
S240A 99% 100 3. 5 : 2 + 
T297V 98% 100 3.2 : 2 + 
S240A+S244A N/A 45 3.9 : 2 + 
S240A+S244A+T297V N/A 5 4 : 2 + 
W166F 100% 10 3.5 : 2 + 
W166H 37 1.6 : 2 + 
W166A 12 3.5 : 2 + 
Above the 
high spin 
heme b3 
H341Y 99% 0 0.9 : 2 - 
H341D 0 0.6 :2 - 
H341A 0 0.7 : 2 - 
N337D 92% 0 1.0 : 2 - 
N337I 2 1.1 : 2 - 
N337L 2 1.2 : 2 - 
Above the 
low spin 
heme b 
R59K 98% 80 1.8 : 2 + 
R59Q 3 0.7 : 2 - 
R61K 99% 71 2.7 : 2 + 
R61Q 11 3 : 2 + 
R441K 97% 70 4 : 2 + 
R441Q N/A N/A N/A 
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Chapter 4 : METAL ANALYSIS OF CALCIUM METAL BINDING 
SITES OF CYTOCHROME CBB3 FROM VIBRIO CHOLEREA 
4.1     Introduction 
4.1.1     Nonredox Metals Associated with HCO 
Crystal structures of HCOs have provided clear images about metal ions associated with 
protein. Except for irons and coppers associated with the redox active prosthetic groups, Mg2+, 
Na+, Ca2+, Zn2+ or Mn2+ can also be present as nonredox active metals in HCOs. Nonredox metals 
ions were first revealed by analytical methods and confirmed subsequently by X-ray diffraction 
studies of the crystal structures. Zn2+ is tightly bound to a small, nuclear-coded subunit Vb [31] 
and Mg2+ [163] or Mn2+ [164] is located at the interface between subunits I and II, close to the 
propionate groups of heme a3, suggesting possible involvement in water exit pathway or water 
formation.  
                      
Figure 4.1. Ca2+ binding sites of aa3 oxidases from both bovine heart and R. sphaeroides [165]. 
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Subsequent crystallographic studies had drawn attention to the presence and potential 
significance of a ‘novel cation binding site’ in subuinit I of bovine aa3 which could bind Ca
2+ or 
Na+. Wikstrom and his collaborators discovered that Ca2+ ions bind reversibly to bovine aa3, 
resulting in a small red shift (1-2 nm) of the absorption spectrum of the reduced heme a [166] 
and competing with protons [167] for the binding site. These observations were confirmed by 
other groups [168-170]. The binding site was initially reported to be specific for Ca2+ [167] and 
H+/H3O
+. Subsequent studies showed that Na+, at physiological concentrations, competed 
specifically with Ca2+ and H+ for the binding site [169], although binding of Na+ did not induce the 
spectral shift of heme a. The cation binding sites was identified coordinating a Na+ in the X-ray 
structure of the bovine aa3 (Figure 4.1.)[43], whereas in that aa3 of P. denitrificans [42] and R. 
sphaeroides [14], the site was found complexed to Ca2+. In both mammalian and bacterial 
version of aa3, the cation is located at the periplasmic periphery of subunit I, close to heme a. In 
addition, absorption spectra shift was not observed in aa3 from either P. denitrificans or R. 
sphaeroides, apparently because the Ca2+ is bound tightly in the bacterial version of aa3 as 
prolonged incubation with excess EGTA still retained this cation. The cation binding site appears 
to be missing in the quinol oxidase members [38] and also the B type HCOs [171]. 
Site-specific mutagenesis had then been directed to the Ca2+ binding sites in aa3 from 
both P. denitrificans [172, 173] and R. sphaeroides [165]. Mutants didn’t show any impact on 
electron transfer, enzymatic turnover or any intermediate transitions in the catalytic cycle. 
However, D485A in aa3 from R. sphaeroides and D477A in aa3 from P. denitrificans resulted in 
the loss of the tightly bound Ca2+ with reversibly Ca2+ binding behavior like that for bovine aa3 
and also the red shift of reduced heme a absorption spectra. In addition, Ca2+/Na+ equilibrium 
titration again displayed no effect on the enzymatic activity of WT bovine aa3/D447A P.d. 
aa3/D485A R.s. aa3, whereas D485A R.s. aa3 exhibited noticeable instability in both reduce and 
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oxidized states, losing heme absorption. Therefore, Ca2+ in aa3 is so far believed to maintain the 
enzyme structure stability. 
4.1.2     Non-redox Ca2+ in cbb3 Type Oxidases 
Metal analysis with the ICP (inductively-coupled-plasma)-MS of of cbb3 from P. stutzeri 
prior to crystallization discovered two calcium’s per enzyme [135]. However, the X-ray structure 
of cbb3 from P. stutzeri could only unambiguously locate one Ca
2+ at the interface of CcoN and 
CcoO. This Ca2+ is totally of different location than the Ca2+/Na+ site in the A type oxidases. The 
Ca2+ cation is coordinated to D propionate carboxylic groups of heme b, heme b3 and the 
conserved Glu126 (V.c. numbering) from CcoN, together with the hydroxyl oxygen from SerII107 
(V.c. numbering) of CcoO (Figure 4.2.). Interestingly, cNOR ( C family Nitric Oxide reductase ) 
which shares the highest similarity with cbb3 also has a homologous Ca
2+ site at the equivalent 
position to the conserved Glu as one of the cation’s ligands [134]. This equivalent site is taken by 
a Mn2+ [164] or Mg2+ [163] in A type oxidase and left unoccupied in B type oxidase [171]. 
   
Figure 4.2. Coordination shell of the Ca2+ ion in cbb3 oxidase from P. stutzeri [135](left) and the 
homologous Ca2+ site in NOR between the interface of NorC and NorB [134].  
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Unassigned electron density and the geometry of side chain oxygens of Ala124, Leu162, 
Asn179 and Asp131 (P.s. numbering) suggests the binding of a second Ca2+ in the P. stutzeri cbb3. 
Unfortunately, these residues are not conserved in the C type oxidase. However, the second 
conserved Glu129 is close to both the unambiguous and putative Ca2+ sites (Figure 4.3). 
Moreover, the conserved Glu126 in the case of NOR was suggested to participate in a putative 
proton uptake pathway leading from the periplasmic side [134]. Studies in this chapter 
therefore targets at the Ca2+ stoichiometry in cbb3 from both R. sphaeroides and V. cholerae as 
well as the correlation between Ca2+ binding and the two conserved Glu.  
 
Figure 4.3. Glu126 and glu129 relative position to Ca2+ in V.cholerae cbb3. CcoO was presented in 
transparent orange surface texture.  
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4.1.3     Metal Detection and ICP Technology 
An inductively coupled plasma (ICP) is a type of plasma source in which the energy is 
supplied by electric currents which are produced by electromagnetic induction, that is, by time-
varying magnetic fields. When a time-varying electric current is passed through the coil, it 
creates a time-varying magnetic field around it, which in turn induces azimuthal electric currents 
in the rarefied gas, leading to the formation of plasma. Argon is one example of a commonly-
used rarefied gas. Plasma temperatures can range between 6 000 K and 10 000 K, comparable to 
the surface of the sun. ICP discharges are of relatively high electron density, on the order of 
1015 cm−3. As a result, ICP discharges have wide applications where high-density plasma is 
needed. Another benefit of ICP discharges is that they are relatively free of contamination 
because the electrodes are completely outside the reaction chamber. By contrast, in capacitively 
coupled plasma (CCP), the electrodes are often placed inside the reactor and are thus exposed 
to the plasma and subsequent reactive chemical species. 
ICP has a great potential to be used as a powerful analytical technique in chemistry, 
biology based research and industries. At temperature of approximately 8000 °C, sample 
solution introduced into the core of inductively coupled argon plasma breaks down to basic 
component atoms which get ionized and excited and emit light at their characteristic 
wavelengths. For the detection of these atoms, ICP is usually coupled with optical (atomic) 
emission spectroscopy as ICP-OES (AES) or mass spectrometry as ICP-MS. This is an 
advantageous practice, as both the AES and MS require that sample to be in an aerosol or 
gaseous form prior to injection into the instrument. Thus, using an ICP in conjunction with either 
of these instruments eliminates any sample preparation time which would be required in the 
absence of an ICP.  
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Advantages of using an ICP as an analytical technique include its ability to identify and 
quantify all elements with the exception of Argon; since many wavelengths of varied sensitivity 
are available for determination of any one element, the ICP is suitable for all concentrations 
from ultra-trace levels to major components; detection limits are generally low for most 
elements with a typical range of 1 - 100 g/L. Probably the largest advantage of employing an ICP 
when performing quantitative analysis is the fact that multi-elemental analysis can be 
accomplished, and quite rapidly. A complete multi-element analysis can be undertaken in a 
period as short as 30 seconds, consuming only 0.5 ml of sample solution. Although in theory, all 
elements except Argon can be determined using and ICP, certain unstable elements require 
special facilities for handling the radioactive fume of the plasma. However, an ICP has difficulty 
handling halogens. Special optics for the transmission of the very short wavelengths become 
necessary in this case. 
4.2     Materials and Methods 
4.2.1     Materials 
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT, 
Coralville, IA). QuickChange Kits were obtained from Stratagene (Agilent Technologies, Santa 
Clara, CA). The pBADVCB plasmid (Ampr) used as template for mutagenesis and 1kb DNA 
standard for DNA agarose gel were purchased from Invitrogen (Life Technologies, Grand Island, 
NY). Restriction enzyemes were purchased from New England BioLabs (Ipswich, MA). Miniprep 
Kit was purchased from Fermentas (Thermo Scientific, Glen Burnie, MD). N-dodecyl-ß-D-
maltoside (DDM) was purchased from Anatrace (Maumee, OH). Arabinose, ampicillin, 
streptomycin and other chemicals used in LB/M9 medium and purification buffers were 
obtained from Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). Filter paper/kits 
were purchased from Millipore (Billerica, MA). Ni-NTA resin for purification was purchased from 
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Qiagen (Valencia, CA). Slide-A-Lyzer dialysis cassette was obtained from Pierce (Thermo 
Scientific, Glen Burnie, MD). GeneMate Express 6%-18% gradient PAGE gels were purchased 
from ISC BioExpress (Kaysville, UT). E. coli X10 Gold used for cloning of sited-directed 
mutagenesis PCR products was purchased from Stratagene (Agilent Technologies, Santa Clara, 
CA). Vibrio cholerae O395 strain (deletion of pathogen gene and ΔccoNOQP Smr) used for cbb3 
expression was constructed by Dr. Hemp. Microfluidizer for cell lysing was manufactured by 
Watts Fluidair, Inc. Beckman ultracentrifuge L-8M was manufactured by Beckman Coulter, Inc 
(Indianapolis, IN) and Sorvall RC-5B+ centrifuge systems were manufactured by DuPont 
(Wilmington, DE). 
4.2.2     Site Directed Mutagenesis 
Site-directed mutagenesis was performed using QuickChange kits as previously reported 
[155]. The quick change PCR primers used for mutagenesis were synthesized by Integrated DNA 
Technologies (IDT). Sequence verification of the mutagenesis reactions was performed at the 
Biotechnology Center at the University of Illinois, Urbana-Champaign.  
4.2.3     Cell Growth and Purification of the His-tagged cbb3-Type Oxidases 
R. sphaeroides was grown semi-aerobically at 30 °C in Sistrom media with 2 µg/mL 
tetracycline (Sigma). V. cholerae was grown aerobically at 37 °C in modified M9 medium (0.1% 
glucose, 1mM MgSO4 and supplemented with, 10 mg/L thiamine, 10 μM CuSO4, 50 μM FeSO4) 
with 100 µg/mL ampicillin (Fisher Biotech) and 100 µg/mL streptomycin (Sigma).  It was found 
that the expression of the V. cholerae cbb3 was equally good if the cells were grown in the 
minimal medium as in LB.  However, protein purified from cells grown in minimal medium had 
fewer metal contaminants and more consistent metal analyses.  
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The wild type and mutant cbb3 proteins (with polyhistidine tags) from R. sphaeroides and V. 
cholerae were overexpressed and purified as previously described [155] using the detergent 
dodecylmaltoside (DDM).  GeneMate Express SDS-PAGE gels from ISC BioExpress were used to 
evaluate the isolated protein complexes, using Coomassie Brilliant Blue staining. The CcoO and 
CcoP subunits were visualized by heme staining [158] since each of these subunits contains 
covalently bound heme c.   
4.2.4     UV/Vis Spectroscopy 
A Shimadzu UV/Vis-2101PC spectrophotometer was used to obtain the spectra of wild 
type and mutant enzymes. The concentrated protein samples were diluted with 10-20 mM Tris 
buffer and 0.05% DDM at pH 7.5-8.0. The enzymes were oxidized by air and reduced with 
sodium dithionite (Sigma). Spectra were measured from 300 nm to 800 nm and analyzed using 
Origin software. 
4.2.5     Pyridine Hemochrome Assay 
The concentrations of heme b and heme c were determined as previously described 
[157]. 0.5ml of a stock solution containing 200 mM NaOH and 40% (by volume) pyridine and 3µl 
of 0.1M K3Fe(CN)6 were placed in a 1 mL cuvette.  A 0.5 mL aliquot of the protein sample (~5 μM) 
was added with thorough mixing and spectrum of the oxidized hemes was recorded within 1 
minute. Solid sodium dithionite (2-5mg) was then added and several successive spectra of the 
reduced pyridine hemochromes were recorded.  The absorbance differences at selected 
wavelengths were used to obtain the concentrations of heme b and heme c. In some cases after 
reduction by dithionite, turbidity resulted in a distorted baseline.  This was corrected by fitting 
the baseline to either an exponential or a 3rd order polynomial and subtracting this from the 
experimental spectrum. 
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4.2.6     Steady-state Activity 
A YSI model 53 oxygen monitor was used to polarographically measure steady-state 
oxidase activity at 25° C. To the sample chamber was added 20µL 1 M ascorbate, pH 7.4, 10µL of 
0.1 M TMPD and 1.8 mL of 50 mM sodium phosphate buffer, pH 6.5 containing 100 mM NaCl 
and 0.05% DDM. Horse heart cytochrome c (Sigma) was added as the substrate to a final 
concentration of 40 µM in the case of R. sphaeroides cbb3. The reaction was initiated by adding 
10 µL of a solution containing 1 µM enzyme, and the rate of oxygen consumption was 
monitored.  
4.2.7     Metal Analysis by ICP-OES 
Metal content of the protein was determined by inductively coupled plasma - optical 
emission spectroscopy (ICP-OES) using a Spectro Genesis spectrometer as previously described 
[174]. The buffer containing the purified V. cholerae cbb3 protein was exchanged using a 100 kD 
cut-off Amicon concentrator (Millipore). The buffer was exchanged 3 times with 10 mM Tris 
buffer, pH 8, containing 0.05% DDM, 5% glycerol, 0.25 mM EDTA and 0.1 mM EGTA, followed by 
another 3 times with the same buffer without EDTA and EGTA.  Purified R. sphaeroides cbb3 
protein samples were incubated with 1 mM EDTA and 0.1 mM EGTA and then dialyzed against 
20 mM Tris buffer, pH 7.5, containing 30 mM KCl, 1 mM EDTA and 0.05% DDM. After dialysis, 
the protein was concentrated using the 100 kD cut-off Amicon concentrator. Metal 
concentrations were calculated from regression lines of element standards run as samples 
rather than the regression lines produced by the Spectro software to avoid a 10% 
underestimation of element concentrations at low levels of the metals. 
4.3     Results 
4.3.1     Conservation of the Glutamate Residues at or Near the Ca2+ Binding Site 
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The one Ca2+ clearly observed in the structure of the cbb3-type oxidase from P. stutzeri is 
ligated to the carboxyl of E122 (CcoN subunit) and to a serine, S102, located in the CcoO subunit, 
in addition to the two D-propionates from the low-spin heme b and the active-site heme b3, 
which are located in the CcoN subunit.  Sequence alignments show that E122 (CcoN) is >99% 
conserved, replaced by a glutamine in the few exceptions, and S102(CcoO) is completely 
conserved.  The nearby glutamate, E125 (CcoN) is not ligated to the Ca2+ but is also very highly 
conserved (>99%).  These data are included in Table 4.1. Also shown is the pattern of 
conservation of the equivalent residues in the qNOR and cNOR families. In the cNOR enzymes, 
as in the C-family oxygen reductases, the Ca2+ has ligands that bridge two separate subunits 
(NorC and NorB), and it is the ligand from the subunit which contains cytochrome c (CcoO or 
NorC), which is most highly conserved. The two glutamates are less conserved in the cNOR 
family than in the cbb3 oxygen reductases, and even less conserved in the qNOR family.   
4.3.2     Metal and Heme Content of the Wild Type cbb3-Type Oxygen Reductases 
 The metal contents of the cbb3 enzymes from V. cholerae and from R. sphaeroides are 
shown in Table 4.2.  These enzymes contain 3 hemes c, 2 hemes b and 1 CuB, so the Fe/Cu ratio 
should be 5/1.  The observed ratios are higher than this, Fe/Cu = 7.5 and 10.1 for the V. cholerae 
and R. sphaeroides enzymes, respectively.  These high values could be due to loss of CuB or 
contaminating Fe, or both. The ratio of heme c/heme b should be 3/2=1.5, and the measured 
values are 1.9 and 1.5 for the V. cholerae and R. sphaeroides enzymes, respectively (Table 4.2).   
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Family E1221 (in CcoN) 
Ca+2 ligand 
E1251 (in CcoN) S1021 (in CcoO) 
Ca2+ ligand 
C-family E (Q) >99% E (D, Q, K) 99% S, T 100%  (in CcoO) 
cNOR E (K, P, H, V, G) 85% E (D) 95% Y >99%  (in NorC) 
qNOR E (A, S, D, P) 80% D (E, S, Q, N, T) 45% Y 90% 
Table 4.1. Conservation of residues important for calcium binding in the C-family of oxygen 
reductases and the cNOR and qNOR families of NO reductases. The percent conservation of the 
residues is given, along with the variants for each family. 
 The Ca contents of the enzymes are presented in Table 4.2 as either a ratio to Cu or to 
Fe.  If the Ca stoichiometry is taken as a ratio to the total iron content, the data indicate at Ca 
content of 1.1 and 1.4 equivalents per mol of enzyme (5 Fe per enzyme molecule) for the V. 
cholerae and R. sphaeroides cbb3 oxygen reductases, respectively.  The Ca stoichiometry that is 
determined from the Ca/Cu ratio is higher in both cases, about 1.8 for the V. cholerae enzyme 
and 2.4 for the R. sphaeroides enzyme. It is noted that the possible presence of a second Ca2+ in 
the cbb3 from P. stutzeri is also unclear, both from the crystal structure itself and from the metal 
analysis [135].  
 At this point, with the current enzyme preparations, it is not possible to conclude with 
confidence whether these enzymes contain one or two equivalents of Ca2+.  For convenience, 
the Ca2+ stoichiometries of various mutants are reported as the values determined based on the 
amount of Fe present (assuming 5 Fe per mol of enzyme). 
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Subunit 
 
Strain Mutant Activity 
(% WT) 
[C]/[B] 
ratio 
Ca/Cu 5(Ca/Fe) 
 
 
 
 
 
 
 
 
CcoN 
R. sphaeroides WT 1001 1.5 2.4±0.3 1.44±0.5 
R. sphaeroides E180D <1 1.72  0 
R. sphaeroides E180Q 1 1.62  0 
R. sphaeroides E180G <1 2   
R. sphaeroides E183D 1 1.62  0 
R. sphaeroides E183Q 7 1.5 1.92±0.34 1.13±0.23 
R. sphaeroides E183G 1 4   
      
V. cholerae WT 1001 1.9 1.82±0.05 1.11±0.2 
V. cholerae E126D 2 1.8   
V. cholerae E126Q <1 1.2  0.55±0.33 
V. cholerae E126G <1 1.2   
V. cholerae E129D 11 1.3   
V. cholerae E129Q 18 1.7  0.63±0.4 
V. cholerae E129G 2 1.8   
V. cholerae E129A 2 1.5   
      
 
CcoO 
R. sphaeroides S105T <1    
R. sphaeroides S105A <1    
R. sphaeroides S105G <1    
 Table 4.2. Characteristics of wild type and mutant cbb3-type oxygen reductases. 
 
1The activities of the R. sphaeroides and V. cholerae cbb3-type oxygen reductases were 800 e
-
/sec and 500 e-/sec, respectively.  See Methods section for details.  
2For these mutants, the low spin heme b component of the oxidase, though present, was not 
reduced by dithionite in the assembled enzyme. 
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4.3.3     Site-directed Mutagenesis of the V. cholerae cbb3 Oxygen Reductase 
 E126 (Ca2+ ligand): The E126D, E126Q and E126G mutations were characterized.  As 
shown in Table 4.2, each of these mutations is virtually inactive (2%, <1%, <1%, respectively).  
The ratio of heme c to heme b of the E126D mutant is similar to that of the wild type, but both 
E126Q and E126G have a lower ratio. SDS-PAGE analysis shows that both of the heme c-
containing subunits [135]. CcoO and CcoP, are present in each mutant, though this is qualitative 
and not quantitative.  The Ca stoichiometry was measured for the E126Q mutant and is about 
half of the wild type.  Hence, mutation of the Ca ligand results in both the loss of Ca and loss of 
activity. 
 E129:  The E129D, E129Q, E129G and E129A mutants were characterized.  The E129D 
and E129Q mutants have 11% and 18% of the wild type activity, whereas the E129G and E129A 
have less than 2% activity (Table 4.2).  The heme c/heme b ratio ranges from 1.3 to 1.8 
(expected is 1.5). The Ca stoichiometry was determined for the E129Q mutant and was shown to 
be about half of the wild-type value (Table 4.2), 0.63 vs 1.11 equivalents of Ca per mol of 
enzyme.  Even though E129 is not directly ligated to the bound Ca, a mutation in E129 can still 
cause loss of this metal, apparently by an indirect interaction. 
4.3.4     Site-directed Mutagenesis of the R. sphaeroides cbb3 Oxygen Reductase 
 E180 (Ca2+ ligand):  The E180D, E180Q and E180G mutants were examined.  All were 
virtually inactive (Table 4.2) and the yield of E180G was very low, implying instability or an 
assembly problem.  The E180G mutant was not examined further. Metal analysis of both E180D 
and E180Q showed that not only was there no Ca but also that there was no Cu.  In addition, the 
dithionite reduced-minus-oxidized UV/visible spectra show that the loss of Cu in E180Q and 
E180D is coincident with the lack of reduction of heme b.  The content of heme b in the mutant 
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enzymes is similar to that of the wild type enzyme, as shown by the pyridine-hemochrome 
analysis (Table 4.2), but the low spin heme is not reduced by dithionite in the assembled enzyme 
(Figure 4.4).  This indicates substantially more damage due to the alteration of the Ca ligand in 
the R. sphaeroides enzyme than in the V. cholerae enzyme. The nature of this perturbation to 
the low spin heme b was not explored further. It is noted, however, that this unusual mutant 
phenotype of a heme that is not reducible by dithionite has been previously observed in a 
mutant of the cytochrome bd quinol oxidase from E. coli [175]. 
 E183: The E183D, E183Q and E183G mutants were characterized. All the mutants have 
very low (or no) oxidase activity, with the highest activity (7%) observed with E183Q (Table 4.2).  
The E183G was obtained in very low yield and was not examined further.  The E183D mutant 
had properties similar to those of the E180 mutants insofar as there was loss of both Ca and CuB, 
and the low spin heme b component was not reduced by dithionite (Figure 4.4).  The E183Q 
mutant retains a small amount of oxidase activity (7%), and has partial loss of Ca2+ but no loss of 
Cu (Table 4.2).  This is the only R. sphaeroides mutant of those examined in which loss of activity 
is not correlated with a massive loss of Ca2+.  
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Figure 4.4. Dithionite-minus-air oxidized difference spectra of the R. sphaeroides cbb3–type 
oxygen reductases. The 551 nm peak is due to hemes c and 561 nm peak is mostly due to the 
low spin heme b.  The data show the absence of the spectroscopic signature for reduced heme b 
in the E180D, E180Q and E183D mutants. 
 S105 (CcoO):  The S105T, S105A and S105G mutations were made but no expressed 
protein was obtained for any of the mutants.  This Ca2+ ligand appears to be absolutely 
necessary for protein assembly/stability. 
4.4     Discussion 
Prior to the availability of X-ray structures, the conserved pair of glutamates in a 
putative periplasmic “loop” appeared to be reasonable candidates as participants in proton 
translocation to/from the active sites of the cbb3-type (C-family) oxygen reductases as well as 
the related cNOR and qNOR families of NO reductases . Models suggested that these glutamates 
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might be located near the perisplasmic surface of the proteins [176, 177] and site-directed 
mutagenesis indicated that the glutamates are functionally important in both the cbb3
 oxygen 
reductases and cNOR enzymes [149, 176, 178].  In the case of the cNOR enzymes, protons 
required for the chemistry at the active site come from the periplasm [176, 179, 180] and the 
limited data were consistent with these glutamates playing a role to provide a pathway for 
proton transfer to the active site [180].  For the cbb3 enzymes, protons for the chemistry at the 
active site must come from the opposite side of the membrane [146, 154], so the glutamates 
were proposed to provide a pathway for pumped protons to exit to the periplasm [146].  The X-
ray structures [135, 181, 182] as well as recent functional information, including the data 
presented in the current work, make these proposals less likely. 
The X-ray structures of the cbb3 oxygen reductase, the cNOR and the qNOR each reveal 
a single Ca2+ that bridges propionates on heme b and heme b3, and is also ligated to a glutamate 
carboxyl [135, 181, 182], E122 in the case of the P. stutzeri cbb3.  There is extra electron density 
in the P. stutzeri cbb3 structure [135] that suggests the possibility of a second Ca
2+ near E125.  
Metal analysis also indicates that there might be a second Ca2+ present in the P. stutzeri cbb3 
oxidase [135].  The current data on the V. cholerae and R. sphaeroides cbb3 enzymes are 
similarly ambiguous about the possibility of a second Ca2+ (Table 4.2). Metal impurities in the 
protein preparations, present even after three column chromatography steps, as well as 
possible loss of metals, contribute to the uncertainty.   
The X-ray data [135, 181, 182] show that in each of these enzyme families (cbb3, cNOR, 
qNOR) , the two glutamates are not near the surface in contact with the bulk aqueous phase, 
but are more interior.  The upstream member of the pair (lower residue number) is, in each case, 
ligated to a Ca2+.  The downstream glutamate is not ligated to the Ca2+ nor part of a salt bridge, 
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but participates in a network of hydrogen bond interactions in each protein. The possible 
second Ca2+ in the cbb3 structure is located near this downstream glutamate [135].  There is only 
one Ca2+ in the structures of the cNOR and qNOR [181, 182].  
The very high (> 99%) degree of conservation of each of the two glutamates in the 
sequences of the cbb3 oxygen reductases makes it evident that they are both important in these 
enzymes (Table 4.1).  This is confirmed by the site-directed mutagenesis presented in the 
current work (Table 4.2).  Regardless of the uncertainty of whether there is one or two Ca2+ in 
the wild type enzymes, the pattern for both the V. cholerae and R. sphaeroides cbb3 mutants is 
that substitution for either of the glutamates results in substantial loss of activity as well as 
partial or complete loss of Ca2+ (Table 4.2).  Changing the Ca2+ ligand, E126 (V. cholerae) or E180 
(R. sphaeroides), results in virtually complete loss of function as well as partial or complete loss 
of Ca2+ (Table 4.2).  In the R. sphaeroides mutants, the extent of evident damage is greater, 
including loss of CuB.  Note that if the wild type enzyme is interpreted to contain 2 Ca
2+, then a 
single mutation (E180D or E180Q) results in the loss of both Ca2+.  Loss of function due to these 
mutations can be most easily interpreted as a consequence of gross conformational changes.  
The mutagenesis data do not rule out a role of this glutamate in proton translocation but, 
importantly, cannot be used in support of such a role. If E180 were to cycle through a state 
during catalysis in which it were protonated and no ligated to the Ca2+, one would not expect 
the E180Q mutation to cause so much damage since glutamine to some extent resembles a 
protonated glutamate. 
Changing the downstream glutamate, E129 (V. cholerae) or E183 (R. sphaeroides), also 
invariably results in loss of function, though the results are more varied and not as absolute as 
observed with the mutations of the Ca2+-ligating glutamate. The V. cholerae protein is more 
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tolerant of mutations at this position than is the R. sphaeroides enzyme. E129D and E129Q in 
the V. cholerae enzyme retain 11% and 18% activity, respectively, whereas E183D and E183Q 
from the R. sphaeroides oxidases retain only 1% and 7% activity. In all cases, either partial or 
complete loss of Ca2+ is observed. 
The following are reasonable conclusions from the data. 
1) The cbb3 oxygen reductases contain either one or two Ca
2+.  Our data do not 
resolve this uncertainly, raised initially from the work on the enzyme from the P. stutzeri 
enzyme [135].  
2) The Ca2+ at the binding site that is apparent in the X-ray structure is essential for 
function of the cbb3 oxygen reductases. Mutations that result in the loss of Ca
2+ or disruption of 
the Ca2+ binding site results in the loss of enzyme activity.  It is likely that the Ca2+ is important to 
maintain the protein in a conformation in which the hemes and CuB are functional. The role of 
the Ca2+ to form a bridge between the CcoN and CcoO subunits is also critical, as evidenced by 
the lack of protein assembly when the Ca2+-liganding amino acid in the CcoO subunit (S105) is 
substituted by another amino acid. The essential nature of the Ca2+ in the cbb3 oxygen 
reductases is in contrast to the Ca2+ which binds near the low-spin heme in some of the A-family 
oxygen reductases, but which is not required for assembly or enzyme activity [165, 183]. 
3) Depending on the mutation and which enzyme is studied, mutating the non-
liganding glutamate (downstream member of the pair), the cbb3 enzyme can be inactivated 
along with partial or complete loss of Ca2+.  There is no reason to attribute the loss of function to 
blocking proton transfer of the pumped proton away from the cbb3 active site. It is not evident, 
in any event, that blocking the pumped proton would necessarily inhibit oxidase activity. 
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The conclusion that the role of the Ca2+ is primarily to stabilize the heme and protein for 
optimal activity has also been made for the related NOR enzymes [182, 184-186]. Note that the 
two glutamates examined in the current work are not nearly as well conserved in the cNOR and 
qNOR sequences as in the sequences of the cbb3 oxygen reductases (Table 4.1).  This is 
particularly true for the qNORs.  When present, the Ca2+ ligands are important, as shown by the 
fact that mutants of each of the Ca2+ ligands (E429 and Y93) in the qNOR from Geobacillus 
stearothermophilus lose most of their activity as well as Ca2+ [182].  It’s possible that among 
those variants lacking the equivalent glutamate in the qNOR and cNOR, some use different 
ligands instead, while the others abandon Ca2+ site because alternative structural features fulfill 
the role of Ca2+. It is possible that in the qNOR and cNOR variants lacking the equivalent 
glutamate, the Ca2+ has a different ligand or, alternatively, the role of the Ca2+ is filled by 
alternative structural features.  There are credible hydrophilic pathways which bypass the two 
glutamates for delivering protons from the periplasm to the active site in the cNOR enzymes, so 
there is no certain need for the role of the glutamate pair in proton translocation in either the 
cNOR or qNOR enzymes [184, 185].  Experimental tests will be required, however, to determine 
the input pathway(s) for protons to reach the active sites of the qNOR and cNOR enzymes. 
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Chapter 5 : STOPPED-FLOW AND EPR STUDY OF PM AND F 
RADICAL IN BO3 TYPE QUINOL OXIDASE WITH REGULAR AND 
RING DEUTERATED TYROSINE INCORPORATION 
5.1     Introduction 
5.1.1     Bo3 Type Ubiquinol Oxidase and Comparison with A-type Cytochrome c Oxidase 
Cytochrome bo3 is a transmembrane, four-subunit enzyme in the plasma membrane of E. 
coli coded by the cyoABCED operon. With a molecular weight of 144KDa [187], cytochrome bo3 
belongs to the heme-copper oxidase superfamily and is highly homologous to A type 
cytochrome c oxidases. It serves as the primary terminal oxidase in E. coli under aerobic 
conditions, catalyzing the oxidation of ubiquinol, from the quinol pool, and reduction of 
dioxygen. The energy released by the reaction results in net translocation of protons across the 
membrane to generate proton motive force. The overall reaction is summarized in Figure 5.1. 
                         
Figure 5.1. The overall reaction catalyzed by cytochrome bo3 ubiquinol oxidase from E. coli. The 
protons from the oxidation of ubiquinol (QH2) are released into the periplasm (H
+
out) while the 
protons for the oxygen reduction are taken up from the cytoplasm (H+in). In addition, the 
enzyme pumps two protons across the membrane. 
N-side
P-side
QH2
Q
Q
2H+out
2e–
4H+in
2H+out
½O2
H2O
heme b
heme o3
CuB
(QH-site)
QH2 Q + 2H+out + 2e–
2e– + ½O2 + 2H+in H2O
QH2 + ½O2 + 4H+in Q + H2O + 4H+out
2H+in 2H+out
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Sequence analysis revealed high homology between subunits I, II and III of bo3 with its 
counterparts of the aa3 type cytochrome c oxidase, especially aa3 from P. denitrificans. The 
crystal structure of cytochrome bo3 at a resolution of 3.5 Å has shed light on the correlation 
between structure and function of the enzyme (Figure 5.2.)[38].  
Subunit I has 15 transmembrane helices which is three more (one at N terminus (helix 0) 
and two at C terminus (helix XIII and XIV)) compared to its counterpart in aa3. Subunit I in bo3 
shares very similar proton uptake pathways to those in aa3 and this suggests that they have 
similar mechanisms. The equivalent Asp135 and Glu286 were found at the lower and upper end 
of D channel in bo3. Bo3 has the putative cross-linked Tyr288 and hydroxyl group (from heme o) 
at the upper end, similar to aa3, while Glu
II89 at the protein interface serves as the entrance of 
the K pathway. However, at the current resolution, it’s not possible to determine if a covalent 
bond forms between His284 and Tyr288. Bo3 has a heme b at the low spin site and o heme at 
the high spin site coupled with CuB instead of two a hemes. A QH site for quinol binding, is 
present in the membrane domain involving residues from helix I, II and III, since bo3 uses quinol 
as the electron donor, unlike aa3 which uses cytochrome c. Neither Mg
2+/Mn2+ nor Ca2+/Na+ 
binding sites, which can be found in aa3, is observed in this enzyme. 
99 
 
 
Figure 5.2. Subunits’ arrangement and redox cofactors comparision between bo3 in E.coli and 
aa3 in P. denitrificans. Upper row are the top views from periplasmic side and lower row are side 
views through the membrane [38]. 
Subunit II in bo3 has a similar combination of two transmembrane helices and a soluble 
periplasmic domain with notably similar location, as within the complex of aa3. However, bo3 
has no CuA center and lacks some of the metal ligands (His 181, His224, Cys216 and Cys220 in 
P.d. aa3). Subunit III has five helices compared to seven in P.d. aa3. The positions of these five 
helices are similar to those of helices III-VII in P.d. aa3. Interestingly, helices 0 and XIV from bo3 
subuint I are at the same location as helices I and II in P.s. aa3 (Figure 5.2.). Subunit IV in bo3 
contains 3 transmembrane helices with the third helix residing in a similar position to the single 
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helix in subunit IV from P.d. aa3. The last two subunits from both bo3 and aa3 have no redox 
cofactor/metal groups associated. 
5.1.2     Comparison of P and F Intermediates in aa3 and bo3 
High degree of structural homology between bo3 and aa3 suggested that the mechanism 
of proton uptake and the transition of intermediates in the catalytic cycle might be similar. In 
fact, this hypothesis has been supported in many aspects by a rich collection of experiments. 
Reaction of O2 with UQ-8 bound fully reduced bo3 displayed very similar multiphasic kinetics in 
flow-flash experiment as those in aa3 cytochrome c oxidase [188]. Starting from fully reduced 
bo3 enzyme without the bound UQ-8, the final product of bo3 with O2 should be F assuming the 
aa3 type mechanism is followed. This was also confirmed experimentally. The oxidation phase of 
the catalytic cycle of bo3 is better characterized than the reduction phase with the emphasis on 
the P and F intermediates. These intermediates could be generated transiently in the forward 
reaction with O2 [189], as described in Chapter 1, or trapped by partially reversed reaction [190], 
incomplete forward reaction [191] or mimic reaction with H2O2 [192, 193].  
In aa3 for example, incubating the CO-inhibited fully oxidized enzyme (R4) with O2, after 
flash photolysis of CO, starts the reaction of O2 with R4. Single wavelength detector was able to 
detect 3 transitions corresponding to 3 intermediates [79]. Comparing with the oxidized form (O) 
of enzyme,  these intermediates were later on assigned A, PR (607nm species) and F (580nm 
species) with low temperature experiments [189]. However, the conversion from O to PR is still 
too transient for any detailed static spectroscopic study. One way to overcome this is incubation 
of O with CO which generates 2 electron reduced R2. R2 could only be converted by O2 to the 
second intermediate P(PM) [191]. PM and PR are optically indistinguishable except that the 
crosslinked tyrosine is a neutral radical in PM instead of a tyrosinate as in PR.  An alternative 
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route to generate PM is by reaction of O with stoichiometric amount of H2O2 at alkaline pH [192, 
193]. PM produced this way is also stable enough till another equivalent H2O2 is available when 
PM can be further reduced to F. Both PM generated with COMV or H2O2 favors alkaline pH. Shift 
from alkaline to acidic pH causes the formation of a new artificial species F• which has the same 
optical feature at 580nm as F and is isoelectronic with PM. 
  
Figure 5.3. Left: PM-O(607 nm)  and F-O(580 nm) intermediates optical spectra in aa3 [190]. Right: 
PM-O(582nm) and F-O(557nm) intermediates optical spectra in bo3 [194]. Both PM-O and F-O in 
aa3 and bo3 feature the ligand-metal charge transfer(LMCT) band lost at 650nm and 624nm 
respectively. This indicates that both of the two intermediates convert the high spin heme iron 
(Fe3+-OH) into low a spin heme iron (Fe4+=O2-) 
Several studies have demonstrated that cytochrome bo3 follows the same pattern of 
native [188, 195]/mimic intermediates conversion in the oxidation phase with several distinct 
features.  A) The optical spectra peaks generally blue shifted ~24nm (Figure 5.3) [194] given that 
this reaction is taking place at heme o rather than heme a. B) PM generated with either 
stoichiometric amount of H2O2 under alkaline pH [196] or COMV [197] in bo3 is not as stable as 
that in aa3, and will decay into F. This might indicate that the electron responsible for the decay 
does not come from peroxide. The source of this electron is still elusive since UQ-8 free bo3 
displayed the same decay in this thesis. However, it’s unlikely that the decay is the real 
transition from P to F in the catalytic cycle since the rate constant is much slower than the 
enzyme turn over.      
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5.1.3     Debate Over the Radical Associated with Ferryl-oxo Intermediates 
In the study of P and F intermediates from P. denitrificans aa3, two free radical species 
were detected (Figure 5.4) in the X band CW-EPR [192] under the condition where F or F• is 
produced in H2O2 mimic reaction but not with the COMV experiment. Control experiments with 
KCN inhibited enzyme failed to display the same radical signal, which suggested the involvement 
of the binuclear center. In addition, proton exchange experiments with D2O revealed no 
exchangeable H+ is associated with the radicals as no collapse/change of signal was observed. 
MCD data further ruled out the possibility of porphyrin π-cation participation. The finding was 
thus taken as evidence of nearby amino acid being oxidized as radical during the formation of F/ 
F•. Tyrosines and tryptophans close to the active site were thought to be good candidates. This 
discovery initiated a series of studies trying to identify the radical species and their correlation 
with ferryl-oxo intermediates.  
Following investigations illustrated that the radical species could also be observed with 
PM produced with H2O2 reaction in P.d. aa3 (Figure 5.4)[198] and bovine cytochrome c oxidase 
(Figure 5.4)[193]. PM generated with COMV in bovine cytochrome c oxidase also failed to 
generate radical of any kind. However, F• generated with COMV displayed the radical signal [199] 
which is coherent with the early finding in P.d. aa3. Observation of radical species for both P.d. 
aa3 and E. coli bo3 corresponding to PR later on was achieved in microsecond-freeze-
hyperquenching experiment [200]. 
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Figure 5.4. Upper left: The two radical species, one with 45G peak-to-trough line width and the 
other with 11G line width, originally discovered in P. denitrificans. aa3 reaction with H2O2 under 
the condition for F/ F• [192]. Upper right: The same radical species later found in bovine 
cytochrome c oxidase reacting with H2O2 for F• (Trace A), F•/F (Trace B), F (Trace C,E), PM (Trace 
D) [193].Lower left: The same radical species found in the PM (Trace C), F• (Trace A) and F (Trace 
B) by H2O2 reaction with P. denitrificans aa3 [199].Lower right, radicals found corresponding to 
PR by MHQ technique for both bo3 and P. denitrificans aa3 [200]. 
Meanwhile, studies to identify the origin of the radical species were carried out to 
decide between, primarily, Tyr or Trp being the origin of the radical generated. Nevertheless, 
radical assignment on other amino acid like Cys498 was also suggested [201]. 
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Evidences supporting tyrosine origin mainly came from radical signal change upon 
deuterated tyrosine [202] incorporation and site-directed mutagenesis [198]. The hyperfine 
structures were further analyzed by simulation from Tyr spin density distribution and anisotropy 
parameters [202, 203] and try to resolve the anisotropic structure in higher frequency Q and D 
band EPR [198]. ß-hydrogen orientation was successfully correlated with the hyperfine splitting 
pattern and therefore both crystal structure and mutagenesis data [198] lead to the conclusion 
that Tyr167 (P.d. numbering) is the origin of the 45G line-width F signal. Another creative 
experiment was done with bovine cytochrome c oxidase P generated with COMV [12]. The 
radical is trapped by 125I and the protein is broken down by hydrolysis and subsequently mapped 
and tracked for the 125I isotope. 125I was found on the crosslinked Tyr244 (bovine numbering) 
instead of Tyr167 (P.d. numbering). In contrast, F failed to carry 125I radioactivity. Most recent 
study by rapid freeze quench technology combined with X-band and D-band analysis led to 
the identification of radicals on Tyr-244 and Tyr-129 (bovine numbering)[204] whereas no 
detailed analysis has been provided. 
Support for Trp origin of the 45G line-width F• radical came from similarity of ENDOR 
spectrum produced by H2O2 reaction with bovine cytochrome c oxidase and with cytochrome c 
peroxidase [199, 205]. Further D2O exchange data revealed hyperfine coupling assigned to N1-
proton typically seen in Trp cation radical. Similar to the above, ß-hydrogen orientation / hfc 
coorelation was discussed and mapped onto X-ray structure. As a result, Trp126 or Trp236 were  
tentatively assigned to the broad signal which was also later detected in F• converted from 
COMV produced PM  [199]. Moreover, radicals observed by MHQ technique for P.d. aa3 and 
E.coli bo3 were also interpreted as Trp cation radical [200]. However, no further evidence was 
presented. In addition, the 11G-linewidth radical associated with PM in bovine cytochrome c 
oxidase was also investigated with ENDOR in [203]. The similarity between this radical and horse 
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radish peroxidase lead to the assignment of a porphyrin cation radical. Even though MCD data in 
Fabian’s work [192] had rejected this assignment earlier, it was argued that the concentration of 
this radical is much lower (<7% spin/aa3) than  the total ferryl iron species. 
EPR studies on the radicals associated with ferryl-oxo intermediates so far are still scarce, 
mainly focused on fast freeze quenching capture of the radicals in a single turn over with O2 
[200, 206, 207]. High spin heme o3 signals at g=6.0 were lowered coincided with the emerging of 
free radical signals similar to those in bovine and P.d. aa3 were observed. This indicates the 
radical is associated with ferryl-oxo species, or in other words, P/F intermediates. Trp cation 
radical was tentatively assigned though no hyperfine structure in detail could be resolved so far. 
Scarcity of information about radical intermediates inspired the study in Chapter 5. 
5.1.4     Bo3 Over-Expression System 
The over-expression system used in E. coli strain for bo3 production takes advantage of 
the highly specific binding of bacteriophage T7 RNA polymerase to the T7 promoter [208]. In 
such an expression system, the gene encoding WT/mutant cytochrome bo3 (cyoABCED) is cloned 
into the expression pET-17b plasmid under the control of a T7 promoter. The recombinant pET-
17b vector is then transformed into an E. coli strain which carries a copy of T7 RNA polymerase 
gene under control of lacUV5 promoter in its genome [209]. Upon addition of IPTG, T7 
polymerase is produced and binds specifically with the T7 promoter on the pET-17 vector, which 
initiates the expression of bo3 protein encoded in pET-17 plasmid.  
Over-expression of membrane proteins is generally more difficult than that for their 
soluble counterparts. In E. coli, a helper protein, namely Sec translocon, mediates the 
translocation of secretory proteins across the cytoplasmic membrane and integration of 
membrane proteins into the lipid bilayer. Over-expression systems often overload Sec 
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translocon with membrane proteins than it can handle. As a result, high levels of cytoplasmic 
aggregates, inefficient ATP production due to reduced quantities of respiratory chain complexes 
and therefore bacterial cell death are often responsible for the difficulties encountered with 
membrane protein over-expression [210]. However, some mutant strains of E.coli BL21(DE3) like 
the commercially available OverExpressTM C43(DE3) are immune to the toxicity of membrane 
proteins over-expression [211]. It was discovered in C43(DE3) that mutations in the lacUV5 
promoter lead to reduced T7 RNA polymerase expression and thus improve membrane protein 
production. An alternative way to tune regular BL21(DE3) for optimized membrane protein 
over-expression is to control the activity of T7 lysozyme, the natural inhibitor of T7 RNA 
polymerase [212]. 
5.1.5     E. coli Auxotroph for Selective Tyrosine Isotopic Labeling 
In some cases, incorporation of deuteratued tyrosine (d-tyr) is required by the design of 
experiments. This can be achieved in theoretically via two routes. One is by inactivating the gene 
specific for tyrosine biosynthesis and supplement in the culture medium exogenous d-tyr as 
universal protein expression building block. An alternative way is direct supplement of d-tyr at 
certain concentration range where feedback inhibition of Tyr biosynthesis starts to prevent host 
strain from adopting endogenous regular Tyr rather than exogenous d-tyr as protein expression 
building block. 
For the first route, tyrA gene was chosen for inactivation [213]. TyrA gene product is 
known as chorismate mutase/prephenate dehydrogenase (CM/PDH, TyrA) which is a 
bifunctional enzyme occurring as a homodimer with a molecular weight of approximately 
78,000 and is involved in tyrosine biosynthesis in Escherichia coli [214]. First, the common 
shikimate pathway intermediate chorismate undergoes rearrangement into prephenate 
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catalyzed by the N-terminal CM domain of TyrA. Second, oxidative decarboxylation of 
prephenate into to 4-hydroxyphenylpyruvate is catalyzed by C-terminal PDH domain of TyrA. 
The product is eventually transaminated using glutamate as nitrogen source into L-tyrosine via 
TyrB (Figure 5.5.) [215]. TyrB is shared by other biosynthetic pathway like Leu, Phe and Asp as 
aminotransferase [216], while TyrA only specialized in the first two steps converting chorismate 
to tyrosine. TyrA gene was therefore chosen for inactivation since only it would discontinue 
tyrosine biosynthesis while leaving the other biosynthetic pathways undisturbed.  
 
Figure 5.5. Part of shikimate pathway for biosynthesis of L-tyrosine from chorismate to tyrosine. 
Tyr A is a bifunctional enzyme responsible for chorismate rearrangement and prephenate 
decarboxylation while Tyr B serves as an aminotransferase. 
Inactivation of tyrA gene in E. coli chromosome relies on homologous recombination via 
bacteriophage λ-Red system [213]. This strategy applies molecular cloning methods to construct 
short linear recombinant DNA molecules in vitro that include nucleotide sequences homologous 
to the regions flanking target genes on the chromosome ~30-50 basepairs (bp). The synthetic 
genes are used as primers to integrate with drug resistance cassette. The resulting new drug 
resistance cassette flanked by homologous ends is introduced into the target strain and 
recombinate with chromosomal target gene which is replaced by the drug marker as a result.   
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The λ-Red system also possesses auxiliary components that stabilize linear DNA 
fragments in E. coli, and therefore, the construction of recombinant plasmids is no longer 
required. Instead, linear double-stranded DNA molecules for homologous recombination can be 
generated by two series of PCR reactions as shown in Figure 5.6. [217]. First round of PCR 
reactions amplify ~500bp upstream/downstream regions of the target chromosomal gene with 
5’ ends overhang of UP.R and DOWN.F primers overlaping with antibiotic resistance marker. The 
overhangs are used in the second round of PCR to extend and amplify an antibiotic resistance 
marker. Two different markers sandwiched by FLP recognition tags (FRT, for later on deletion of 
drug cassette if needed) were designed with kanamycin resistance gene (kan) and 
chloramphenicol resistance gene (cat) and assembled into pKD4 and pKD3 plasmids respectively 
as standard PCR templates in our lab. Recombination of PCR product with genomic DNA is 
catalyzed by co-transformation of a helper plasmid called pKD46 which harbors three genes (γ, 
β and exo) that make up the λ-Red system under the control of a tight arabinose-inducible ParaB 
promoter. After the transformation of the PCR-generated linear recombinant DNA into the cells 
that have expressed the λ-Red enzymes and replacement of the target gene by the antibiotic 
cassette, the antibiotic gene can be readily eliminated by the action of FLP recombinase 
harbored by another helper plasmid named pCP20 (Figure 5.6). The scars left behind after the 
elimination of FRT-flanked resistance markers were designed to contain stop codons in all six 
reading frames to minimize the effects on the downstream genes. The ability to easily eliminate 
the resistance marker is very valuable in the construction of auxotrophs that require multiple 
genes to be knocked out. In addition, both pKD46 and pCP20 plasmids are equipped with 
temperature-sensitive replicons so that they can be readily removed after the desired 
recombination events. 
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Figure 5.6. Schematics showing the deletion of a chromosomal gene with the λ-Red 
recombination system originally developed by Datsenko and Wanner [217] and modified by Lin 
[213]. In the first step, ~500 bp from each end of the target is amplified by 1st PCR. Please note 
that UP.R and DOWN.F primers have 5’ overhands that overlap with the two ends of the 
resistance cassette. The 2nd PCR to generate the linear recombinant DNA involves three 
templates: the resistance cassette and the two PCR products from the first step. Replacement of 
the target gene by the resistance cassette is achieved by transformation of cells that has already 
expressed the λ-Red system from pKD46 with the linear DNA. If desired, the resistance cassette 
can be removed by the action of Flp recombinase expressed from pCP20. 
The alternative way of d-tyr incorporation is achieved by taking advantage of alleviated 
feedback inhibition by the end product (tyrosine) of tyrosine biosynthesis [218]. A collection of 
genes, as shown in Figure 5.7.,  responsible for tyrosine biosynthesis (aroF, aroL, tyrA, tyrB) and 
transport (aroP, trpP) belong to a group of transcription units  under control of a single protein 
(regulon), TyrR, in E. coli [219]. Binding to specific DNA sequences known as strong/weak TyrR 
boxes, the TyrR protein can either activate or repress transcription at different σ70 promotors 
[220]. For efficient regulation to occur, the TyrR protein must interact with small ligand 
molecules ATP, Tyr and Phe. In the absence of cofactor or in the presence of Phe alone, TyrR 
transformed into cells with 
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exists as a dimer, while in the presence of ATP and Tyr, TyrR self-aggregates to form a hexamer 
[221]. The genes in the TyrR regulon that are repressed by Tyr contain at least two TyrR boxes 
located adjacent to each other and differing in their respective affinities for TyrR protein (Figure 
5.7.). Practically, addition of 1mM tyrosine/Phe into growth medium will be enough to switch 
the host strain from endogenous biosynthetic Tyr to exogenous supplemental Tyr. This is proved 
in MacMillan’s work on P. d. aa3 d4-tyr incorporation with 0.9 mM d4-tyr supplement at 90% 
labeling efficiency. At 1mM Tyr supplement, host E. coli strain also starts to encounter growth 
inhibition [218] presumably by disruption of both aromatic amino acid uptake machinery and 
other downstream biosynthesis like vitamins (quinones, folate) and siderophores (enterobactin). 
 
Figure 5.7. Left: Common and terminal pathways for aromatic amino acid biosynthesis and 
genes for aromatic amino acid transport [222]. Right: Examples of genes regulated by TyrR with 
SB/WB boxes and bound TyrR shown [223]. 
5.1.6     Introduction to EPR Spectroscopy 
Interaction of the magnetic moment of an unpaired electron with an external magnetic 
field produces energy levels defined by the projections of the magnetic moment on the 
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magnetic field direction. Only electrons with the simplest spin S = ½ will be discussed here. In an 
external magnetic field (B0), an electron with S = ½ can have two energy levels corresponding to 
the two spin states with Ms of +½ and -½. The energy (hν) of each spin state is proportional to 
the external magnetic field according to hν = geβeBMs where ge and βe are the electron’s g-factor 
and Bohr magneton respectively. According to this definition, the spins with Ms = +½ occupy the 
exited state (hν = +½geβeB), whereas those with Ms = -½ reside in the ground state (hν = -
½geβeB). The energy difference between the two states is therefore hν = geβeB, which normally 
falls in the range of microwave frequencies for magnetic fields commonly generated in 
laboratories. EPR spectroscopy is generally applied to analyze the transition energy between the 
two spin states of an unpaired electron. The microwave frequencies commonly used in EPR 
studies are listed in Table 5.1. X-band microwave frequencies represent the most widely used 
ones in EPR studies. The experiments in this study were also carried out with X-band frequencies. 
Band Frequency (GHz) 
L 1 
S 3 
X 9.4 
P 15 
K 18 
Q 35 
W 94 
Table 5.1. Commonly used microwave frequencies in EPR spectroscopy 
The simplest EPR experiment is the continuous wave (CW) EPR, which is usually 
performed with a fixed microwave frequency (ν) while the magnetic field (B) is being varied. A 
net absorption of the microwave energy is then detected at each B value, where the resonant 
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condition of hν = geβeB is satisfied. Such experiments typically yield the g-factor (ge) of the 
paramagnetic electron. For a freely spinning electron, ge has an approximate value of 2.0023. 
One primary cause of deviation of ge from that of a free electron is the electron’s orbital angular 
momentum, which can have substantial dependence on the orientation of the system related to 
the external magnetic field and therefore can give rise to the g-factor’s anisotropy. The 
electron’s g-factor and its anisotropic nature make up the fingerprint of an unpaired electron, 
from which the electronic structure and the source of the unpaired electron can be determined. 
Another factor that can influence the g-factor is the interactions between the unpaired 
electron and nearby nuclei with non-zero magnetic moments. The external magnetic field that 
splits the electron spin (S = ½) into two energy levels also partitions the energy of each nuclear 
magnet with nuclear spin I into 2I+1 distinct values. Such effects of an external magnetic field on 
magnetic spins are known as Zeeman effects. In the presence of interactions between the 
unpaired electron and nearby nuclei, the energy of each spin state becomes modified from the 
value determined by the Zeeman effects (Figure ‎5.8). Such interactions between an unpaired 
electron and nearby nuclei are known as hyperfine interactions. Usually, an atom or ion that is 
the source of the paramagnetic electron has significant hyperfine interactions resulting in the 
splitting of electron’s resonant peak that can be detected by CW-EPR experiments. The 
hyperfine coupling constant (A) usually measured in MHz can be determined from the 
difference between the peaks split by the hyperfine interactions. However, CW-EPR usually 
cannot resolve small hyperfine couplings arising from surrounding nuclei. In those cases, 
electron-nuclear double resonance (ENDOR) and pulsed EPR techniques such as electron spin 
echo envelope modulation (ESEEM) are usually used to obtain the values of those couplings. 
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A hyperfine coupling between an unpaired electron and a nearby nucleus can be divided 
into two components known as isotropic and anisotropic hyperfine couplings. The isotropic 
hyperfine coupling is due to the presence of the unpaired electron’s spin density at an atomic s 
orbital around the nucleus. Thus, isotropic hyperfine coupling between a radical species and a 
nearby nucleus from the protein harboring the radical usually means the presence of a hydrogen 
bond between the radical and that particular nucleus. The spin density transferred to the 
nucleus through the hydrogen bond can then be calculated from the isotropic hyperfine 
coupling constant. The anisotropic part of the hyperfine coupling can originate from two sources: 
the presence of the spin density at a non-spherical orbital such as a p orbital around the nucleus 
and the through-space dipolar interaction between the nuclear spin and the unpaired electron 
spin. The dipolar coupling is highly dependent on the orientation of the system in the external 
magnetic field as well as the distance between the two dipoles. In most cases, the dipolar 
interaction is mainly responsible for the anisotropic hyperfine coupling, from which the distance 
between the coupling nucleus and the unpaired electron can be estimated. 
 
Figure 5.8. The energy diagrams of an electron spin (Ms = ½) and a nearby nucleus with a nuclear 
spin MI = ½ (A) or MI = 1 (B) in an external magnetic field (B0). Please note that the energy levels 
shown are only for illustration. Their relative values depend on each scenario.  νI = Zeeman 
frequency, να and νβ = Nuclear transition frequencies modified by hyperfine interactions 
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Table 5.2 lists the nuclei commonly encountered in EPR studies of biological systems. 
Nuclei with I = 0 such as 12C and 16O do not possess a net magnetic moment and therefore are 
not involved in hyperfine interactions. Nuclei with I = ½ such as 1H, 13C and 15N are split into two 
spin states, MI = +½ or -½, which can be modified by hyperfine interactions with the unpaired 
electron spin. Nuclei with I > ½ are quadrupolar in nature due to nonspherical charge 
distribution. Nuclei such as 2H and 14N have nuclear spin I = 1, which produces three energy 
states in a magnetic field as shown in Figure ‎5.8. The individual states are influenced not only by 
hyperfine interactions, but also by nuclear quadrupole interactions (nqi) between the nuclear 
quadrupole moment and the electric field gradient of surrounding electrons, and therefore, 
interpretation of the interactions between these quadrupole nuclei and an unpaired electron 
requires more complex analyses.  
Isotope Nuclear Spin (I) % Abundance 
1H 1/2 99.9 
2H 1 0.02 
12C 0 98.9 
13C 1/2 1.1 
14N 1 99.6 
15N 1/2 0.37 
16O 0 99.8 
17O 5/2 0.037 
32S 0 95.0 
33S 3/2 0.76 
Table 5.2. The nuclear spins and % natural abundances of some isotopes commonly 
encountered in biological samples. 
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5.2     Materials and Methods 
5.2.1     Materials 
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT, 
Coralville, IA). QuickChange Kits were from Stratagene (Agilent Technologies, Santa Clara, CA). 
The pET-17b plasmid (Ampr) used as template for mutagenesis and 1kb DNA standard for DNA 
agarose gel were purchased from EMD Biosciences (San Diego, CA) and Invitrogen (Life 
Technologies, Grand Island, NY) respectively. Restriction enzymes were purchased from New 
England BioLabs (Ipswich, MA). Miniprep Kit was purchased from Fermentas (Thermo Scientific, 
Glen Burnie, MD). N-dodecyl-ß-D-maltoside (DDM) and Triton X-100 were purchased from 
Anatrace (Maumee, OH). Isopropyl-β-D-thiogalactopyranoside (IPTG), arabinose, ampicillin, 
kanamycin and other chemicals used in M63 medium, cell culture and purification buffers were 
from Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) unless otherwise noted. -
Ring 2H4 -L-tyrosine (d4-tyrosine) for the growth of E. coli CLY-ML14 strains to express universal 
d4-tyrosine labeled cytochrome bo3 was ordered from Cambridge Isotope Laboratories (Andover, 
MA). Filter paper/kits were purchased from Millipore (Billerica, MA). Ni-NTA resin for 
purification was purchased from Qiagen (Valencia, CA). Slide-A-Lyzer dialysis cassette obtained 
from Pierce (Thermo Scientific, Glen Burnie, MD). GeneMate Express 6%-18% gradient PAGE 
gels purchased from ISC BioExpress (Kaysville, UT). E. coli X10 Gold used for cloning of sited-
directed mutagenesis PCR products was purchased from Stratagene (Agilent Technologies, Santa 
Clara, CA). E. coli C43/CLY strains for WT/mutant bo3 expression were obtained from Dr. Lin at 
Univeristy of Illinois Urbana Champaign. Microfluidizer for cell lysing was manufactured by 
Watts Fluidair, Inc. Beckman ultracentrifuge L-8M was manufactured by Beckman Coulter, Inc 
(Indianapolis, IN) and Sorvall RC-5B+ centrifuge systems were manufactured by DuPont 
(Wilmington, DE). Biosequential SX-17MV stopped-flow spectrometer used for intermediates 
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transition was obtained from Applied Photophysics (Leatherhead, UK). EPR spectra were 
collected at X-band using a Varian E-122 spectrometer together with an Air Products 
helium cryostat. 
5.2.2     Expression and Purification of bo3 Protein 
WT bo3 was expressed with C43(DE3) strain which encodes cyoABCED genes in the 
chromosome. Regular bo3 proteins with site directed point mutations were expressed with E. 
coli CLY host strain whose cyoABCED gene (recombination with Km resistance cassette) was 
knocked out from the chromosome. Universal d4-tyrosine labeled bo3 proteins with site directed 
point mutations were expressed in E. coli CLY-ML14 (derived from E. coli CLY by Dr. Lin) host 
strain with both cyoABCED gene (recombination with Km resistance cassette) and tyrA gene 
(recombination with Cm resistance cassette) knocked out as described in 5.1.5. Each of the 
above host strains was transformed with the pET-17b vector, into which an insertion of a 6xHis 
tag at the C terminus of subunit II was engineered in the encoded cyo operon. The cyo operon 
was under the control of a T7 promoter. Addition of IPTG initiated the expression of T7 RNA 
polymerase from the bacterial chromosome, which then drove the transcription of the cyo 
operon from the pET-17b plasmid. The cyo operon construct for the histidine-tagged enzyme 
was generated by Rumbley et. al. [224] and the pET-17b vectors were assembled by Yap et. al.  
[225].  
Each bacterial culture was inoculated in 5 mL LB with corresponding antibiotics 
overnight (12-16 hrs) at 37 ⁰C from glycerol stocks and enlarged into 20-40 mL modified M63 
minimal medium (specified below) at 37⁰C for every 1 L culture grown later for protein 
expression. After 12 hours, 20-30 mL saturated inoculums was introduce into 1 L of modified 
M63 minimal medium consisting of 7 g/L K2HPO4, 3 g/L KH2PO4, 2 g/L NH4Cl, 2 g/L glucose, 10 
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mg/L thiamine, 10 µM CuSO4, 30 µM FeSO4 and 1 mM MgSO4. d4-tyrosine was dissolved at 18 
mg/10 mL in H2O at ~85 ⁰C and added to M63 medium for ML14 strains at 0.1 mM. Each 2 L 
baffled flask contained only 1 L culture medium to ensure aerobic growth condition. The 
temperature was maintained at 37°C, and the flasks were shaken at 200 rpm throughout the 
entire growth. When the density of the culture reached an OD600 of 0.6–0.7, the expression of 
cytochrome bo3 was induced with 1 mM IPTG, and the cells were shaken for an additional 4 
hours but no longer than 4 hours to prevent expression of inactive cytochrome oo3. The cells 
were then pelleted by centrifugation at 16,000 x g.  
All the subsequent steps were carried out at 4°C and pH 8.0. The harvested cells were 
resuspended in 50 mM KPi buffer with ~ 20 mM MgSO4 and ~ 10-20 mg/L deoxyribonuclease I, 
and broken five to eight times through a Microfluidizer high pressure fluids processor at 10,000 
psi. The cell debris was removed by centrifugation at 16,000 x g for 10 min. The membranes 
were then pelleted from the supernatant by centrifugation at 180,000 x g for 4 h, and 
solubilized in 50 mM KPi buffer with 1 % n-dodecyl β-D-maltoside (DDM) at 4 °C for at 2 to 8 
hours. After the unsolubilized particles were removed by centrifugation at 180,000 x g for 1 h, 5 
mM imidazole was added to the supernatant which was then loaded onto a column packed with 
5–10 mL Ni-NTA resin. The loaded Ni-NTA column (loading capacity: 4 mg max for WT and 3 mg 
max for most mutants) was washed with 5 volumes of 10 mM imidazole, 50 mM KPi, 0.05% DDM 
at pH 8, followed by 5 volumes of 15 mM imidazole, 50 mM KPi, 0.05% DDM. The histidine-
tagged cytochrome bo3 was eluted with 100 mM imidazole, 50 mM KPi, 0.05% DDM. Imidazole 
was removed from each purified cytochrome bo3 sample via buffer exchange or dialysis against 
50 mM KPi, 0. 05% DDM and 5% glycerol at pH 8.3 with 100,000 molecular weight cutoff. The 
concentrated protein sample was flash-frozen in liquid nitrogen and stored at – 80 °C before use. 
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5.2.3     UV-Vis and SDS-PAGE  
Shimadzu UV/Vis-2101PC spectrophotometer was used to obtain the spectra of wild-
type and mutant enzymes. The concentrated protein samples were diluted with 10-20mM Tris 
buffer and 0.05% DDM at pH 7.5-8.0. The enzymes were oxidized by air and reduced with a few 
grains of sodium dithionite. The concentration of cytochrome bo3 was determined using an 
extinction coefficient of 188 mM-1cm-1 for the peak of the Soret band (~409 nm) of oxidized 
enzyme or 24 mM-1cm-1 for the peak difference of 560 nm over 580 nm in the reduced-minus-
oxidized spectrum [226].  
[bo3]/μM = 1000×[A560nm(red-ox)-A580nm(red-ox)]/24 
or 
[bo3] / μM= = 1000×A409nm(ox)/188 
GeneMate Express 8%-16% gradient PAGE gels from ISC BioExpress with Tris/Hepes/SDS 
buffer system or the home made 15% SDS/2.5 M urea gel with Tris/Glycine/SDS buffer system 
were used to separate the purified protein complexes. Gels were subject to Coomassie Brilliant 
Blue R-250 staining for all subuints. 
5.2.4     Steady State Enzymatic Activity 
The steady state oxygen reduction activity of cytochrome bo3 proteins were measured 
at 25 ⁰C using a YSI model 53 oxygen electrode which was assembled with a temperature-
controlled 1.8mL electrode chamber. The reaction buffer contains 50 mM K2HPO4 and 0.1% 
DDM at pH 7.0. 2 mM dithiothreitol (DTT) and 200 μM ubiquinoe-1 (Q1, ethanol stock) were 
added as mimic reductive substrate to shuttle electron from DTT, via Q1, into cytochrome bo3. In 
the presence of O2 (aerobic), the reaction was initiated by injection of a few microliters of 
diluted enzyme. 
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The turnover numbers of the enzyme (number of electrons per second per enzyme) was 
calculated by the following equation from the slope of oxygen consumption corrected by 
subtraction of background baseline drift. Inhibition of KCN at 100 μM in some cased was applied 
to rule out the possibility of oxygen consumption by artifact rather than oxidase turnover. 
Turnover = 17280 × Slopecorrected / ([bo3 (μM)]×Volenzyme (μL)) 
5.2.5     Preparation of UQ8-free Cytochrome bo3 
Purified cytochrome bo3 was diluted into 50 mM K2HPO4 at no more than 1 μM with 0.1% 
Triton X-100 (TX-100) detergent at pH 8.3. Incubation with gentle stirring at 4 ⁰C for at least 2 
hours were allowed before loading on to Ni-NTA column equilibrated with the same KPi buffer 
system. Loaded resin was washed with 5 times column volume of the same KPi buffer containing 
0.2-0.4% TX-100 and was washed with 5 times column volume of the same KPi buffer containing 
0.05% DDM. The eluted enzyme with 50 mM K2HPO4, 100 mM imidazole, 0.5 mM EDTA, 5% 
glycerol and 0.05% DDM at pH 8.3 was subjected to dialysis to remove imidazole.  
5.2.6     Preparation of Pulsed Cytochrome bo3 for Generation of PM with H2O2 
Reduction followed by re-oxidation turns the resting enzyme (O) to a high energy level  
(OH) which improves the yield of PM intermediate in the H2O2 mimic reaction [227]. The 
procedure, namely ‘pulsing’, used for bo3 generally follow the work in [228]. 4 mM sodium 
ascorbate and 50 μM 5-methylphenazinium methosulphate (both from concentrated liquid 
stock pre-adjusted to pH 8.0) were added into ~500 μL bo3 protein at up to 250 μM in 50mM KPi 
buffer at pH 8.0. The system was incubated at room temperature for 10 min. Subsequently, the 
enzyme was dialyzed against at least 200 fold 50 mM potassium borate buffer at pH 8.5 
containing 0.5 mM EDTA and 0.05% DDM for 1.5-2 hours (3 times) at 4 ⁰C. Additional dialysis 
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against 100 mM CHES buffer at pH 9.0 containing 10% glycerol and 0.05% DDM for 1.5-2 hours 
(2 times) at 4 ⁰C completed the pulse procedure.  
5.2.7     Stopped-flow Experiment for PM and F Production with H2O2 
The reaction of pulsed cytochrome bo3 with H2O2 under pseudo first order conditions 
was monitored by Biosequential SX-17MV stopped-flow system equipped with temperature-
controlled sample loading syringes and a 1 cm path length cuvette at 25 ⁰C as described in [194]. 
The complete spectrum (300-1100 nm) was collected from within 1 s to 50 s at a time resolution 
from 1 ms to 50 ms accordingly. In case of single wavelength detection, a side window 
photomutiplier was connected instead. Syringe A contained 10-16 μM pulsed bo3 protein in 
CHES buffer at pH 9.0 while syringe B contains either plain CHES buffer or 10 mM freshly 
prepared H2O2 ( from 30% stock by analytical grade, Fluka) in the same CHES buffer. H2O2 
concentration was determined with extinction coefficient of 43.6 M-1cm-1 at 240 nm. Detectable 
signal appeared typically from the 3rd push and a single push consumed 250 μL liquid (total 
volume from A and B syringes). Background spectra was collected from mixing bo3 containing 
solution and plain CHES buffer load for 1 sec, while reactions was initiated upon mixing bo3 
containing solution with H2O2 containing solution and monitored for 1 to 100s.  
The time-resolved spectra were analyzed globally from 450 nm to 700 nm 
simultaneously with Pro-Kineticist software from Applied Photophysics. Components were set to 
O -> PM -> F transition mode. Background (oxidized form of bo3) was subtracted. 
5.2.8     CW X-band EPR 
EPR spectra were collected with a Varian E-122 spectrometer X-band (9.5 GHz) 
at 60-80 K with the equipped Air Products helium cryostat. Unless otherwise noted, a 
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microwave power of 5 mW was used, with a combination of modulation amplitude at 
5.0/2.0/1.0 guass and gain level at 12500/6300. The magnetic field was calibrated with 
a Varian NMR Gaussmeter, and the microwave frequency was determined with and EIP 
frequency meter (San Jose, CA). 
Protein was made UQ8 free to prevent potential formation of semiquinone radical. 
In addition, the sample was dialyzed and pulsed as described in 5.2.6 and concentrated 
to ~ 200 μL at 400-600 μM. Generation of radical containing samples were achieved by 
adding 10 μL 100 mM H2O2 into a commercial Wilmad 707-SQ-250M EPR tube (Vineland, 
NJ) preloaded with the enzyme ( resuspended in 100mM CHES, 10% glycerol, 0.05% DDM 
at pH 9.0 ) at 4 ⁰C. Thorough mixing was achieved by pulling the syringe plunger up and 
down 3 times and bubbles were allowed to escape from the sample before hand-
quenching the reaction in liquid nitrogen within a time scale of 30-45 seconds. 10% 
glycerol was a minimum requirement for uniform glass formation to prevent tube 
cracking upon freezing in liquid nitrogen. In cases when longer reaction time was 
desired, the same sample was thawed, sitting in the room temperature for the additional 
time lapse and frozen again. Data were analyzed in Origin software and g values were 
calculated as follow. 
g = 714.484 × ν (Ghz) /B (guass) 
Subtraction of enzyme signal free of H2O2 was applied to reveal only the radical signal. 
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5.3     Results and discussion 
5.3.1     SDS-PAGE, UV-Vis and Steady State Turnover  
Similar to the study of P/F radical in aa3, equivalent residues in bo3 were subjected to 
mutagenesis. Cross-linked Tyr288 was mutated to Phe and His respectively and Tyr173 (Tyr167 
in P.d. aa3) was mutated to Phe. Double mutation Y173F+Y288H was also made. No recombinant 
protein was obtained for Y288F, probably due to dramatic destabilization introduced by Phe 
substitution. Otherwise, Y173F, Y288H and Y173F+Y288H were of regular yield comparable to 
WT bo3 (4-5 mg / L culture). In order to investigate the radical signal detected in CW EPR, d4-
tyrosine universally incorporated bo3 proteins were also obtained for WT, Y173F, Y288H and 
Y173F+Y288H. The yields were lower than WT bo3 at 2-3 mg / L culture. SDS PAGE demonstrated 
regular subunits assembly as shown in Figure 5.9 (Y173F+Y288H not shown). Reduced and 
oxidized spectra of Y173F were the same as WT, while those for Y288H and Y173F+Y288H (not 
shown) displayed hampered oxidation even with presence of K3FeCN6. Steady state turnover 
assay displayed 99% WT activity for Y173F and lower than 2% WT activity for both Y288H and 
Y173F+Y288H. 
  
Figure 5.9. Left: SDS-PAGE. Subunits I to IV were marked on gel. Right: UV-Vis spectra of both 
reduced and oxidized enzymes. Dotted line for Y288H oxidized by K3FeCN6. All the data shown 
were applicable for both regular and d4-tyrosine labeled bo3 proteins. Y173F+Y288H data were 
not shown.  
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d4-tyrosine labeled bo3 proteins demonstrated the same pattern in SDS-PAGE, UV-Vis 
spectra and steady state turnover assay as their non-deuterated counterparts, except that all 
deuterated samples retained only ~ 80% of their non-deuterated counterparts’ turnover 
numbers.  
5.3.2     O-PM-F Transition in H2O2 Reaction in Stopped-flow 
The reaction of bo3 and H2O2 is believed to be a steady-state turn over, as in aa3. In 
contrast to aa3 enzyme, WT bo3 eventually decays into F from PM regardless of the H2O2 
stoichiometry or pH, although the decay can be slowed down at alkaline pH [194]. Therefore, 
the transition from O to F via PM was monitored in stopped-flow spectrometer. Results for WT, 
Y173F, Y288H and Y173F+Y288H reaction with H2O2 for 20 s were displayed in Figure 5.10. 
   
  
Figure 5.10. Kinetic components-minius-O difference spectra from global fitting of 20s reaction 
between 5 mM H2O2 and 5-8 μM WT (upper left), Y173F (upper right), Y288H (lower left) and 
Y173H+Y288H (lower right) bo3 enzymes.  
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Global fitting was applied to the time-revolved absorption data from 450 nm to 700 on 
the time span from 20ms to 20s in Pro-Kineticist software. The kinetic model was set to be a 
linear bi-phase transition from OPM and PMF and the initial component composition was 
tentatively assigned as O=1.0, PM=0 and F=0 based on the kinetic parameters reported in [197]. 
For WT bo3 in this experiment, k1=8.4 s
-1  and k2=0.57 s
-1 were obtained for OPM and PMF 
transitions respectively which were coherent with reported values in literature [197]. The 
tentative assignment of initial composition of components was verified by tracking the 
absorption change at 557 nm. No transition at 557 nm from O to P was detected within 20ms of 
dead time from the comparison of first spectrum recorded for the reaction and the spectrum of 
O, which validated the initial components composition assignment.  
Similar for Y173F mutant, a bi-phase transition global fitting returned with minimal 
variance and stable solutions within 3 times of iterations. Initial component composition was 
also set to O=1.0, X1=0 and X2=0, where X1 and X2 stood for the two unidentified components. 
k1=8.0 s
-1 and k2=0.061 s
-1 was obtained for Y173F mutant. The optical spectra of X1 displayed a 
developing 582 nm shoulder and a developing 557 nm peak which were both fully developed in 
X2. Both of the unknown intermediates retained the 624 nm trough for oxoferro intermediates 
while the signature 530 nm shoulder for F was missing in both cases. Therefore, X1 was 
identified as developing P and X2 as P.  Similar to WT, the tentative assignment of initial 
components composition for Y173 was verified by the comparing the first spectrum recorded 
and the spectrum of O. No transition at 557 nm from O to P was detected within the dead time. 
It is concluded that the final product for Y173F in the reaction with H2O2 is P instead of F. 
Development of P in Y173F is initiated with a fast phase followed by a slow one. Notably, Y173F 
was not affected in steady state turnover assay as in 5.3.1.  
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Y288H mutants failed to undergo any transition from O (except for noise) upon reacting 
with H2O2 within a time scale from 5 s to 500 s.  The histidine mutation might have greatly 
perturbed the substrate interaction with heme o. The result was coherent with the low activity 
(2%) and impaired heme o redox UV-Vis absorption in Figure 5.9, where it could not be fully 
oxidized. The same pattern was found in Y173F+Y288H double mutant. 
  
Figure 5.11. Spectra in alpha bands of oxidized WT bo3 (right) and KCN inhibited WT bo3 (left) 
To demonstrate the above transitions with optical spectra change requires participation 
of the active site, KCN inhibited bo3 samples comparison experiments were carried out. KCN 
bound heme o and turned the high spin heme into a low spin heme, which was characterized by 
the loss of the broad LMCT band [229] at ~624 nm (Figure 5.11). KCN incubation blocks the 
active site from further access to any other ligand/substrate. Therefore, if the above 
intermediate transitions disappear after KCN incubation, they must be associated with the 
binuclear center. The results were presented in Figure 5.12. No change was detected in any of 
the samples tested above.   
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Figure 5.12. Kinetic component-minus-O spectra from bi-phase linear transition global fitting 
results for H2O2 reacting with KCN incubated 5-8 μM WT (upper), Y173F (middle) and Y288H 
(lower) bo3 for 20 s.  
5.3.3     CW X-band EPR 
Reaction of bo3 with H2O2 was also characterized by continuous wave X band EPR. Bo3 at 
300-500 μM in CHES buffer at pH 9.0 mixed with 5 mM H2O2 was hand quenched in liquid 
nitrogen and then compared with H2O2 free sample. Some EPR signal features of oxidized 
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enzyme changed upon treatment of H2O2 (Figure 5.13). In the low field region, g⊥ at ~6.0 for high 
spin heme o3 became much weaker while g⊥ at 3.0 for low spin heme b didn’t change as 
expected. In the high field region, a prominent new feature with high intensity emerged at g=2.0 
which corresponding to an amino acid based free radical (S=1/2). In addition, appearance of a 
type II Cu (CuB) signal with g∥=2.20 and g⊥=2.06 overlapped the high spin heme o3 with g∥=2.19. 
Well resolved seven-line hyperfine structure at g⊥=2.06 with a separation of ~15 G was also 
detected, which was attributed to couplings from three nitrogen atoms coordinating CuB as that 
found in aa3 oxidase [230]. The loss of high spin (S=5/2) signal and appearance of CuB signal 
together with its nitrogen ligands coupling indicated the break of anti-ferromagnetic coupling 
between heme o3 and    
   [231] since heme o3 was turned into low spin. The free radical 
formation required participation of binuclear center as KCN incubated cytochrome bo3 failed to 
generate the same radical signal (Figure 5.13).  
 
Figure 5.13. EPR spectra of WT bo3 after (blue) and before (red) treatment of H2O2. KCN 
incubated WT bo3 was also treated with H2O2 (black) as control.  
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While aa3 studies attributed this radical to a tyrosine or a tryptophan, limited number of 
studies on bo3 only tentatively assigned this free radical to a tryptophan from rapid-freeze-
quench EPR spectra in O2 single turnover condition at low signal/noise ratio. To determine the 
origin of this free radical, ring deuterated d4-tyrosine was incorporated into WT bo3 universally 
and subjected to the same EPR characterization. H2O2 free enzyme EPR spectra was subtracted 
from the data for both non-deuterated WT bo3 and d4-tyrosine WT bo3 to reveal only the radical 
signals (Figure 5.14). It can be clearly seen that incorporation of d4-tyrosine into WT bo3 
collapsed the broad band signal (blue line) into a triplet hyperfine structure with aiso=17 as 
reported in [202]. The change in EPR signal pattern was introduced by deuteration of tyrosine 
phenyl ring hydrogen atoms. This effect could only be possible if the radical is associated with a 
tyrosine. Ongoing HYSCORE experiment with d4-tyrosine incorporated WT bo3 showed 
appearance of deuteron signal, which also demonstrated this free radical was associated with a 
tyrosine.  
 
Figure 5.14. Difference spectra of regular WT bo3 (blue) and d4-tyrosine (red, structure shown in 
lower left quarter) WT bo3 upon reaction with H2O2. In both cases, signal of enzyme before H2O2 
treatment was subtracted to reveal only radical signal.  
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To further identify which tyrosine is responsible for the free radical signal, Y288H, Y173F 
and Y173F+Y288H mutants were subjected to EPR examination. Similar to WT, non-deuterated 
mutants were compared with their d4-tyrosine incorporated counterparts to verify whether it 
was a tyrosine responsible for the signals (Figure 5.15). Y288H generated the same radical with 
aiso=17 gauss as that of d4-tyrosine WT bo3 oxidase. However, regular Y288H didn’t share the 
fully developed 45 G wide wing feature with non-deuterated WT bo3 oxidase. Y173F generated a 
different radial in contrast to WT bo3 oxidase. In addition, d4-tyrosine incorporation collapsed 
the Y173F radical into a signal predominated by a doublet hyperfine structure with aiso=18.8 
gauss. In the case of Y173F +Y288H double mutant, only a very weak residue signal was detected 
and the pattern didn’t change fundamentally upon d4-tyrosine incorporation.  
 
       
 
Figure 5.15. (To be continued on page 132) 
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Figure 5.15. Difference spectra of regular undeuterated (blue) and d4-tyrosine (red) Y288H (B), 
Y173F (C) and Y173F+Y288H (D) bo3 upon reaction with H2O2. In every  case, signal of enzyme 
before H2O2 treatment was subtracted to reveal only radical signal 
It was clear that only Y173 and Y288 were responsible for the radical signal in the H2O2 
reaction since the signal can be eliminated by double mutation. However, none of the single 
mutation alone could eliminate the signal. In the case of Y288H single mutant, a radical was 
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produced and was very similar to WT bo3. On top of Y288H mutation, Y173F fully eliminated the 
signal. This indicated Y288H was able to generate the same radical detected in WT and it should 
be on Y173. On the other hand, Y173F single mutant didn’t eliminate the signal but produced a 
tyrosine radical with different hyperfine structure instead. This suggested that the radical in WT 
may not be originated on Y173 but another tyrosine instead, or otherwise Y173F mutation alone 
would be adequate enough to eliminate the radical signal. The prediction was also compatible 
with the fact that Y173F mutant was able to transform oxidized enzyme into PM (see 5.3.2) since 
Y173 was not the direct electron source for this transition. However, further decay from PM into 
F was impaired by Y173F mutation since it blocked the way for the second electron source for 
reduction of the earlier radical and thus failed to turn the enzyme from PM into F. In conclusion, 
Y173F chemically trapped enzyme transition one step ahead of F at PM. On top of Y173F 
mutation, Y288H eliminate the signal. Therefore, the tyrosine radical associated with PM seen in 
Y173F was likely to be on the crosslinked Y288. 
Further interpretation on the two different radicals is possible based on the ß hydrogen 
contribution on hyperfine structure of free radical (Figure 5.16) [203], which can be described by 
McConnell relation empirically:  
    
    (             𝛳 ) 
  is the spin density of C1 carbon; 𝛳 is the phenoxyl ring rotation angle as defined in 
Figure 5.15.; B’ and B’’ are constants. B’ is commonly neglected in practical application and B’’ is 
equal to 58 G (or 162 MHz).     
   is the isotropic value of the hyperfine splitting constant for a ß 
proton, which roughly equals to 1/3×(Axx + Ayy + Azz). Reference for the three anisotropic splitting 
constants can be found in literature and further adjusted to best fit the experimental spectrum 
when they are used to simulate the EPR spectrum by software like EasySpin or Simpow6. 
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Possible combinations of   and 𝛳 can be obtained and the 𝛳 value at reasonable   (  <1) is then 
take as a reference to correlate with the structure of possible tyrosine candidates. This has been 
successfully applied with aa3 oxidase at a resolution of 2.7 Å [198, 203].  The 3.5 Å resolution of 
the only available bo3 protein X-ray structure significantly lower the accuracy of the above 
simulation. However, for the cross-linked tyrosine, the conformation is much more rigid than 
other tyrosines because of the covalent C-N bond and its proximity to heavy atoms (Fe, Cu). Hß1 
has a 𝛳1 of 83.4⁰ while Hß2 has a 𝛳2 of -36.3⁰. Therefore, contribution of Hß1 is significantly 
smaller than that of Hß2, which was coherent with the pseudo-doublet feature observed in d4-
tyrosine Y173F mutant. Non-deuterated Y173F spectrum was similar to that in Ovine 
prostaglandin H synthase [232] in terms of line width and partially resolved hyperfine structure 
as regular Y173F protein.  Ovine prostaglandin H synthase has a very similar 𝛳1 of 83⁰. However 
so far, cross-linked nitrogen splitting contribution was not resolved. This might be explained as 
small spin distribution on imidazole NƐ atom. Moreover, Y122YNO2 in E. coli RNR protein, which 
share similar 𝛳 values and C-N bond didn’t have nitrogen signal resolved either [233]. Therefore, 
the possibility of Y288 radical could not be ruled out by undetected N hyperfine structure in CW 
EPR experiment. ENDOR experiment is currently undergoing in the hope to detect splitting from 
NƐ atom. 
  
Figure 5.16. Definition of Hß and 𝛳 [203]. View A is when a tyrosine is looked at along Cß-C1 bond 
from Cß (not the other one). Positive angles corresponding to the clockwised direction.  
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Further attempt to identify the source of the signal would take advantage of the special 
feature of C-N bond from the cross link if the radical is on Y288. One of the strategies is to 
compare d4-tyrosine Y173F and d4-tyrosine WT in HYSORE EPR experiment. Introduction of the 
cross-link on Y288 eliminates one ortho-2H, which would make a difference in the deuteron 
coupling in HYSCORE. 
5.4     Conclusion 
So far, all the information from both stopped-flow and EPR experiments could be 
mapped on to the model described in Figure 5.17. The first step is initiated by a molecule of 
H2O2 binding to the high spin heme o Fe
3+-OH(H2O) and triggers electron rearrangement. As a 
result, the O-O bond in H2O2 cleaves to form Fe
4+=O, during which the fourth electron comes 
from cross-linked Y288 which itself turned into a neutral radical as a result. Fe4+=O and Y288• 
marked the complete formation of PM intermediate. The neutral Y288• then draws electron 
from another tyrosine (Y173). Y288• gets reduced to and a new radical is generated at Y173. The 
reduced Y288- together with Fe4+=O characterizes the formation of F intermediate. Further two 
electron transfer by H2O2 reduces Fe
4+=O to Fe3+-OH (or H2O) and Y173• to Y173 and the system 
returned to oxidized state (O). F to O transition is the slowest of the three transitions while O to 
PM is the most rapid. Therefore, starting from purely oxidized enzyme, accumulation of PM is 
observed as the first phase. In the second phase, PM decays into F till steady state concentration 
is achieved. As a result, in the WT bo3, only Y173 radical can be detected by EPR and only F is 
stable as final product since it’s the predominant species in steady state.  
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Figure 5.17. Proposed model for H2O2 reaction with cytochrome bo3. Refer to text for details.  
In the case of Y288H mutation, Em of histidine radical is raised to ~+1170 mV. Therefore, 
residue at 288 site is no longer capable of electron donation to ferryl-oxo heme o. In addition, 
Em of heme o is also greatly perturbed by this mutation. As a result, H2O2 fails to oxidize heme o 
to generate any ferryl-oxo intermediate. However, a collection of tyrosines close to the surface 
including Y173 site are still intact and could possibly react with H2O2 directly to generate a 
tyrosine radical without involvement of active site.  
In the case of Y173F mutation, active site is not perturbed and thus O to PM transition is 
not affected. However, further transition to F requires intact Y173 as electron donor which was 
inhibited by this mutation. Therefore, accumulation of PM was observed optically. At the same 
time Y288 radical is trapped and detected by EPR.  
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Chapter 6 : CHARACTERIZATION OF PM AND F RADICAL IN BO3 
TYPE QUINOL OXIDASE WITH SITE SPECIFIC INCORPORATION 
OF 3-AMINO-L-TYROSINE 
6.1     Introduction 
6.1.1     Amber Codon Suppressor and 3-Amino-L-Tyrosine Expression System 
With the rare exceptions of selenocysteine and pyrrolysine, nature encodes only 20 
amino acids as building blocks. Chemosynthetic and biosynthetic strategies have been 
developed to incorporate unnatural amino acids into proteins. These strategies are either 
limited to simple peptides/small proteins as that in chemical solid-phase peptide synthesis [234] 
or modification only close to N/C terminus as that in semisynthesis mediated by interin [235]. In 
vitro biosynthetic methods were later developed creatively using nonsense (triplet codon) or 
frameshift (quadruplet codon) suppressor tRNAs that are chemically mis-acylated with 
unnatural amino acids [236]. However, this cell-free translation system gave rise to low protein 
yield and the generation of aminoacyl-tRNA is relatively complex. Even through microinjection 
of chemically synthesized aminoacyl-tRNA into host strain [237], yield was still a concern since 
the tRNA can’t be re-acylated in vivo. At the meanwhile, development of in vivo biosynthetic 
methods like relaxation of aminoacyl-tRNA synthetase specificity [238] and attenuation of 
synthetase proofreading accuracy [239] was also carried out. Nonetheless, specificity or 
accuracy could not meet the requirement of downstream experiment in a lot of cases. Recently, 
the methodology developed in Dr. Shultz lab takes one step further from the in vitro nonsense 
suppressor tRNA technique which allows easy site specific incorporation of a large collection of 
synthetic amino acids with high yield and fidelity in vivo [240]. In this methodology, an archaea 
tRNA is engineered to be charged in host E. coli strain with only the desired synthetic amino acid 
and delivers the amino acid to an amber stop codon to achieve site specific incorporation. The 
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acylation of the synthetic amino acids to the tRNA takes place with high fidelity in an engineered 
aminoacyl-tRNA synthetase in a recyclable manner, which avoids both the complexity of 
chemical acylation and re-acylation issue, leading to high yield of protein expression.  
The engineering procedure starts with design of a unique tRNA. Two requirements must 
be met: 1) that it should not be recognized by any endogenous aminoacyl-tRNA synthetase, 2) 
and that it functions efficiently during translation (an orthogonal tRNA). In the widely used E. 
coli host strain, amber nonsense codon (UAG) is chosen to specify the unnatural amino acids 
since it is the least used stop codon. Amber codon was also routinely used by chemically 
aminoacylated suppressor tRNA to incorporate synthetic amino acids in vitro [241]. However, 
some E. coli strains contain natural amber suppressor tRNAs that efficiently incorporate 
common amino acids without significantly affecting growth rates [242].  
 
Figure 6.1. a. Comparison of tRNATyr in three different strains. b. Negative/positive selection 
protocol for orthogonal M.j. tRNATyr. c. 11 base (in N) sites for randomizing mutation 
engineering.Note: GUA anticodon has already changed into CUA for Amber codon recognition. d. 
One candidate tRNATyr with changes highlighted in red [240]. 
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Existing E. coli glutaminyl tRNA was originally used to design this orthogonal tRNA-codon 
pair, but the corresponding glutaminyl-tRNA synthetase could not be engineered for selective 
recognition of new suppressor tRNA rather than the WT tRNA. This lead to mis-charging of WT 
tRNA with unnatural amino acid and thus mis-incorporation of the unnatural amino acid at 
glutamine sites [243]. Attention was then drawn to archaea as a new source of orthogonal 
tRNA/synthetase pairs to use in E. coli with three advantages: 1). Efficient expression in their 
native forms in E. coli. 2) Acceptor stem participates only weakly in identity determination by 
tRNA synthetase [244].  3) Minimalist anticodon loop binding domain size. The latter two (Figure 
6.1.a) make it possible to change the anticodon loop of archaea’s cognate tRNA to CUA with 
little loss in affinity to synthetase [245]. M. jannascbii tyrosyl tRNA was chosen to build a 
starting library in plasmid 1 for random mutation at 11 base sites [240] as shown in Figure 6.1.c. 
Negative selection screens for survivors encoding non-functional or        
   
 that won’t be 
charged with endogenous natural amino acids (orthogonal, as in Figure 6.1.b.). The following 
positive screening of negative selection survivors excludes the nonfunctional ones and leave 
only orthogonal        
   
s by selecting candidates that can be acylated by M. Jannashcii tyrosyl 
aminoacyl tRNATyr synthetase and thus suppresses amber codon for Amp resistance (example in 
Figure 6.1.d). The candidates are stored in a second plasmid library. 
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Figure 6.2. Left: positive and negative screening protocol for orthogonal M.j. TyrRS. Right: 
Example of binding pocket analysis and residues selected for randomizing mutation [240]. 
The next thing to do is engineering of orthogonal M. Jannashcii tyrosyl aminoacyl 
tRNATyr synthetase that recognizes only the above candidate         
   
 and charges it with only 
the desired synthetic amino acid. Five or six residues in the amino acid binding pocket are 
chosen by analysis of key binding features and subject to randomizing mutations. Similar 
screenings are carried out. Positive screening with presence of the desired synthetic amino acid 
guarantees survivor tyrRSs capable of charging the cognate tRNA with natural/synthetic amino 
acid. Undesired ones charging natural amino acids can be excluded in the following negative 
screening. Several rounds of selections are carried out to ensure high fidelity in synthetic amino 
acid charging and low background (natural aa) charging (Figure 6.2.). 
In this thesis, 3-amino-L-tyrosine (YNH2) is used to study the mechanism of radical 
intermediates in cytochrome bo3. The plasmid encoding        
    and aaRSYNH2 was originally 
developed and optimized in Dr. Schultz’s lab at Scripps and kindly provided by Stubbe’s lab in 
MIT. The plasmid is named pEVOL-YNH2 with mid to low copy-number p15A origin (Figure 6.3). 
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Further optimization in tRNA sequence, copy number of tRNA/ aaRS and inducible promoters 
affords higher yields of mutant protein [246]. 
 
        
Figure 6.3. DNA constructs and tRNA sequences in pEVOL plasmid [246]. 
6.1.2     3-Amino-L-Tyrosine for Radical Trapping in E. coli RNR 
 Radical participation is a common strategy adopted by various biochemical processes 
[247]. One example other than HCO is ribonucleotide reductase (RNR) which catalyzes the 
conversion of nucleotide to 2’-deoxynucleotides, the precursors for DNA biosynthesis and repair 
[248, 249]. The class I RNR found in organisms like E. coli consists of two subunits. α2 contains 
the active site where a transiently formed thiyl radical (C439•) mediated nucleotide reduction 
occurs [250], while ß2 houses the stable diferric tyrosyl radical (Y122•) [251] which acts as the 
radical source for  C439• in catalysis. X-ray structures for both subunits have been solved [252, 
253] but their relative orientation as a functional complex still remains elusive so far. Site-
directed mutagenesis [254] and complementation studies [255] have come up with a proposed 
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radical propagation pathway as shown in Figure 6.4. However, the absence of activity in these 
mutants precludes possibility of mechanistic investigation [256]. Expressed protein ligation 
methods have successfully incorporated 3,4-dihydorxylphenylalanine (DOPA) [257], a radical 
trap, at Y356. Detection of DOPA• in a kinetically competent fashion demonstrate Y356 is redox-
active. However, similar ligation strategy is not feasible for Y730/Y731 given their location in the 
α2 subunit. 
  
Figure 6.4. Left: Proposed radical propagation pathway in class I RNR from E. coli. Right: YNH2 
and neutral YNH2 radical with reduction potential at 640mV [258]. 
YNH2 was therefore genetically incorporated into the two sites using the technique 
introduced in 6.1.1.   
  of YNH2 is 190mV lower than that of Y, indicating that it might act as a 
radical trap similar to DOPA. Both stopped-flow and CW-EPR detected the formation of YNH2• 
(Figure 6.5, red trace) suggesting participation of Y730/Y731 in radical propagation pathway 
[258]. The identity of the radical was further validated via isotopic labeling experiment with EPR 
spectroscopy of different frequencies to resolve g factor anisotropy and contribution from ß-
methylene hydrogen and amino group nitrogen [259].  
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Figure 6.5. Left: EPR signal from reaction of Y730YNH2-α2/ATP with ß2/CDP (black). Subtraction 
of unreacted portion of Y122• (blue) gives rise to the Y730YNH2•(red) [258]. Right: The same 
reaction with isotope effect collapsing the signal [259].  
In this chapter of study, YNH2 was site specifically incorporated for the first time into 
cytochrome bo3 to trap the radical formed in the ferryl-oxo intermediates.  
6.2     Materials and Methods 
6.2.1     Materials 
Oligonucleotide primers were synthesized by Integrated DNA Technologies (IDT, 
Coralville, IA). QuickChange Kits are from Stratagene (Agilent Technologies, Santa Clara, CA). The 
pET-17b plasmid (Ampr) used as template for mutagenesis and 1kb DNA standard for DNA 
agarose gel were purchased from EMD Biosciences (San Diego, CA) and Invitrogen (Life 
Technologies, Grand Island, NY) respectively. pEVOL-YNH2 plasmid for expression of 3-amino-L-
tyrosine (YNH2) incorporated bo3 was kindly offered by Dr. Stubbe from Massachusetts Institute 
of Technology. Restriction enzyemes were purchased from New England BioLabs (Ipswich, MA). 
Miniprep Kit was purchased from Fermentas (Thermo Scientific, Glen Burnie, MD). N-dodecyl-ß-
D-maltoside (DDM) and Triton X-100 were purchased from Anatrace (Maumee, OH). 3-amino-L-
tyrosine•2HCl, isopropyl-β-D-thiogalactopyranoside (IPTG), arabinose, ampicillin, 
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chloramphenicol, kanamycin  and other chemicals used in M63 medium, cell culture and 
purification buffers were from Sigma-Aldrich (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) 
unless otherwise noted. Filter paper/kits were purchased from Millipore (Billerica, MA). Ni-NTA 
resin for purification was purchased from Qiagen (Valencia, CA). TSK-GEL DEAE-5PW resin for 
anion exchange column was purchased from Tosoh (King of Prussia, PA). Slide-A-Lyzer dialysis 
cassette was obtained from Pierce (Thermo Scientific, Glen Burnie, MD). GeneMate Express 6%-
18% gradient PAGE gels were purchased from ISC BioExpress (Kaysville, UT). E. coli X10 Gold 
strain used for cloning of sited-directed mutagenesis PCR products was purchased from 
Stratagene (Agilent Technologies, Santa Clara, CA). E. coli C43, CLY and ML14 strain for WT, 
mutants and d4-tyrosine labeled mutant bo3 expression were obtained from Dr. Lin at University 
of Illinois at Urbana Champaign. Microfluidizer for cell lysing was manufactured by Watts 
Fluidair, Inc. Beckman ultracentrifuge L-8M was manufactured by Beckman Coulter, Inc 
(Indianapolis, IN) and Sorvall RC-5B+ centrifuge systems were manufactured by DuPont 
(Wilmington, DE). Biosequential SX-17MV stopped-flow spectrometer used for intermediates 
transition was obtained from Applied Photophysics (Leatherhead, UK). EPR spectra were 
collected at X-band using a Varian E-122 spectrometer together with an Air Products 
helium cryostat. 
6.2.2     Expression and Purification of  Y173YNH2 and Y288YNH2 bo3 Proteins 
WT bo3 was expressed with C43(DE3) strain which encodes cyoABCED genes in the 
chromosome. Site specific 3-amino-L-tyrosine incorporated bo3 proteins were expressed with E. 
coli CLY host strain which knocked out cyoABCED genes (recombination with Km resistance 
cassette) in the chromosome. Each of the above host strains was transformed first with the pET-
17b vector (Ampr), where the cyo operon insertion encodes cytochrome bo3 with a poly-His tag 
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at the C terminus of subunit II was placed under the control of a T7 promoter. In the case of 
YNH2 bo3 protein expression, desired site for YNH2 incorporation was made into an amber stop 
condon (TAG) at the corresponding site within cyoABCED of pET-17b plasmid. Transformation of 
pEVOL-YNH2 plasmid was followed after pET plasmid. pEVOL-YNH2 plasmid carries Cm 
resistance, orthogonal tRNA and two copies of YNH2 tRNA synthetase under control of 
arabinose promoter, which enable the CLY strain to suppress the amber stop codon in cyoABCED 
with YNH2. Addition of arabinose initiated the expression of YNH2-tRNA synthetase. Later on 
addition of IPTG drove the transcription of the cyoABCDE gene from the pET-17b plasmid and 
incorporated YNH2 at designed sites.  
Each bacterial culture was inoculated in 5 mL LB with corresponding antibiotics 
overnight (12-16 hrs) at 37 ⁰C from glycerol stocks and enlarged into 20-40 mL modified M63 
minimal medium (specified below) at 37 ⁰C for every 1L culture grown later for protein 
expression. After 12 hours, 20-30 mL saturated inoculums was introduce into every 1L of 
modified M63 minimal medium consisting of 7 g/L K2HPO4, 3 g/L KH2PO4, 2 g/L NH4Cl, 2 g/L 
glucose, 10 mg/L thiamine, 10 µM CuSO4, 30 µM FeSO4 and 1 mM MgSO4. 3-amino-L-tyrosine 
was added to M63 medium for E. coli CLY strains at 1 mM together with 0.1 mM DTT at no early 
than OD600=0.5 to prevent oxidation of YNH2 [258]. Each 2L baffled flask contained only 1 L 
culture medium to ensure aerobic growth condition. The temperature was maintained at 37 °C, 
and the flasks were shaken at 200 rpm throughout the entire growth. When the density of the 
culture reached an OD600 of 0.55-0.6, freshly prepared 1mM YNH2 and 0.1 mM DTT together 
with 0.1% arabinose were added to the culture. Resumed shaking for an additional 15 min untill 
OD600 fell between 0.6 and 0.7 and the expression of cytochrome bo3 was induced with 1 mM 
IPTG. The culture was shaken for an additional 4 hours but no longer than 4 hours to prevent 
144 
 
expression of inactive cytochrome oo3. The cells were then pelleted by centrifugation at 16,000 
x g.  
All the subsequent steps were carried out at 4 °C and pH 8.0. The harvested cells were 
resuspended in 50 mM KPi buffer with ~ 20 mM MgSO4 and ~ 10-20 mg/L deoxyribonuclease I, 
and broken five to eight times through a Microfluidizer high pressure fluids processor at 10,000 
psi. The cell debris was removed by centrifugation at 16,000 x g for 20 min. The membranes 
were then pelleted from the supernatant by centrifugation at 180,000 x g for 4 h, and 
solubilized in 50 mM KPi buffer with 1% n-dodecyl β-D-maltoside (DDM) at 4 °C for 2 to 4 hours. 
After the unsolubilized particles were removed by centrifugation at 180,000 x g for 1 h, 5 mM 
imidazole was added to the supernatant which was then loaded onto 5–10 mL Ni-NTA resin. The 
loaded Ni-NTA resin (loading capacity: 4 mg max for WT and 3 mg max for mutants) was washed 
with 5 column volumes of 10 mM imidazole, 50 mM KPi, 0.05 % DDM at pH 8, followed by 5 
column volumes of 15 mM imidazole, 50 mM KPi, 0.05% DDM. The polyhis-tagged cytochrome 
bo3 was eluted with 100 mM imidazole, 50 mM KPi, 0.05% DDM. Imidazole was removed from 
each purified cytochrome bo3 sample by buffer exchange with 50 mM KPi, 0. 05% DDM, 10 mM 
EDTA, 5% glycerol at pH 8.3, using an Amicon Ultra 15 concentrator with a 100,000 molecular 
weight cutoff. The concentration of cytochrome bo3 was determined using an extinction 
coefficient of 188 mM-1cm-1 for the peak of the Soret band (~409 nm) or 24 mM-1cm-1 for the 
absorption difference between 560 nm and 580 nm in the reduced-minus-oxidized spectrum. 
The concentrated protein sample was flash-frozen in liquid nitrogen and stored at – 80 °C before 
use. 
In some cases, second purification through DEAE anion exchange column was required 
for assays like LC/MS/MS or ICP-OES. Buffer consisted of 20 mM Tris, 0.05 mM EDTA, 5% 
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glycerol, 0.05% DDM at pH 8.5. Buffer A contained no salt while buffer B contained 1 M NaCl. 
Bo3 protein started to elute between 80 mM and 130 mM NaCl.  
6.2.3     UV-Vis and SDS-PAGE 
Shimadzu UV/Vis-2101PC spectrophotometer was used to obtain the spectra of wild-
type and mutant enzymes. The concentrated protein samples were diluted with 10-20mM Tris 
buffer containing 0.05% DDM at pH 7.5-8.0. The samples were oxidized by air and reduced with 
a few grains of sodium dithionite. The concentration of cytochrome bo3 was determined using 
an extinction coefficient of 188 mM-1cm-1 for the peak at~409 nm of oxidized form or 24 mM-
1cm-1 for the absorption difference between 560nm and 580nm in the reduced-minus-oxidized 
spectrum [226].  
[bo3] /μM = 1000*[A560nm(red-ox)-A580nm(red-ox)]/24 
or 
[bo3] / μM= = 1000*A409nm(ox)/188 
GeneMate Express 8%-16% gradient SDS PAGE gels from ISC BioExpress with 
Tris/Hepes/SDS buffer system or the home made 15% SDS/2.5 M urea gel with Tris/Glycine/SDS 
buffer system were used to separate the purified protein complexes. Gels were subject to 
Coomassie Brilliant Blue R-250 staining for all subuints. 
6.2.4     Heme and Ubiquinone Quantification via HPLC 
The amount of ubiquinone (UQ8) in the purified cytochrome bo3 was determined by 
quinone extraction followed by reversed phase HPLC analysis as described in [260]. Exactly 3 
nmole of purified enzyme, together with 3 nmole of ubiquinone-10, was diluted in 50 mM 
K2HPO4, 0.05% DDM at pH 8.3 and extracted with 3 mL of 6:4 methanol : petroleum ether by 
vortexing vigorously for 1 min for 3 times.  The mixture was allowed to sit for 10 min for layer 
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separation. The upper ether layer was collected and the solvent was evaporated under nitrogen 
flush. The dried oily residue was re-dissolved in ethanol. The extracted ubiquinone was loaded 
onto and run through a reversed phase C18 HPLC column (Microsob-MV 100-5) monitored at 
278 nm on a Beckman System Gold HPLC system. Mobile phase consisted of ethanol : 
acetonitrile : H2O at 70 : 17  : 13 and flow rate was set at 0.5 mL/min.   Peak area was compared 
between UQ8 (shorter retention time) and UQ10 (longer retention time) for quantification of 
UQ8 based on UQ10 quantity.  
The ratio of heme b to heme o in the purified cytochrome bo3 was determined by heme 
extraction, followed by reversed phase HPLC analysis as described in [260]. 500 μL of fresh cold 
acid acetone (9:1:1 acetone:HCl:H2O) was added to ~10 nmole of purified enzyme and the 
mixture was vortexed vigorously, followed by centrifuging at 13,000 rpm for 2 min at 4 ⁰C.  The 
supernatant was transferred and extracted with 600 μL of diethylether once. Upper organic 
layer was washed with 600 μL H2O and then evaporated under nitrogen flush. The red residue 
containing the hemes were re-suspended in an mixture of ethanol : acetic acid : H2O at 70:17:13, 
load onto and run through a reversed phase C18 HPLC column (Microsob-MV 100-5) monitored 
at 402 nm on a Beckman System Gold HPLC system. Mobile phase consisted of ethanol : acetic 
acid : H2O at 70 : 17  : 7 and flow rate was set at 0.5 mL/min. The ratio of hemes was quantified 
from the peak area heme b (shorter retention time) with respect to that of heme o (longer 
retention time). 
6.2.5     Nanocapillary LC-MS/MS to Investigate YNH2 Incorporation in Y288YNH2 
1 M ammonium bicarbonate was added into the purified proteins in storage buffer to 
make the final concentration of ammonium bicarbonate 100 mM. 0.2 μg freshly prepared 
trypsin (0.1 μg/μL in 100 mM ammonium bicarbonate, pH 7.8, Promega, Madison, WI) was 
147 
 
added at a substrate-to-enzyme ratio of about 50:1. After overnight incubation at 37 ˚C (or 
chymotrypsin in 100 mM Tris-HCl, 10 mM CaCl2, pH 8.0 at the same substrate-to-enzyme ratio), 
digested samples were loaded onto an Eksigent 2D nano-LC system (Eksigent, Dublin, CA, USA). 
A C18 trap column (New Objective, Inc., Woburn, MA, USA), 150 μm i.d. with 3 cm media length, 
was used for sample loading, followed by a 10-cm 75-μm i.d. C18 analytical column for sample 
separation. A linear gradient started from 95% buffer A (95% H2O, 5% acetonitrile, 0.2% formic 
acid) and 5% buffer B (5% H2O, 95% acetonitrile, 0.2% formic acid), ramped up to 40% buffer B 
in 50 minutes, and reached 95% buffer B in 10 minutes. Sampled eluted from the nano-LC was 
electrosprayed into an 11 Tesla LTQ-FT-Ultra mass spectrometer (Thermo Fisher Scientific, San 
Jose, CA, USA). A top three data-dependent method was used for mass spectrometry analysis. 
Briefly, MS1 was scanned in FT-ICR with a scan range of 350-1300 m/z and a target value of one 
million at resolving power 50,000; MS2 was also scanned in FT-ICR with a target value of half 
million at resolving power 25,000 after collision-induced dissociation with an isolation window 
of 10 m/z for precursor ions. Data was collected in .raw files and analyzed through ProSightPC 
2.0 SP1 (Thermo Fisher Scientific) as described before [261]. 
6.2.6     Resonance Ramen 
Resonance Raman spectra was measured by Dr. Egawa at Albert Einstein College of 
Medicine. The 413.1 nm excitation from a Kr ion laser (Spectra Physics, Mountain View, CA) was 
focused to a 30 μm spot on the spinning quartz cell rotating at 6000 rpm. The scattered light, 
collected at right angles to the incident laser beam, was focused on the 100 μm wide entrance 
slit of a 1.25 m Spex spectrometer equipped with a 1200 grooves/mm grating (Horiba Jobin 
Yvon, Edison, NJ), where it was dispersed and then detected by a liquid nitrogen cooled CCD 
detector (Princeton Instruments, Trenton, NJ). A holographic notch filter (Kaiser, Ann Arbor, MI) 
was used to remove the laser line. The Raman shift was calibrated with indene. The laser power 
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was kept <25 μW for the CO complex to avoid photodissociation of the heme-bound CO. The 
spectral acquisition times for the νFe−CO and νC−O measurements were 20 hours. For other 
measurements, the laser power was kept <1 mW, and the spectral acquisition times were 2 
hours. The concentration for cytochrome bo3 was 30 μM. 
6.2.7     Steady State Enzymatic Activity 
The steady state oxygen reduction activity of cytochrome bo3 proteins was measured at 
25 ⁰C using an YSI model 53 oxygen electrode which was assembled with a temperature-
controlled 1.8mL electrode chamber. The reaction buffer contained 50 mM K2HPO4 and 0.1% 
DDM at pH 7.0. 2 mM dithiothreitol (DTT) and 200 μM ubiquinoe-1 (UQ1, ethanol stock) were 
added as mimic reductive substrate to transfer electron from DTT, via Q1, into cytochrome bo3. 
In the presence of O2 (aerobic), the reaction was initiated by injection of a few microliters of 
diluted enzyme. 
The turnover numbers of enzyme (number of electrons per second per enzyme) was 
calculated by the following equation from the slope of oxygen consumption corrected by 
subtraction of background baseline drift. Inhibition of KCN at 100 μM in some cased was applied 
to rule out the possibility of oxygen consumption by artifact rather than oxidase activity. 
Turnover = 17280 × Slopecorrected / ([bo3 (μM)]×Volenzyme (μL)) 
6.2.8     PM and F Production with H2O2 in Stopped-flow 
The reaction of pulsed cytochrome bo3 with H2O2 under pseudo first order conditions 
was monitored by Biosequential SX-17MV stopped-flow reaction analyser equipped with 
temperature-controlled sample loading syringes and a 1 cm path length cuvette at 25 ⁰C as 
described in [194]. The complete spectrum (300-1100 nm) was collected from within 1 s to 50 s 
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at a time resolution from 1 ms to 50 ms accordingly. In case of single wavelength detection, a 
side window photomutiplier was connected instead. Syringe A contained 10-16 μM pulsed bo3 
protein in CHES buffer (100 mM CHES, 0.05% DDM) at pH 9.0 while syringe B contained either 
plain CHES buffer or 10 mM freshly diluted H2O2 in the same CHES buffer from 30% stock 
(analytical grade, Fluka). H2O2 concentration was determined with extinction coefficient of 43.6 
M-1cm-1 at 240 nm. Efficient mixing typically started from the 3rd push and a single push 
consumed 250 μL liquid (total of A and B syringes). Background spectra was collected from 
mixing bo3 containing solution and plain CHES buffer load for 1 sec, while reactions was initiated 
upon mixing bo3 containing solution with H2O2 containing solution and monitored for 1-50 sec.  
The time-resolved spectra were analyzed globally at full time span and wavelengths 
from 450 nm to 700 nm simultaneously with Pro-Kinetics software from Applied Photophysics. 
Components were set to an O -> PM -> F transition mode. Background (oxidized form of bo3) was 
subtracted. 
6.2.9     Half Reactions of O2 Single Turnover in Stopped-flow  
The kinetics study of heme groups reduction and oxidation in O2 turn over were carried 
out as described in [188, 262] with the same stopped-flow equipment used above. 
To study the oxidation kinetics, flow path of stopped-flow apparatus was washed before 
sample loading with argon flushed MOPS buffer (100 mM MOPS, pH 7.0) to make it fully 
anaerobic. A solution containing 20 μM UQ-8 free bo3 and 60 μg/mL catalase in 100 mM Tris 
with 0.05% DDM at pH 7.0 [188] was loaded into a gastight syringe (A). The solution was argon 
flushed gently for at least 20 min to make it O2 free. About 200 μM fresh powder of dithionite 
was loaded into syringe A subsequently to fully reduce the enzyme. In another gastight syringe 
(B), 100 mM MOPS at pH 7.0 was added and either argon flushed to make it O2 free or O2 
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bubbled to make it saturated with O2 (1.2 mM) for background and turnover reaction 
measurements respectively. Upon mixing solution from A and B (O2 containing) syringes, the 
residual dithionite was rapidly eliminated by reaction with O2, and the fully reduced enzyme (R3) 
was subsequently oxidized by excess O2. Reference spectra were taken with A and B (O2 free) 
mixing for fully reduced enzyme and A (UQ-8 attached bo3, oxidized) and B (O2 containing) 
mixing for fully oxidized enzyme. 
To study the reduction kinetics, 8-10 μM bo3 with bound UQ8 (at OL site) in 100mM 
MOPS buffer with 0.05% DDM at pH 7.0 was loaded into a gastight syringe (A). To another 
gastight syringe (B) was added 200 μM UQ1 and 15 mM DTT. Both the solutions were argon 
flushed to make them O2 free for at least 20 min. Upon mixing of solutions from A and B, 
reduction of bo3 by DTT via UQ1 was recorded for 1 sec in the stopped-flow. Reference spectra 
were taken with A and B (plain O2 free buffer) mixing for oxidized enzyme and A and B (UQ1 and 
DTT) at >50s of reaction for the fully reduced enzyme. 
Data analysis was carried out with the same software as in 6.2.8. 
6.2.10   CW X-band EPR 
EPR spectra were collected with a Varian E-122 spectrometer X-band (9.5 GHz) at 55-85 
K with the equipped Air Products helium cryostat. Unless otherwise noted, a microwave power 
of 5 mW was used, with a combination of modulation amplitude at 5.0/2.0/1.0 gauss and gain 
level at 12500/6300. The magnetic field was calibrated with a Varian NMR Gaussmeter, and the 
microwave frequency was determined with and EIP frequency meter (San Jose, CA).  
Protein was made UQ8 free to prevent potential formation of semiquinone radical. In 
addition, the sample was dialyzed and pulsed as described in 5.2.6 and concentrated to ~ 200 μL 
at 200-600 μM in 100mM CHES, 10% glycerol, 0.05% DDM. Generation of radical containing 
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samples was achieved by adding the enzyme at pH 9.0 into a commercial Wilmad 707-SQ-250M 
EPR tube (Vineland, NJ) preloaded with 10 uL H2O2 at 100 mM. Thorough mixing by pulling the 
syringe septum up and down 3 times was necessary and bubbles were allowed to escape from 
the sample before hand-quenching the reaction in liquid nitrogen within a time scale of 30-45 
seconds. 10% glycerol is a minimum requirement for uniform glass formation to prevent tube 
cracking upon freezing in liquid nitrogen. In cases when longer reaction time was desired, the 
same sample was thawed, sitting in the room temperature for the additional time lapse and 
frozen again. Data were analyzed in Origin software and g values were calculated as follow. 
g = 714.484 × ν (Ghz) /B (gauss) 
Subtraction of enzyme signal free of H2O2 was applied to reveal only the radical signal. 
6.3     Results and Discussion 
Enlightened by the result in Chapter 5 indicating Y288 and Y173 as potential sites for the 
radical species, 3-amino-L-tyrosine was therefore site specifically incorporated at Y288 site in 
the hope to trap the radical before it would migrate to Y173. In addition, 3-amino-L-tyrosine was 
also incorporated at Y173 site as an internal reference. 
6.3.1     SDS-PAGE, UV-Vis and Steady State Turnover Activity 
Yields of YNH2 incorporated bo3 proteins were generally around 1 mg/L culture, which 
are ~20% to 25% of WT. SDS-PAGE displayed intact subunits assembly as WT (Figure 6.6). UV-Vis 
spectra were also similar between WT bo3 protein and YNH2 bo3 proteins and no peak shift was 
observed. However, the degree of reduction in YNH2 bo3 proteins was not as complete as that in 
WT. Steady state turnover was 60% in Y173YNH2 bo3 and 5% in Y288YNH2 bo3.  
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Figure 6.6. Left: Reduced and oxidized spectra for WT, Y173YNH2 and Y288YNH2 bo3. Right: SDS-
PAGE for WT, Y173YNH2 and Y288YNH2 bo3.  
In summary, both of the mutants have the same subunits and probably also the same 
heme prosthetic groups correctly assembled just like that in WT. YNH2 were highly likely get 
incorporated at the desired site or otherwise, peptide synthesis would be discontinued at the 
amber stop codons which lead to no recombinant protein assembly as no recombinant mutant 
proteins were obtained in control culture without addition of YNH2. Moreover, different 
turnover numbers also indicates the possibility of successful incorporation of YNH2 was high.  
6.3.2     Heme, Ubiquinone and ICP-OES 
Figure 6.7 summarized the results for heme and ubiquinone analysis by HPLC. UQ8 : 
UQ10 was 0.92 : 1 in WT, 0.97 : 1 in Y288YNH2 bo3 and 0.95 : 1 in Y173YNH2 bo3. Heme b : heme 
o ratio was 1 : 0.65 in WT, 1 : 0.86 in Y288YNH2 bo3 and 1: 0.89 in Y173YNH2 bo3. Reversed 
phase C18 column was used and thus molecules with lower polarity required longer retention 
time like UQ10 and heme o in each case. ICP-OES analysis detected only Fe and Cu in all bo3 
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protein samples and the ratio of Cu/Fe was 0.55 0.02 : 1. In summary, both of the mutants 
share the same redox cofactors constitution as WT protein.  
 
Figure 6.7. Quinone analysis by HPLC for WT bo3 (upper left) and Y288YNH2 bo3 (lower left) and 
heme analysis by HPLC for WT bo3 (upper right) and Y288YNH2 bo3 (lower right). Data for 
Y173YNH2 were not shown. 
6.3.3     LC-MS/MS for Y288YNH2 bo3 
Trypsin digested Y288YNH2 bo3 sample was run through C18 reversed phased column, 
and peptides with retention time over 30 min electrosprayed onto MS1 were analyzed. 
m/z=1052.56(z=+2) peptide was fragmentized in MS2. m/z=920.99(z=+2) fragment peptide was 
identified as the sequence containing cross-linked tyrosine (Figure 6.8, 
YLGTHFFTNDMGGNMMMYINLIWAWGHPEVYILILPVFGVFSEIAATFSR). Noted that Y288YNH2 
mutant side chain was able to carry an additional positive charge other than the C terminal Arg, 
which is coherent with the observation that this fragment peptide is a +2 cation. A mass 
modification on the peptide of +49.98 over theoretical peptide value was calculated. Due to the 
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lack of WT fragment library data, it could be only concluded so far that chemical modification 
was done on the peptide harboring the cross-linked Y288. However, clear assignments of 
whether the cross-link is formed and what exactly the modification is, require reference data 
from WT fragmentation pattern. Y173YNH2 data is not available at this point. 
6.3.4     Resonance Ramen for WT and Y288YNH2 bo3 
For the oxidized state, the 6chs heme o in the WT protein became a 5chs form in 
Y288YNH2 (3, 1493 cm
-1), indicating that the 6th ligation by a water molecule was destabilized 
upon the mutation (Figure 6.9, upper).  The 4 frequency was also shifted to 1362 cm
-1. Although 
this new frequency is close to the 4 of reduced form, it is unlikely that the reduced form was 
formed by the laser light during the measurement, since lower laser power caused no changes. 
On the other hand, Raman band frequencies from heme b were essentially unchanged. The 
reduced spectrum of Y288YNH2 was similar to that of WT. However, the 3 frequency of 
reduced heme o slightly down-shifted (from 1473 to 1470), while 2 of heme o (1575 cm
-1) 
became very weak in the mutant (Figure 6.9, lower).The iron-histidine stretching mode of 
Y288YNH2 was too weak to be identified (Figure 6.9, lower insert). 
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Figure 6.8. Identification of peptide fragment containing cross-linked Y288 from Y288YNH2 bo3 
sample.  
In the reduced-CO state, the 4 RR band of porphyrin was clearly split into two (1362 
and 1371 cm-1) in Y288YNH2, and small changes also occurred in other band frequencies (Figure 
6.10, upper). This is not likely to be due to an enhanced photo-dissociation of the CO ligand, 
since lower laser power caused only minor changes. The mutant showed the major Fe-CO band 
at 495 cm-1 with minor component at ~516 cm-1 (Figure 6.10, lower left).  Both bands were 
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significantly broad as compared to the Fe-CO of WT at 521 cm
-1.  The δFe-C-O RR band of Y288YNH2 
was very weak. The C-O RR band in the mutant was very broad and up-shifted as compared to 
that in the WT protein (Figure 6.10, lower right). 
To sum up, low spin heme b was not affected by Y288YNH2 mutation. On the other 
hand, high spin heme o was perturbed by this mutation in the way it binds substrate O2. In 
general the binding is weaker than that in WT. This provided a possible explanation for the 5% 
activity detected in Y288YNH2 bo3.  
 
 
Figure 6.9. Resonance Raman spectra for oxidized (upper) and reduced (lower) WT and 
Y288YNH2 bo3.  
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Figure 6.10. Resonance Raman spectra for reduced-CO WT bo3 and Y288YNH2 bo3 in terms of 
porphyrine mode (upper), Fe-CO stretching / Fe-C-O bending mode (lower left) and C-O 
stretching mode (lower right, 12C16O-13C18O difference spectra) .  
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6.3.5     Oxidative and Reductive Half Reactions in O2 Turnover 
It was already displayed in the steady state turn over that Y288YNH2 retained only 5% 
WT activity. In addition, resonance Raman spectra revealed weaker substrate (O2) interaction 
with heme o in the mutant. In order to determine which step(s) in the O2 turn over reaction is 
slowed down and whether the mutant went through the same intermediate transition like WT, 
O2 single turn over reactions were examined for both oxidative phase and reductive phase in 
stopped-flow spectrometer.  
In the oxidative kinetics experiment, reduced enzymes were allowed to react with 
dioxygen for 5 s in the case of WT and 50s for Y288YNH2. In both cases, absorption data from 
300 to 700 nm were collected for analysis. Theoretically, for UQ8 free WT bo3, the enzyme was 
supposed to transit as R3 P  F, which took place at millisecond scale. However, the final 
product F relaxed to O over a period of several seconds as described in [188]. Given the physical 
limit of time resolution at 1 ms, reaction occurs within 1 ms is virtually invisible. In other words, 
transiently formed P and F would be hard to capture in the experiment. However, the UQ8 free 
WT bo3 started off from R3 state and stopped at F theoretically, followed by a slowed down 
FO transition at second scale. This provides the possibility to detect late phase of fast 
transition from R via P to F.  This assumption is consistent with the kinetic model tested in global 
fitting. No stable iteration result could be obtained with tri-phase (R3PFO )global fitting, 
while single phase ( FO ) global fitting returned unacceptable large variance. Bi-phase global 
fitting displayed minimal variance with stable iteration number (2), which corresponded to an 
R3FO transition. The fitting result for kinetic components-minus-oxidized WT enzyme 
difference spectra was shown in Figure 6.11. The initial component composition was estimated 
as 0.05 for R, 0.95 for F and 0 for O. As a result, k1 / k2 at 18.69 s
-1 / 0.5833 s-1 were obtained 
respectively. The initial component constitutions were verified by calculation of Soret peak 
159 
 
decrement at 426 nm, which marked the decay of R3 and concomitant development of fully 
oxidized enzyme (O) via intermediates (P and F). (A426nm-AF-426nm)/(AR-426nm – AF-426nm)×100% was 
used to calculate how much R3  remained which hadn’t decayed into F. AR-426nm was obtained 
from reduced enzyme spectrum as 0.601. AF-426nm was obtained from the fitted spectrum as 
0.370. A426nm (0.385) was read from the first spectrum recorded in this experiment. From the 
calculation, 94% R already decayed into F within the dead time of 5 ms. 
    
    
Figure 6.11. Global fitting results for UQ8 free WT bo3 enzyme upon reaction with O2. 5 seconds 
was recorded. First component in red (upper right) had mostly R feature while the second 
component in green (lower left) was purely F. WT R-O difference spectra (upper left) was shown 
as a reference. Concentration profile was shown in the lower right quarter.  
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Y288YNH2 sample was analyzed in a similar way as described for WT. 50s was optimized 
to include all possible transitions at a reasonable time resolution where no component was 
made invisible. Different transition models were tested. The most stable solution came from bi-
phase transition as well. Initial component composition was set to be 0.8 R, 0.2 I and 0 O and 
was later corrected to be 0.7 R, 0.2 I and 0 O based on similar calculation. k1 and k2 at 1.05 s
-1 
and 0.0698 s-1 were obtained respectively. Results were shown in Figure 6.12.  
     
       
Figure 6.12. Global fitting results for UQ8 free Y288YNH2 bo3 enzyme upon reaction with O2. 50 
seconds was recorded. Both the first component in red (upper right) the second component in 
green (lower left) shared optical features with R mostly. WT R-O difference spectra (upper left) 
was shown as a reference and components were also shown in component-minus-O difference 
spectra. Concentration profile was shown in the lower right quarter.  
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In contrast to WT, the unidentified pseudo intermediate I did not share the optical 
feature with F but R instead. Neither the 624 nm trough for charge transfer band nor the 
additional absorption at ~530 nm / 582 nm for ferryl-oxo intermediates was present, which 
indicating Y288YNH2 bo3 was not capable of converting O2 through WT-like ferryl-oxo 
intermediates. The observation is compatible with greatly impaired enzymatic activity. Oxidation 
phase overall rate for Y288YNH2 mutant was only 5.6% of WT. It’s also coherent with resonance 
Raman data that the active site was perturbed for regular binding of O2.  
For the reductive phase, only single wavelength change within 1.2 second at 426 nm 
was monitored for reduction of both heme b and heme o, similar to the study in aa3 [262]. WT 
and Y288YNH2 demonstrated comparable dead time and recorded reduced enzyme distribution. 
WT had 53% reduction done before recording and 22% additional reduction done in 1.2s of 
recording phase while Y288YNH2 had 42% and 20% for these two respectively. Biphasic 
exponential fitting yielded k1=44.8/k2=1.04 for WT and k1=14.3/k2=0.88 for the mutant (Figure 
6.13). In summary, Y288YNH2 was only 3 folds slower in the reductive phase than WT, which did 
not determine the 5% enzymatic activity in Y288YNH2. Clearly, the rate-limiting step is in the 
oxidative phase ( R F ) since it is difficult for Y288YNH2 to generate ferryl-oxo intermediates.  
 
Figure 6.13. Reductive phase double exponential fitting for WT (left) and Y288YNH2 bo3.Fitting 
curves were red for WT and green for Y288YNH2.  
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6.3.6     O-PM-F Transitions in H2O2 Reaction 
In contrast to the rapid O2 single turn over reaction, intermediates transition in H2O2 
turnover occurs at a time scale of 10 ms to 10 s, which were at least 1000 folds higher. This 
makes it feasible to capture and optically characterize P intermediate which is invisible in the O2 
turnover at the resolution of stopped-flow apparatus.  
The reaction of H2O2 with both Y288YNH2 and Y173YNH2 bo3 were monitored for 20 
seconds in stopped-flow spectrometer. For global fitting analysis, kinetic model was also set as 
O X1 X2. Similar to the WT, only bi-phase fittings returned robust solutions within 3 
iterations. The tentative assignment of initial components composition was O=1.0, X1=0 and 
X2=0 for both of the mutants, which was later on verified by the observation that no transition 
occurred from O within dead time for both mutants.  
As a result, k1=3.6 and k2=0.13 were obtained for transitions from OX1 and X1X2 for 
Y173YNH2, which were 82% and 37% of those in WT (k1=4.4 and k2=0.35). In addition, the 
optical features (Figure 6.14) of X1 and X2 corresponded to P and F respectively, which was 
different from Y173F mutant where only P was formed and no decay from P to F was detected.  
Fitting results for Y288YNH2 showed k1=4.2 and k2=0.08 which were 95% and 23% of 
those in WT respectively. However, the optical features were not easy to identify (Figure 6.14). 
For X1, the 624 nm trough red shifted 6 nm to 630 nm while both the 557 nm peak and 582 nm 
shoulder blue shifted 7 nm to 550nm and 575nm accordingly. So far, X1 was tentatively assigned 
as P like intermediate. For X2, additional increment of absorption at ~523 nm and 550 nm were 
present, together with the trough at 630 nm.  However, the shoulder now at 575 nm didn’t 
decay. In conclusion, X2 probably shared more P like feature rather than F. In other words, 
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Y288YNH2 was likely to form a ferryl-oxo bond between H2O2 and heme o, but it either got stuck 
in P like intermediate or in the early stage of transition from P to F.  
 
   
 
Figure 6.14. Component-minius-O difference spectra from global fitting of 20s reaction between 
5 mM H2O2 and 5-8 μM WT (upper), Y173YNH2 (middle) and Y288YNH2 (lower).  
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To demonstrate the transitions with optical absorption change detected in Y288YNH2 
was associated with binuclear center, similar KCN inhibition control experiment like that in 5.3.2 
was carried out and the data (Figure 6.15) indicated that there were transitions occurring  in 
Y288YNH2 and it required participation of binuclear center.  
 
Figure 6.15. Kinetic component-minus-O spectra from bi-phase linear transition global fitting 
results for H2O2 reacting with KCN incubated 5 μM Y288NH2 bo3 for 20 s. 
6.3.7     CW X-band EPR 
H2O2 reaction with both Y288YNH2 and Y173YNH2 mutants were subjected to EPR 
characterization. Conditions were the same for WT and other mutants. Full field scan (Figure 
6.16) revealed that the high spin heme o3 feature at g⊥=6.0 were low after treatment of H2O2, 
indicating heme o3 was in a low spin state in both mutants.  However, Y288YNH2 displayed more 
residual high spin feature than Y173YNH2. A strong radical signal showed up at g=2.0 with ~ 3 
times higher the intensity of that from WT after normalization based on enzyme concentration. 
Well resolved seven-line hyperfine structure in the g⊥=2.06 with a separation of ~15 G from 
nitrogen was also detected. This was attributed to couplings from three nitrogen atoms 
coordinated to CuB as that found in aa3 oxidase [230]. The loss of high spin (S=5/2) signal and 
appearance of CuB signal together with its nitrogen ligand coupling indicated the break of anti-
ferromagnetic coupling between heme o3 and    
   [231] since heme o3 was turned into low 
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spin. However, the free radical formation didn’t seem to require participation of binuclear 
center as KCN incubated cytochrome bo3 failed to inhibit the same signal.  
 
 
Figure 6.16. Full field scan EPR spectra for Y288YNH2 (black) and Y173YNH2 (red) bo3 upon 
reacting with H2O2.  
Difference spectra were plotted to reveal the structure of free radical as shown in Figure 
6.17. Both Y288YNH2 and Y173YNH2 radicals were different from that of WT bo3. For Y173YNH2, 
the 45G line width wing feature disappeared and a single peak without any hyperfine structure 
was displayed instead. In the case of Y288YNH2, unresolved hyperfine structure was present. To 
further investigate whether these radicals were YNH2 origin, D2O exchange experiments were 
carried out. Hydrogens  from amino group of YNH2 would in principle exchange with D2O and 
decrease the amino group hydrogen contribution on the hyperfine structure as those describe in 
Y127YNH2 RNR from E. coli [259]. However, no detectable change was observed on either 
Y173YNH2 or Y288YNH2 like that on WT. Further characterization with higher frequency 
continuous wave EPR to reveal anisotropic g values or pulsed EPR to reveal N splitting are 
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currently carried out. In the meanwhile, possibility of YNH2 being oxidized to YNO2 by O2 and 
H2O2 turnover reactions should also been examined.  
 
Figure 6.17. EPR difference spectra comparison of H2O2 generated free radical with WT (black), 
Y173YNH2 (red) and Y288YNH2 (blue). 
 
Figure 6.18. EPR spectra comparison of of H2O2 generated free radical with WT (black) in H2O v.s. 
WT (red), Y173YNH2 (cyan) and Y288YNH2 (blue) in D2O.  
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